<SEC-DOCUMENT>0000950170-23-022264.txt : 20230515
<SEC-HEADER>0000950170-23-022264.hdr.sgml : 20230515
<ACCEPTANCE-DATETIME>20230515164425
ACCESSION NUMBER:		0000950170-23-022264
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20230515
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230515
DATE AS OF CHANGE:		20230515

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Terns Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001831363
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39926
		FILM NUMBER:		23923547

	BUSINESS ADDRESS:	
		STREET 1:		1065 EAST HILLSDALE BLVD., SUITE 100
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		650-525-5535 EXT.101

	MAIL ADDRESS:	
		STREET 1:		1065 EAST HILLSDALE BLVD., SUITE 100
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tern-20230515.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2023-05-15T13:31:59.9724+00:00 --><!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:tern="http://www.ternspharma.com/20230515" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_f56cf9f4-58fb-4c89-af41-1770cbae2738" name="dei:EntityCentralIndexKey" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652">0001831363</ix:nonNumeric><ix:nonNumeric id="F_d86f097c-e11b-4c57-b73e-49c2206583a1" name="dei:AmendmentFlag" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="tern-20230515.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001831363</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <p style="border-top:2.25pt double rgba(0,0,0,1);text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UNITED STATES<br />SECURITIES AND EXCHANGE COMMISSION<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FORM </span><span style="font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_02003622-2c09-43ae-a277-bd0069ec1c63" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.02986111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8ec5f9ce-20f9-4d6d-ba04-e63210e11ca1" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 15, 2023</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:5.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:24.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_047373b3-d5e3-4037-aa0b-81dd1a3b6d25" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:24.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Terns Pharmaceuticals, Inc.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:20.0%;"></td>
    <td style="width:18.0%;"></td>
    <td style="width:41.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fd9a4bbe-9ceb-482d-be2f-390eb8ee9cae" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_965f27e4-ba36-4028-b6b9-26c26b36f30d" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">001-39926</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_92c751e0-4fab-45e1-a6cd-e2d52b1cb75f" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98-1448275</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(State or Other Jurisdiction<br />of Incorporation)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(IRS Employer<br />Identification No.)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1b1fbd51-1800-42c4-8524-db249acda9ed" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1065 East Hillsdale Blvd.</span></ix:nonNumeric></span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a1fe2e0a-48c4-4fa3-8659-1dcf2433fb4a" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:EntityAddressAddressLine2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Suite 100</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d1d3b7fb-3c27-4326-af07-08d345cf4b14" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foster City</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ed52d6a0-0022-4b8e-99ee-09ec0418d5bc" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">California</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ad479786-169b-455e-8a9c-64c50d1196f4" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94404</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.125in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.02986111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registrant&#x2019;s Telephone Number, Including Area Code:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_67a91fe6-1255-4c4f-aa36-ff4dae9e6bb6" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(650)</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b275a92d-77f1-4fa6-bc1b-4b3565312c11" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">525-5535</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.125in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_493d2375-eb9e-4e2c-be63-e882231caf2a" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:EntityInformationFormerLegalOrRegisteredName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">N/A</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d33847cb-6f0e-43b5-821d-10f2d260728f" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9e4c5499-d0c8-4916-9edc-54c32d512272" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_218f6234-a586-4a0e-933b-d09b88966cf5" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_01923edb-09e5-4715-8a6e-9581531c59e7" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:9.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:15.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trading<br />Symbol(s)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6e932075-b725-4d60-b805-8d0beec70b9d" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock, $0.0001 par value per share</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2f19d6d0-b5a2-4493-9ad4-f478ca7cb3ad" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TERN</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6fc7aa51-f081-442c-9779-bbae35a694ea" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nasdaq Global Select Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#x202f;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#x202f;240.12b-2 of this chapter).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emerging growth company </span><span style="font-size:10.0pt;"><ix:nonNumeric id="F_51025c74-f953-45b6-91cf-7dc927a84bf9" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10.0pt;"><ix:nonNumeric id="F_de4c9f74-0ebb-4f38-b2af-e83846937f39" contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double rgba(0,0,0,1);text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1.01 Entry into a Material Definitive Agreement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On May 15, 2023, Terns Pharmaceuticals, Inc. (the &#x201c;Company&#x201d;) entered into a Sales Agreement (the &#x201c;May 2023 Sales Agreement&#x201d;), with Cowen and Company, LLC (&#x201c;Cowen&#x201d;), as sales agent, pursuant to which the Company may offer and sell shares of its common stock, $0.0001 par value per share (&#x201c;Common Stock&#x201d;), having an aggregate offering price of up to $150,000,000 (the &#x201c;Shares&#x201d;) from time to time through Cowen. The Shares to be sold under the May 2023 Sales Agreement, if any, may be issued and sold pursuant to the Company&#x2019;s shelf Registration Statement on Form S-3 (File No. 333-269508), which became effective on February 10, 2023 (the &#x201c;Registration Statement&#x201d;), a prospectus contained within the Registration Statement and a prospectus supplement, dated May 15, 2023, that the Company has filed with the Securities and Exchange Commission (together, the &#x201c;May 2023 Prospectus&#x201d;).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon delivery of a placement notice and subject to the terms and conditions of the May 2023 Sales Agreement, Cowen may sell Shares by any method that is deemed an &#x201c;at the market offering&#x201d; as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), including sales made directly on or through The Nasdaq Global Select Market</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or any other trading market for the Company&#x2019;s Common Stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company or Cowen may suspend the offering of Shares being made through Cowen under the May 2023 Sales Agreement upon proper notice to the other party, subject to certain conditions. Cowen, when acting as sales agent, will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of the Nasdaq Stock Market, Inc. to sell on the Company&#x2019;s behalf all of the Shares requested to be sold by the Company.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company also may sell Shares to Cowen as principal for its own account at a price agreed upon at the time of sale.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The compensation to Cowen for sales of Shares pursuant to the May 2023 Sales Agreement will be an amount up to 3.0% of the gross proceeds of any Shares sold under the May 2023 Sales Agreement. The Company has also agreed to provide indemnification and contribution to Cowen with respect to certain liabilities, including liabilities under the Securities Act.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A copy of the May 2023 Sales Agreement is attached as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference. The foregoing description of the material terms of the May 2023 Sales Agreement does not purport to be complete and is qualified in its entirety by reference to such exhibit. Wilmer Cutler Pickering Hale and Dorr LLP, counsel to the Company, has issued a legal opinion relating to the Shares. A copy of such legal opinion, including the consent included therein, is attached as Exhibit 5.1 hereto.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Current Report on Form 8-K shall not constitute an offer to sell or solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities law of such state or jurisdiction.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d) Exhibits</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:7.5%;"></td>
    <td style="width:2.5%;"></td>
    <td style="width:90.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:1pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:1pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:1pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="tern-ex1_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sales Agreement, dated May 15, 2023, by and between Terns Pharmaceuticals, Inc. and Cowen and Company, LLC.</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="tern-ex5_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Opinion of Wilmer Cutler Pickering Hale and Dorr LLP, counsel to Terns Pharmaceuticals, Inc.</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6.0%;"></td>
    <td style="width:44.0%;"></td>
    <td style="width:4.0%;"></td>
    <td style="width:46.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TERNS PHARMACEUTICALS, INC.</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 15, 2023</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Bryan Yoon</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bryan Yoon<br />Chief Operating Officer &amp; General Counsel</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tern-ex1_1.htm
<DESCRIPTION>EX-1.1
<TEXT>
<html>
 <head>
  <title>EX-1.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 1.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Execution Version</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Terns Pharmaceuticals, Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> $150,000,000</font><font style="text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SHARES of Common Stock, Par Value $0.0001<br><br>SALES AGREEMENT</font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br></font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 15, 2023</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cowen and Company, LLC</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">599 Lexington Avenue</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">New York, NY 10022</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ladies and Gentlemen:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Terns Pharmaceuticals, Inc., a Delaware company (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), confirms its agreement (this &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) with Cowen and Company, LLC (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cowen</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), as follows:</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">1.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance and Sale of Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company agrees that, from time to time during the term of this Agreement, on the terms and subject to the conditions set forth herein, it may issue and sell through Cowen, acting as agent and/or principal, shares (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placement Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) of the Company&#x2019;s common stock, par value $0.0001 per share (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), having an aggregate offering price of up to $150,000,000 (&#x201c;the </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maximum Amount</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> on the number of shares of Common Stock issued and sold under this Agreement shall be the sole responsibility of the Company, and Cowen shall have no obligation in connection with such compliance.  The issuance and sale of Common Stock through Cowen will be effected pursuant to the Registration Statement (as defined below) filed by the Company and declared effective by the Securities and Exchange Commission (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commission</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), although nothing in this Agreement shall be construed as requiring the Company to use the Registration Statement (as defined below) to issue the Placement Shares.  </font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The Company has prepared and filed, in accordance with the provisions of the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), with the Commission a registration statement on Form S-3 (File No. 333-269508), including a base prospectus, relating to certain securities, including the Common Stock, to be issued from time to time by the Company, and which incorporates by reference documents that the Company has filed or will file in accordance with the provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exchange Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). The Company has prepared a prospectus supplement to the base prospectus included as part of such registration statement specifically relating to the Placement Shares (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ATM Prospectus Supplement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), and shall, if necessary, prepare one or more additional prospectus supplements specifically relating to the Placement Shares (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prospectus Supplement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) to the base prospectus included as part of such registration statement.  The Company shall furnish to Cowen, for use by Cowen, copies of the prospectus included as part of such registration statement, as</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">supplemented by the ATM Prospectus Supplement and each additional Prospectus Supplement, if any.  Except where the context otherwise requires, such registration statement, and any post-effective amendment thereto, as amended when it becomes effective, including all documents filed as part thereof or incorporated by reference therein, and including any information contained in a Prospectus (as defined below) subsequently filed with the Commission pursuant to Rule 424(b) under the Securities Act or deemed to be a part of such registration statement pursuant to Rule 430B or 462(b) of the Securities Act, or any subsequent registration statement on Form S-3 filed pursuant to Rule 415(a)(6) under the Securities Act by the Company to cover any Placement Shares, is herein called the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;  The base prospectus, including all documents incorporated therein by reference, included in the Registration Statement, as supplemented by the ATM Prospectus Supplement and each additional Prospectus Supplement, if any, in the form in which such prospectus, ATM Prospectus Supplement and/or Prospectus Supplement have most recently been filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act, together with any &#x201c;issuer free writing prospectus,&#x201d; as defined in Rule 433 of the Securities Act regulations (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rule 433</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, relating to the Placement Shares that (i) is consented to by Cowen, hereinafter referred to as a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Permitted Free Writing Prospectus,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; (ii) is required to be filed with the Commission by the Company or (iii) is exempt from filing pursuant to Rule 433(d)(5)(i), in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#x2019;s records pursuant to Rule 433(g), is herein called the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prospectus</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.&#x201d; Any reference herein to the Registration Statement, the Prospectus or any amendment or supplement thereto shall be deemed to refer to and include the documents incorporated by reference therein, and any reference herein to the terms &#x201c;amend,&#x201d; &#x201c;amendment&#x201d; or &#x201c;supplement&#x201d; with respect to the Registration Statement or the Prospectus shall be deemed to refer to and include the filing after the execution hereof of any document with the Commission deemed to be incorporated by reference therein.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">   </font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">2.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each time that the Company wishes, in its sole discretion, to issue and sell the Placement Shares hereunder through Cowen, acting as agent (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), it will notify Cowen by email notice (or other method mutually agreed to in writing by the parties) (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placement Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) containing the parameters in accordance with which it desires the Placement Shares to be sold, which shall at a minimum include the number or dollar amount of Placement Shares to be issued, the time period during which sales are requested to be made, any limitation on the number or dollar amount of Placement Shares that may be sold in any one Trading Day (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) and any minimum price below which sales may not be made, a form of which containing such minimum sales parameters necessary is attached hereto as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Placement Notice shall originate from any of the individuals from the Company set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(with a copy to each of the other individuals from the Company listed on such schedule), and shall be addressed to each of the individuals from Cowen set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, as such </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> may be amended from time to time. The Placement Notice shall be effective upon receipt by Cowen unless and until (i) in accordance with the notice requirements set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Cowen declines to accept the terms contained therein for any reason, in its sole discretion, (ii) the entire amount of the Placement Shares have been sold, (iii) in accordance with the notice requirements set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company suspends or terminates the Placement Notice, (iv) the Company issues a subsequent Placement Notice with parameters superseding or amending those on the earlier dated Placement Notice, or (v) this Agreement has been terminated under the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; provided that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Company shall not deliver a Placement Notice under this Agreement at any time that a placement notice under the Sales Agreement, dated March </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8, 2022, by and between the Company and Cowen (as it may be amended from time to time, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 2022 Sales Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) remains effective with respect to future sales of Common Stock thereunder.   The amount of any discount, commission or other compensation to be paid by the Company to Cowen in connection with the sale of the Placement Shares shall be calculated in accordance with the terms set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  It is expressly acknowledged and agreed that neither the Company nor Cowen will have any obligation whatsoever with respect to a Placement or any Placement Shares unless and until the Company delivers a Placement Notice to Cowen and Cowen does not decline such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified therein and herein.  In the event of a conflict between the terms of this Agreement and the terms of a Placement Notice, the terms of the Placement Notice will control.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">3.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sale of Placement Shares by Cowen.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  Subject to the terms and conditions herein set forth, upon the Company&#x2019;s delivery of a Placement Notice, and unless the sale of the Placement Shares described therein has been declined, suspended, or otherwise terminated in accordance with the terms of this Agreement, Cowen, for the period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of the Nasdaq Stock Market, Inc. (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nasdaq</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) to sell such Placement Shares up to the amount specified, and otherwise in accordance with the terms of such Placement Notice.  Cowen will provide written confirmation to the Company (including by email correspondence to each of the individuals of the Company set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) no later than the opening of the Trading Day (as defined below) immediately following the Trading Day on which it has made sales of Placement Shares hereunder setting forth the number of Placement Shares sold on such day, the volume-weighted average price of the Placement Shares sold, and the Net Proceeds (as defined below) payable to the Company.  In the event the Company engages Cowen for a sale of Placement Shares that would constitute a &#x201c;block&#x201d; within the meaning of Rule 10b-18(a)(5) under the Exchange Act, the Company will provide Cowen, at Cowen&#x2019;s request and upon reasonable advance notice to the Company, on or prior to the Settlement Date (as defined below), the opinions of counsel, accountant&#x2019;s letter and officers&#x2019; certificates set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereof, each dated the Settlement Date, and such other documents and information as Cowen shall reasonably request. Subject to the terms and conditions of the applicable Placement Notice, Cowen may sell Placement Shares by any method permitted by law deemed to be an &#x201c;at the market&#x201d; offering as defined in Rule 415 of the Securities Act, including without limitation sales made through Nasdaq or on any other existing trading market for the Common Stock.  Cowen shall not purchase Placement Shares for its own account as principal unless expressly authorized to do so by the Company in a Placement Notice.  The Company acknowledges and agrees that (i) there can be no assurance that Cowen will be successful in selling Placement Shares and (ii) Cowen will incur no liability or obligation to the Company or any other person or entity if it does not sell Placement Shares for any reason other than a failure by Cowen to use its commercially reasonable efforts consistent with its normal trading and sales practices to sell such Placement Shares as required under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  For the purposes hereof, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trading Day</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any day on which the Company&#x2019;s Common Stock is purchased and sold on the principal market on which the Common Stock is listed or quoted.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notwithstanding any other provision of this Agreement, the Company shall not offer, sell or deliver, or request the offer or sale, of any Placement Shares pursuant to this Agreement and, by notice to Cowen given by telephone (confirmed promptly by email), shall cancel any instructions for the offer or sale of any Placement Shares, and Cowen shall not be obligated to offer or sell any Placement Shares, (i) during any period in which the Company is, or would reasonably be deemed to be, in possession of material non-public information, or (ii) at any time from and including the date on which the Company shall issue a press release containing, or shall otherwise publicly announce, its earnings, revenues or other results of operations (an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Earnings Announcement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) through and including the time that the Company files a Quarterly Report on Form 10-Q or an Annual Report on Form 10-K that includes consolidated financial statements as of and for the same period or periods, as the case may be, covered by such Earnings Announcement.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Suspension of Sales</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  </font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	The Company or Cowen may, upon notice to the other party in writing (including by email correspondence to each of the individuals of the other party set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable facsimile transmission or email correspondence to each of the individuals of the other party set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">), suspend any sale of Placement Shares; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that such suspension shall not affect or impair either party&#x2019;s obligations with respect to any Placement Shares sold hereunder prior to the receipt of such notice.  While a suspension is in effect, any obligation under Sections 7(m), 7(n) and 7(o) with respect to delivery of certificates, opinions or comfort letters to Cowen, shall be waived. Each of the parties agrees that no such notice under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shall be effective against the other unless it is made to one of the individuals named on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereto, as such schedule may be amended from time to time.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	(b)	Notwithstanding any other provision of this Agreement, during any period in which the Registration Statement is no longer effective under the Securities Act, the Company shall promptly notify Cowen, the Company shall not request the sale of any Placement Shares, and Cowen shall not be obligated to sell or offer to sell any Placement Shares.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Settlement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(a)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Settlement of Placement Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Unless otherwise specified in the applicable Placement Notice, settlement for sales of Placement Shares will occur on the second (2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">nd</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) Trading Day (or such earlier day as is industry practice for regular-way trading) following the date on which such sales are made (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Settlement Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; and the first such Settlement Date, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First Delivery Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  The amount of proceeds to be delivered to the Company on a Settlement Date against receipt of the Placement Shares sold (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net Proceeds</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) will be equal to the aggregate sales price received by Cowen at which such Placement Shares were sold, after deduction for (i) Cowen&#x2019;s commission, discount or other compensation for such sales payable by the Company pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereof, (ii) any other amounts due and payable by the Company to Cowen hereunder pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(g)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Expenses) hereof, and (iii) any transaction fees imposed by any governmental or self-regulatory organization in respect of such sales that are paid by Cowen.   </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(b)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delivery of Placement Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On or before each Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer the Placement Shares being sold by crediting Cowen&#x2019;s or its designee&#x2019;s account (provided Cowen shall have given the Company written notice of such designee prior to the Settlement Date) at The Depository Trust Company through its Deposit and Withdrawal at Custodian System (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DWAC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) or by such other means of delivery as may be mutually agreed upon by the parties hereto which in all cases shall be freely tradeable, transferable, registered shares in good deliverable form.  On each Settlement Date, Cowen will deliver the related Net Proceeds in same day funds to an account designated by the Company on, or prior to, the Settlement Date.  Cowen will be responsible for providing DWAC instructions or instructions for delivery by other means with regard to the transfer of the Placement Shares being sold. The Company agrees that if the Company, or its transfer agent (if applicable), defaults in its obligation to deliver duly authorized Placement Shares on a Settlement Date through no fault of Cowen, the Company agrees that in addition to and in no way limiting the rights and obligations set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Indemnification and Contribution) hereto, it will (i) hold Cowen harmless against any loss, claim, damage, or reasonable and documented expense (including reasonable and documented legal fees and expenses), as incurred, arising out of or in connection with such default by the Company and (ii) pay to Cowen (without duplication) any commission, discount, or other compensation to which it would otherwise have been entitled absent such default.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">6.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Representations and Warranties of the Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company represents and warrants to, and agrees with, Cowen that, unless such representation, warranty or agreement specifies a different time, as of (i) the date of this Agreement, (ii) each Time of Sale (as defined below), (iii) each Settlement Date, and (iv) each Bring-Down Date (as defined below) (each date included in (i) through (iv), a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Representation Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;): </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(a)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compliance with Registration Requirements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Prior to the delivery of the first Placement Notice (i) the Company has caused and shall cause the Registration Statement and any Rule 462(b) Registration Statement to be declared effective by the Commission under the Securities Act, and (ii) as of each Representation Date (other than the date of this Agreement), the Registration Statement and any Rule 462(b) Registration Statement has been declared effective by the Commission under the Securities Act.  The Company has complied or will comply to the Commission&#x2019;s satisfaction with all requests of the Commission for additional or supplemental information related to the Registration Statement.  No stop order suspending the effectiveness of the Registration Statement or any Rule 462(b) Registration Statement is in effect and no proceedings for such purpose have been instituted or are pending or, to the knowledge of the Company, contemplated or threatened by the Commission.  The Company meets the requirements for use of Form S&#x2011;3 under the Securities Act.  The sale of the Placement Shares hereunder meets the requirements of General Instruction I.B.1. or I.B.6., as applicable, of Form S-3.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(b)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Misstatement or Omission</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Prospectus when filed complied and, as amended or supplemented, if applicable, will comply in all material respects with the requirements of the Securities Act.  Each of the Registration Statement, any Rule 462(b) Registration Statement, the Prospectus and any post-effective amendments or supplements thereto, at the time it became effective or its date, as applicable, complied and as of each Representation Date, complied and will comply in all material respects with the requirements of the Securities Act and did not and, as of each Representation Date, did not and will not contain any untrue statement of a material fact </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. The Prospectus, as amended or supplemented, as of its date, did not and, as of each Representation Date, will not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The representations and warranties set forth in the two immediately preceding sentences do not apply to statements in or omissions from the Registration Statement, any Rule 462(b) Registration Statement, or any post-effective amendment thereto, or the Prospectus, or any amendments or supplements thereto, made in reliance upon and in conformity with information relating to Agent&#x2019;s Information (as defined below).  There are no contracts or other documents required to be described in the Prospectus or to be filed as exhibits to the Registration Statement which have not been described or filed as required.  As used herein, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Time of Sale</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means with respect to each offering of Placement Shares pursuant to this Agreement, the time of Cowen&#x2019;s initial entry into contracts with purchasers for the sale of such Placement Shares.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(c)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emerging Growth Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act (an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emerging Growth Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).   </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(d)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">       </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Incorporated Documents.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The documents incorporated by reference in the Registration Statement and the Prospectus, when they were filed with the Commission conformed in all material respects to the requirements of the Exchange Act, and none of such documents contained any untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(e)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Distribution of Offering Material By the Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Company has not distributed and will not distribute, prior to the completion of Cowen&#x2019;s distribution of the Placement Shares, any offering material in connection with the offering and sale of the Placement Shares other than the Prospectus or the Registration Statement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(f)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Statements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The financial statements (including the related notes thereto) of the Company and its consolidated subsidiaries included or incorporated by reference in the Registration Statement and the Prospectus comply in all material respects with the applicable requirements of the Securities Act and the Exchange Act, as applicable, and present fairly in all material respects, the financial position of the Company and its consolidated subsidiaries as of the dates indicated and the results of their operations and the changes in their cash flows for the periods specified; such financial statements have been prepared in conformity with generally accepted accounting principles (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GAAP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) in the United States applied on a consistent basis throughout the periods covered thereby, except in the case of unaudited interim financial statements, which are subject to normal year-end adjustments and do not contain certain footnotes as permitted by the applicable rules of the Commission, and any supporting schedules included or incorporated by reference in the Registration Statement present fairly in all material respects, the information required to be stated therein; and the other financial information included or incorporated by reference in the Registration Statement and the Prospectus has been derived from the accounting records of the Company and its consolidated subsidiaries and presents fairly in all material respects the information shown thereby.  </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(g)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Material Adverse Change</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Since the date of the most recent financial statements of the Company included or incorporated by reference in the Registration Statement and the Prospectus, (i) there has not been any change in the capital stock (other than the issuance of shares of Common Stock upon exercise of stock options and warrants described as outstanding in, and the grant of options and awards under existing equity incentive plans described in, the Registration Statement and the Prospectus), short-term debt or long-term debt of the Company or any of its subsidiaries, or any dividend or distribution of any kind declared, set aside for payment, paid or made by the Company on any class of capital stock, or any material adverse change, or any development that would reasonably be expected to result in a material adverse change, in or affecting the business, properties, management, financial position, stockholders&#x2019; equity, results of operations or prospects of the Company and its subsidiaries taken as a whole; (ii) neither the Company nor any of its subsidiaries has entered into any transaction or agreement (whether or not in the ordinary course of business) that is material to the Company and its subsidiaries taken as a whole or incurred any liability or obligation, direct or contingent, that is material to the Company and its subsidiaries taken as a whole; and (iii) neither the Company nor any of its subsidiaries has sustained any loss or interference with its business that is material to the Company and its subsidiaries taken as a whole and that is either from fire, explosion, pandemic, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court or arbitrator or governmental or regulatory authority, except in each case as otherwise disclosed in the Registration Statement and the Prospectus.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(h)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Organization and Good Standing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Company and each of its subsidiaries have been duly organized and are validly existing and in good standing under the laws of their respective jurisdictions of organization, are duly qualified to do business and are in good standing in each jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires such qualification, and have all power and authority necessary to own or hold their respective properties and to conduct the businesses in which they are engaged, except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect on the business, properties, management, financial position, stockholders&#x2019; equity, results of operations or prospects of the Company and its subsidiaries taken as a whole or on the performance by the Company of its obligations under this Agreement (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Material Adverse Effect</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  The subsidiaries listed in Exhibit 21.1 to the Company&#x2019;s Annual Report on Form 10-K are the only significant subsidiaries of the Company.</font></div></div>
  <div style="text-indent:7.467%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:7.463%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:1.604%;">(i)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">       </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capital Stock Matters</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  All the outstanding shares of capital stock of the Company have been duly and validly authorized and issued and are fully paid and non-assessable and are not subject to any pre-emptive or similar rights that have not been duly waived or satisfied; except as described in or expressly contemplated by the Registration Statement and the Prospectus, there are no outstanding rights (including, without limitation, pre-emptive rights that have not been duly waived or satisfied), warrants or options to acquire, or instruments convertible into or exchangeable for, any shares of capital stock or other equity interest in the Company or any of its subsidiaries, or any contract, commitment, agreement, understanding or arrangement of any kind relating to the issuance of any capital stock of the Company or any such subsidiary, any such convertible or exchangeable securities or any such rights, warrants or options; the capital stock of the Company conforms in all material respects to the description thereof contained in the Registration Statement and the Prospectus; and all the outstanding shares of capital stock or other </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:7.463%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">equity interests of each subsidiary owned, directly or indirectly, by the Company have been duly and validly authorized and issued, are fully paid and non-assessable (except as otherwise described in the Registration Statement and the Prospectus,) and are owned directly or indirectly by the Company, free and clear of any lien, charge, encumbrance, security interest, restriction on voting or transfer or any other claim of any third party.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(j)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock Options</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  With respect to the stock options (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock Options</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) granted pursuant to the stock-based compensation plans of the Company and its subsidiaries (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company Stock Plans</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), (i) each grant of a Stock Option was duly authorized no later than the date on which the grant of such Stock Option was by its terms to be effective by all necessary corporate action, including, as applicable, approval by the board of directors of the Company (or a duly constituted and authorized committee thereof) and any required stockholder approval by the necessary number of votes or written consents, and the award agreement governing such grant (if any) was duly executed and delivered by each party thereto, (ii) each such grant was made in accordance with the terms of the applicable Company Stock Plan and all other applicable laws and regulatory rules or requirements, and (iv) each such grant was properly accounted for in accordance with GAAP in the financial statements (including the related notes) of the Company and disclosed in the Company&#x2019;s filings with the Commission in accordance with the Exchange Act and all other applicable laws.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(k)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due Authorization</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company has full right, power and authority to execute and deliver this Agreement and to perform its obligations hereunder; and all action required to be taken for the due and proper authorization, execution and delivery by it of this Agreement and the consummation by it of the transactions contemplated hereby has been duly and validly taken.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(l)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sales Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. This Agreement has been duly authorized, executed and delivered by the Company.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(m)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Placement Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Placement Shares to be issued and sold by the Company hereunder have been duly authorized by the Company and, when issued and delivered and paid for as provided herein, will be duly and validly issued, will be fully paid and nonassessable and will conform to the descriptions thereof in the Registration Statement and the Prospectus; and the issuance of the Placement Shares is not subject to any preemptive or similar rights. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(n)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description of the Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. This Agreement conforms in all material respects to the description thereof contained in the Registration Statement and the Prospectus.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(o)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Violation or Default</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Neither the Company nor any of its subsidiaries is (i) in violation of its charter or by-laws or similar organizational documents; (ii) in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any property or asset of the Company or any of its subsidiaries is subject; or (iii) in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (ii) and (iii) above, for any </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">such default or violation that would not, individually or in the aggregate, have a Material Adverse Effect.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(p)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Conflicts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The execution, delivery and performance by the Company of this Agreement, the issuance and sale of the Placement Shares and the consummation of the transactions contemplated by this Agreement or the Prospectus will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, result in the termination, modification or acceleration of, or result in the creation or imposition of any lien, charge or encumbrance upon any property, right or asset of the Company or any of its subsidiaries pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any property, right or asset of the Company or any of its subsidiaries is subject, (ii) result in any violation of the provisions of the charter or by-laws or similar organizational documents of the Company or any of its subsidiaries or (iii) result in the violation of any law or statute or any judgment, order, rule  or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (i) and (iii) above, for any such conflict, breach, violation, default, lien, charge or encumbrance that would not, individually or in the aggregate, have a Material Adverse Effect.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(q)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Consents Required</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No consent, approval, authorization, order, registration or qualification of or with any court or arbitrator or governmental or regulatory authority is required for the execution, delivery and performance by the Company of this Agreement, the issuance and sale of the Placement Shares and the consummation of the transactions contemplated by this Agreement, except for the registration of the Placement Shares under the Securities Act and such consents, approvals, authorizations, orders and registrations or qualifications as may be required by the Financial Industry Regulatory Authority, Inc. (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FINRA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and under applicable state securities laws in connection with the purchase and distribution of the Placement Shares by Cowen.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(r)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legal Proceedings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  Except as described in the Registration Statement and the Prospectus, there are no legal, governmental or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries or proceedings (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Actions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) pending to which the Company or any of its subsidiaries is or, may reasonably be expected to become a party or to which any property of the Company or any of its subsidiaries is or may be the subject that, individually or in the aggregate, if determined adversely to the Company or any of its subsidiaries, would reasonably be expected to have a Material Adverse Effect; to the knowledge of the Company, no such Actions are threatened or contemplated by any governmental or regulatory authority or threatened by others; and (i) there are no current or pending Actions that are required under the Securities Act to be described in the Registration Statement or the Prospectus that are not so described in the Registration Statement and the Prospectus and (ii) there are no statutes, regulations or contracts or other documents that are required under the Securities Act to be filed as exhibits to the Registration Statement or described in the Registration Statement or the Prospectus that are not so filed as exhibits to the Registration Statement or described in the Registration Statement and the Prospectus.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(s)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Independent Accountants</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Ernst &amp; Young LLP, who have certified certain financial statements of the Company and its subsidiaries, is an independent registered public accounting firm with respect to the Company and its subsidiaries within the applicable rules and </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulations adopted by the Commission and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(t)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title to Real and Personal Property</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company and its subsidiaries have good and marketable title in fee simple (in the case of real property) to, or have valid rights to lease or otherwise use, all items of real and personal property that are material to the respective businesses of the Company and its subsidiaries, in each case free and clear of all liens, encumbrances, claims and defects and imperfections of title except those that (i) do not materially interfere with the use made and proposed to be made of such property by the Company and its subsidiaries or (ii) would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(u)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intellectual Property</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Except as disclosed in the Registration Statement and the Prospectus, (i) the Company and its subsidiaries own or have the right to use all patents, patent applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, domain names and other source indicators, copyrights and copyrightable works, know-how, trade secrets, systems, procedures, proprietary or confidential information and all other worldwide intellectual property, industrial property and proprietary rights (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intellectual Property</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) used, or as contemplated to be used, in the Registration Statement, in the conduct of their respective businesses; (ii) the Intellectual Property owned by the Company and its subsidiaries and, to the Company&#x2019;s knowledge, the Intellectual Property licensed to the Company and its subsidiaries, are valid, subsisting and enforceable, and there is no pending or, to the Company&#x2019;s knowledge, threatened action, suit, proceeding or claim by others challenging the validity, scope or enforceability of any such Intellectual Property; (iii) to the knowledge of the Company, Company&#x2019;s and its subsidiaries&#x2019; conduct of their respective businesses does not infringe, misappropriate or otherwise violate, and has not infringed, misappropriated or otherwise violated, any Intellectual Property of any person; (iv) the Company and its subsidiaries have not received any notice of any claim challenging the Company&#x2019;s rights in or to its Intellectual Property and there are no actual or, to the knowledge of the Company, threatened claims alleging that the Company or any of its subsidiaries infringe, misappropriate or otherwise violate any third party Intellectual Property; (v) to the knowledge of the Company, the Intellectual Property of the Company and its subsidiaries is not being, and has not been, infringed, misappropriated or otherwise violated by any person; (vi) to the knowledge of the Company, all employees or contractors engaged in the development of Intellectual Property owned by the Company or its subsidiaries, on behalf of the Company or any subsidiary of the Company have executed an invention assignment agreement or other agreement whereby such employees or contractors assign all of their right, title and interest in and to such Intellectual Property to the Company or the applicable subsidiary, and to the Company&#x2019;s knowledge no such agreement has been breached or violated; and (vii) to the knowledge of the Company, the Company and its subsidiaries use, and have used, commercially reasonable efforts to appropriately maintain all information intended by the Company to be maintained as a trade secret.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(v)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Undisclosed Relationships</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No relationship, direct or indirect, exists between or among the Company or any of its subsidiaries, on the one hand, and the directors, officers, stockholders, customers, suppliers or other affiliates of the Company or any of its subsidiaries, on the other, that is required by the Securities Act to be described in each of the Registration Statement and the Prospectus and that is not so described in such documents.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(w)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investment Company Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company is not and, after giving effect to the offering and sale of the Placement Shares and the application of the Net Proceeds as described in the Registration Statement and the Prospectus, will not be required to register as an &#x201c;investment company&#x201d; or an entity &#x201c;controlled&#x201d; by an &#x201c;investment company&#x201d; within the meaning of the Investment Company Act of 1940, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investment Company Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(x)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Taxes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company and its subsidiaries have paid all federal, state, local and foreign taxes and filed all tax returns required to be paid or filed through the date hereof except where the failure to pay such taxes or file such tax returns would not, individually or in the aggregate, have a Material Adverse Effect; and except as otherwise disclosed in each of the Registration Statement and the Prospectus, there is no material tax deficiency that has been, or could reasonably be expected to be, asserted against the Company or any of its subsidiaries or any of their respective properties or assets.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(y)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Licenses and Permits</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company and its subsidiaries possess all licenses, sub-licenses, certificates, permits and other authorizations issued by, and have made all declarations and filings with, the appropriate federal, state, local or foreign governmental or regulatory authorities that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in each of the Registration Statement and the Prospectus, except where the failure to possess or make the same would not, individually or in the aggregate, have a Material Adverse Effect; and except as described in each of the Registration Statement and the Prospectus, neither the Company nor any of its subsidiaries has received notice of any revocation or modification of any such license, sub-license, certificate, permit or authorization or has any reason to believe that any such license, sub-license, certificate, permit or authorization will not be renewed in the ordinary course, except for such revocations, modifications, or non-renewals, that would not, whether individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(z)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Labor Disputes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No labor disturbance by or dispute with employees of the Company or any of its subsidiaries exists or, to the knowledge of the Company, is contemplated or threatened, and the Company is not aware of any existing or imminent labor disturbance by, or dispute with, the employees of any of its or its subsidiaries&#x2019; principal suppliers, contractors or customers, except as would not be reasonably expected to have a Material Adverse Effect.  Neither the Company nor any of its subsidiaries has received any notice of cancellation or termination with respect to any collective bargaining agreement to which it is a party.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(aa)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain Environmental Matters</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  (i) The Company and its subsidiaries (x) are in compliance with all, and have not violated any, applicable federal, state, local and foreign laws (including common law), rules, regulations, requirements, decisions, judgments, decrees, orders and other legally enforceable requirements relating to pollution or the protection of human health or safety, the environment, natural resources, hazardous or toxic substances or wastes, pollutants or contaminants (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Environmental Laws</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); (y) have received and are in compliance with all, and have not violated any, permits, licenses, certificates or other authorizations or approvals required of them under any Environmental Laws to conduct their respective businesses; and (z) have not received notice of any actual or potential liability or obligation under or relating to, or any actual or potential violation of, any Environmental Laws, including for the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">contaminants, and have no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) there are no costs or liabilities associated with Environmental Laws of or relating to the Company or its subsidiaries, except in the case of each of (i) and (ii) above, for any such matter as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and (iii) except as described in each of the Prospectus, (x) there is no proceeding that is pending, or that is known by the Company to be contemplated, against the Company or any of its subsidiaries under any Environmental Laws in which a governmental entity is also a party, other than such proceeding regarding which the Company reasonably believes no monetary sanctions of $100,000 or more will be imposed, (y) the Company and its subsidiaries are not aware of any facts or issues regarding compliance with Environmental Laws, or liabilities or other obligations under Environmental Laws or concerning hazardous or toxic substances or wastes, pollutants or contaminants, that would reasonably be expected to have a material effect on the capital expenditures, earnings or competitive position of the Company and its subsidiaries, and (z) none of the Company or its subsidiaries anticipates material capital expenditures relating to any Environmental Laws.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(bb)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compliance with ERISA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  (i) Each employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ERISA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), for which the Company or any member of its &#x201c;Controlled Group&#x201d; (defined as any entity, whether or not incorporated, that is under common control with the Company within the meaning of Section 4001(a)(14) of ERISA or any entity that would be regarded as a single employer with the Company under Section 414(b),(c),(m) or (o) of the Internal Revenue Code of 1986, as amended (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Code</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) would have any liability (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) has been maintained in compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Code; (ii) no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect to any Plan, excluding transactions effected pursuant to a statutory or administrative exemption; (iii) for each Plan that is subject to the funding rules of Section 412 of the Code or Section 302 of ERISA, no Plan has failed (whether or not waived), or is reasonably expected to fail, to satisfy the minimum funding standards (within the meaning of Section 302 of ERISA or Section 412 of the Code) applicable to such Plan; (iv) no Plan is, or is reasonably expected to be, in &#x201c;at risk status&#x201d; (within the meaning of Section 303(i) of ERISA) and no Plan that is a &#x201c;multiemployer plan&#x201d; within the meaning of Section 4001(a)(3) of ERISA is in &#x201c;endangered status&#x201d; or &#x201c;critical status&#x201d; (within the meaning of Sections 304 and 305 of ERISA) (v) the fair market value of the assets of each Plan exceeds the present value of all benefits accrued under such Plan (determined based on those assumptions used to fund such Plan); (vi) no &#x201c;reportable event&#x201d; (within the meaning of Section 4043(c) of ERISA and the regulations promulgated thereunder) has occurred or is reasonably expected to occur; (vii) each Plan that is intended to be qualified under Section 401(a) of the Code is so qualified, and nothing has occurred, whether by action or by failure to act, which would cause the loss of such qualification; (viii) neither the Company nor any member of the Controlled Group has incurred, nor reasonably expects to incur, any liability under Title IV of ERISA (other than contributions to the Plan or premiums to the Pension Benefit Guaranty Corporation, in the ordinary course and without default) in respect of a Plan (including a &#x201c;multiemployer plan&#x201d; within the meaning of Section 4001(a)(3) of ERISA); and (ix) none of the following events has occurred or is reasonably likely to occur: (A) a material increase in the aggregate amount of contributions required to be made to all Plans by the Company or its Controlled Group affiliates in the current fiscal year of the Company and its Controlled Group affiliates compared to the amount of such </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">contributions made in the Company&#x2019;s and its Controlled Group affiliates&#x2019; most recently completed fiscal year; or (B) a material increase in the Company and its subsidiaries&#x2019; &#x201c;accumulated post-retirement benefit obligations&#x201d; (within the meaning of Accounting Standards Codification Topic 715-60) compared to the amount of such obligations in the Company and its subsidiaries&#x2019; most recently completed fiscal year, except in each case with respect to the events or conditions set forth in (i) through (ix) hereof, as would not, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(cc)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosure Controls</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company and its subsidiaries, on a consolidated basis, maintain an effective system of &#x201c;disclosure controls and procedures&#x201d; (as defined in Rule 13a-15(e) of the Exchange Act) that complies with the requirements of the Exchange Act and that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission&#x2019;s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company&#x2019;s management as appropriate to allow timely decisions regarding required disclosure.  The Company and its subsidiaries, on a consolidated basis, have carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(dd)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounting Controls</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company and its subsidiaries maintain systems of &#x201c;internal control over financial reporting&#x201d; (as defined in Rule 13a-15(f) of the Exchange Act) that comply with the applicable requirements of the Exchange Act and have been designed by, or under the supervision of, their respective principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP.  The Company and its subsidiaries maintain internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management&#x2019;s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management&#x2019;s general or specific authorization; (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and (v) interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement and the Prospectus fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#x2019;s rules and guidelines applicable thereto. Except as disclosed in the Registration Statement and the Prospectus, there are no material weaknesses in the Company&#x2019;s internal controls.  The Company&#x2019;s auditors and the Audit Committee of the Board of Directors of the Company have been advised of:  (i) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which have adversely affected or are reasonably likely to adversely affect the Company&#x2019;s ability to record, process, summarize and report financial information; and (ii) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#x2019;s internal controls over financial reporting.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(ee)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> eXtensible Business Reporting Language.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#x2019;s rules and guidelines applicable thereto.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(ff)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Insurance.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  The Company and its subsidiaries have insurance covering their respective properties, operations, personnel and businesses, including business interruption insurance, which insurance is in amounts and insures against such losses and risks as the Company reasonably believes are adequate to protect the Company and its subsidiaries and their respective businesses; and neither the Company nor any of its subsidiaries has (i) received notice from any insurer or agent of such insurer that capital improvements or other expenditures are required or necessary to be made in order to continue such insurance or (ii) any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage at reasonable cost from similar insurers as may be necessary to continue its business.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(gg)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cybersecurity; Data Protection.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, (i) the Company and its subsidiaries&#x2019; information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IT Systems</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) are adequate for, and operate and perform as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants; (ii) the Company and its subsidiaries have implemented and maintained commercially reasonable controls, policies, procedures, and safeguards to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data (including all personal, personally identifiable, sensitive, confidential or regulated data (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Personal Data</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;)) used in connection with their businesses, and there have been no breaches, violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied without material cost or liability or the duty to notify any other person, nor any incidents under internal review or investigations relating to the same; and (iii) the Company and its subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Data Security Obligations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). The Company has not received any written notification of or written complaint regarding, and is unaware of any other facts that, individually or in the aggregate, would reasonably indicate material non-compliance with any Data Security Obligation, and there is no action, suit or proceeding by or before any court or governmental agency, authority or body pending or, to the knowledge of the Company, threatened alleging non-compliance with any Data Security Obligation.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(hh)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Unlawful Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Neither the Company nor any of its subsidiaries nor any director, officer or employee of the Company or any of its subsidiaries nor, to the knowledge of the Company, any agent, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries has (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) made or taken an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office; (iii) violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, or any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit.  The Company and its subsidiaries have instituted, maintain and enforce, and will continue to maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption laws.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(ii)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compliance with Anti-Money Laundering Laws</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The operations of the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes of all jurisdictions where the Company or any of its subsidiaries conducts business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or enforced by any governmental agency (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Anti-Money Laundering Laws</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(jj)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Conflicts with Sanctions Laws.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  Neither the Company nor any of its subsidiaries, directors, officers, or employees, nor, to the knowledge of the Company, any agent,  affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries is currently the subject or the target of any sanctions administered or enforced by the U.S. government, (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State and including, without limitation, the designation as a &#x201c;specially designated national&#x201d; or &#x201c;blocked person&#x201d;), the United Nations Security Council, the European Union, His Majesty&#x2019;s Treasury or other relevant sanctions authority (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanctions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), nor is the Company or any of its subsidiaries located, organized or resident in a country or territory that is the subject or target of Sanctions, including, without limitation, the so-called Donetsk People&#x2019;s Republic, the so-called Luhansk People&#x2019;s Republic, the Crimea region of Ukraine, Cuba, Iran, North Korea and Syria (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanctioned Country</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); and the Company will not directly or indirectly use the proceeds of the offering of the Placement Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate any activities of or business with any person that, at the time of such funding or facilitation, is the subject or target of Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that will result in a violation by any person (including any person participating in the transaction, whether as Placement agent, advisor, investor or otherwise) of Sanctions.  Since the Company&#x2019;s inception, the Company and its subsidiaries have not knowingly engaged in and are not now knowingly engaged in any dealings or transactions with any person that at the time of the </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(kk)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Restrictions on Subsidiaries.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  No subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, from paying any dividends to the Company, from making any other distribution on such subsidiary&#x2019;s capital stock or similar ownership interest, from repaying to the Company any loans or advances to such subsidiary from the Company or from transferring any of such subsidiary&#x2019;s properties or assets to the Company or any other subsidiary of the Company.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(ll)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Broker&#x2019;s Fees.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  Neither the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with any person (other than this Agreement) that would give rise to a valid claim against any of them or Cowen for a brokerage commission, finder&#x2019;s fee or like payment in connection with the offering and sale of the Placement Shares.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(mm)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Registration Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No person has the right to require the Company or any of its subsidiaries to register any securities for sale under the Securities Act by reason of the filing of the Registration Statement with the Commission or the issuance and sale of the Placement Shares, except for such rights as have been duly waived.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(nn)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Stabilization.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  Neither the Company nor any of its subsidiaries or, to the Company&#x2019;s knowledge, other affiliates has taken, directly or indirectly, without giving effect to activities by Cowen, any action designed to or that would reasonably be expected to cause or result in any stabilization or manipulation of the price of the Placement Shares.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(oo)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Margin Rules.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  Neither the issuance, sale and delivery of the Placement Shares nor the application of the Net Proceeds by the Company as described in each of the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(pp)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forward-Looking Statements. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) included or incorporated by reference in any of the Registration Statement or the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(qq)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Statistical and Market Data.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  Nothing has come to the attention of the Company that has caused the Company to believe that the statistical and market-related data included or incorporated by reference in each of the Registration Statement and the Prospectus is not based on or derived from sources that are reliable and accurate in all material respects.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(rr)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sarbanes-Oxley Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  There is and has been no failure on the part of the Company or any of the Company&#x2019;s directors or officers, in their capacities as such, to comply with any applicable provision of the Sarbanes-Oxley Act of 2002, as amended and the rules and regulations promulgated in connection therewith (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sarbanes-Oxley Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), including Section 402 related to loans and Sections 302 and 906 related to certifications.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(ss)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Status under the Securities Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  At the time of filing the Registration Statement and any post-effective amendment thereto, at the earliest time thereafter that the </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company or any offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) under the Securities Act) of the Placement Shares and at the date hereof, the Company was not and is not an &#x201c;ineligible issuer,&#x201d; as defined in Rule 405 under the Securities Act.  The Company has paid the registration fee for this offering pursuant to Rule 456(b)(1) under the Securities Act or will pay such fee within the time period required by such rule (without giving effect to the proviso therein).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(tt)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Ratings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  There are no debt securities, convertible securities or preferred stock issued or guaranteed by the Company or any of its subsidiaries that are rated by a &#x201c;nationally recognized statistical rating organization&#x201d;, as such term is defined in Section 3(a)(62) under the Exchange Act.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(uu)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Matters; Products and Product Candidates.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  Except as described in the Registration Statement and the Prospectus, the Company (collectively with its subsidiaries) and except, in each case, as would not, individually or in the aggregate, have a Material Adverse Effect: (i) has operated and currently operates its business in compliance with all Health Care Laws (as defined below) applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, storage, import, export or disposal of any of the Company&#x2019;s or its subsidiaries&#x2019; product candidates or any product manufactured or distributed by the Company; (ii) has not received any FDA Form 483, written notice of adverse finding, warning letter, untitled letter or other correspondence or written notice from any court or arbitrator or governmental or regulatory authority alleging or asserting non-compliance with (A) any Health Care Laws or (B) any licenses, certificates, approvals, clearances, exemptions, authorizations, permits and supplements or amendments thereto required by any such Health Care Laws (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Authorizations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); (iii) possesses all Regulatory Authorizations required to conduct its business as currently conducted, and such Regulatory Authorizations are valid and in full force and effect and the Company is not in violation of any term of any such Regulatory Authorizations; (iv) has not received written notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from the Food and Drug Administration (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FDA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), the Department of Health and Human Services or any comparable foreign or other regulatory authority to which they are subject (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Applicable Regulatory Authorities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) alleging that any product of the Company is in violation of any Health Care Laws or Regulatory Authorizations and has no knowledge that the Applicable Regulatory Authorities or any other third party is threatening any such claim, litigation, arbitration, action, suit, investigation or proceeding; (v) has not received written notice that any of the Applicable Regulatory Authorities has taken, is taking or intends to take action to limit, suspend, or revoke any Regulatory Authorizations and has no knowledge that any of the Applicable Regulatory Authorities is considering such action; (vi) has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Health Care Laws or Regulatory Authorizations and, to the knowledge of the Company, that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete and correct on the date filed (or were materially corrected or supplemented by a subsequent submission); (vii) is not a party to and does not have any ongoing reporting obligations pursuant to any corporate integrity agreements, deferred or non-prosecution agreements, monitoring agreements, consent decrees, settlement orders, plans of correction or similar agreements with or imposed by any Applicable Regulatory Authority; and (viii) along with its employees, officers and directors, has not been excluded, suspended or debarred from </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">participation in any government health care program or human clinical research and, to the knowledge of the Company, is not subject to a governmental inquiry, investigation, proceeding, or other similar action that could reasonably be expected to result in debarment, suspension, or exclusion. The term &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Health Care Laws</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means Title XVIII of the Social Security Act, 42 U.S.C. &#167;&#167; 1395-1395hhh (the Medicare statute); Title XIX of the Social Security Act, 42 U.S.C. &#167;&#167; 1396-1396v (the Medicaid statute); the Federal Anti-Kickback Statute, 42 U.S.C. &#167; 1320a-7b(b); the civil False Claims Act, 31 U.S.C. &#167;&#167; 3729 et seq.; the criminal False Claims Act, 42 U.S.C. 1320a-7b(a); any criminal laws relating to health care fraud and abuse, including but not limited to 18 U.S.C. Sections 286, 287, 1347 and 1349, and the health care fraud criminal provisions under the Health Insurance Portability and Accountability Act of 1996, 42 U.S.C. &#167;&#167; 1320d et seq. (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HIPAA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); the Civil Monetary Penalties Law, 42 U.S.C. &#167;&#167; 1320a-7a and 1320a-7b; the Physician Payments Sunshine Act, 42 U.S.C. &#167; 1320a-7h; the Exclusion Statute, 42 U.S.C. &#167; 1320a-7; HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, 42 U.S.C. &#167;&#167; 17921 et seq.; the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. &#167;&#167; 301 et seq.; the regulations promulgated pursuant to such laws; and any similar federal, state and local laws and regulations.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(vv)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preclinical Studies and Clinical Trials.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (i) Except as described in the Registration Statement and the Prospectus, the pre-clinical studies and clinical trials conducted by or, to the knowledge of the Company, on behalf of or sponsored by the Company, or in which the Company has participated that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus, as applicable, were, and if still pending are, being conducted in all material respects in accordance with all applicable Health Care Laws; (ii) the descriptions in the Registration Statement and the Prospectus of the results of such studies and trials are, to the knowledge of the Company, accurate and complete in all material respects and fairly present the data derived therefrom; (iii) the Company has no knowledge of any other studies or trials not described in the Registration Statement and the Prospectus the results of which are inconsistent with or which the Company reasonably believes call into question the results described or referred to in the Registration Statement and the Prospectus; and (iv) the Company has not received any written notices or correspondence from the regulatory authorities or any other governmental agency requiring or threatening the termination, modification or suspension of any pre-clinical studies or clinical trials that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus other than ordinary course communications with respect to modifications in connection with the design and implementation of such studies or trials, and, to the Company&#x2019;s knowledge, there are no reasonable grounds for the same.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(ww)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Listing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company is subject to and in compliance in all material respects with the reporting requirements of Section 13 or Section 15(d) of the Exchange Act.  The Common Stock is registered pursuant to Section 12(b) or Section 12(g) of the Exchange Act and is listed on Nasdaq, and the Company has taken no action designed to, or reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from Nasdaq, nor has the Company received any notification that the Commission or Nasdaq is contemplating terminating such registration or listing.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(xx)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Reliance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Company has not relied upon Cowen or legal counsel for Cowen for any legal, tax or accounting advice in connection with the offering and sale of the Placement Shares.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any certificate signed by an officer of the Company and delivered to Cowen or to counsel for Cowen pursuant to or in connection with this Agreement shall be deemed to be a representation and warranty by the Company to Cowen as to the matters set forth therein.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company acknowledges that Cowen and, for purposes of the opinions to be delivered pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereof, counsel to the Company and counsel to Cowen, will rely upon the accuracy and truthfulness of the foregoing representations and hereby consents to such reliance.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">7.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Covenants of the Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company covenants and agrees with Cowen that:</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(a)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement Amendments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  After the date of this Agreement and during any period in which a Prospectus relating to any Placement Shares is required to be delivered by Cowen under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act), (i) the Company will notify Cowen promptly of the time when any subsequent amendment to the Registration Statement, other than documents incorporated by reference, has been filed with the Commission and/or has become effective or any subsequent supplement to the Prospectus has been filed and of any request by the Commission for any amendment or supplement to the Registration Statement or Prospectus or for additional information, (ii) the Company will prepare and file with the Commission, promptly upon Cowen&#x2019;s reasonable request, any amendments or supplements to the Registration Statement or Prospectus that, in Cowen&#x2019;s reasonable opinion, may be necessary or advisable in connection with the distribution of the Placement Shares by Cowen (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that (A) the failure of Cowen to make such request shall not relieve the Company of any obligation or liability hereunder, or affect Cowen&#x2019;s right to rely on the representations and warranties made by the Company in this Agreement, (B) the Company has no obligation to provide Cowen any advance copy of such filing or to provide Cowen an opportunity to object to such filing if the filing does not name Cowen and does not relate to the transactions herein, and (C) the only remedy that Cowen shall have with respect to the failure by the Company to provide Cowen with such copy or the filing of such amendment or supplement despite Cowen&#x2019;s objection shall be to cease making sales under this Agreement); (iii) the Company will not file any amendment or supplement to the Registration Statement or Prospectus, other than documents incorporated by reference, relating to the Placement Shares or a security convertible into the Placement Shares unless a copy thereof has been submitted to Cowen within a reasonable period of time before the filing and Cowen has not reasonably objected thereto (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that the failure of Cowen to make such objection shall not relieve the Company of any obligation or liability hereunder, or affect Cowen&#x2019;s right to rely on the representations and warranties made by the Company in this Agreement) and the Company will furnish to Cowen at the time of filing thereof a copy of any document that upon filing is deemed to be incorporated by reference into the Registration Statement or Prospectus, except for those documents available via Electronic Data Gathering Analysis and Retrieval System (&#x201c;EDGAR&#x201d;); (iv) the Company will cause each amendment or supplement to the Prospectus, other than documents incorporated by reference, to be filed with the Commission as required pursuant to the applicable paragraph of Rule 424(b) of the Securities Act, and (v) during the term of this Agreement, the Company will notify Cowen if at any time the Registration Statement shall no </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">longer be effective as a result of the passage of time pursuant to Rule 415 under the Securities Act or otherwise. Prior to the initial sale of any Placement Shares, the Company shall file a final Prospectus Supplement pursuant to Rule 424(b) relating to the Placement Shares.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(b)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notice of Commission Stop Orders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company will advise Cowen, promptly after it receives notice or obtains knowledge thereof, of the issuance or threatened issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, of the suspension of the qualification of the Placement Shares for offering or sale in any jurisdiction, or of the initiation or threatening of any proceeding for any such purpose; and it will promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such a stop order should be issued.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(c)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delivery of Prospectus; Subsequent Changes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  During any period in which a Prospectus relating to the Placement Shares is required to be delivered by Cowen under the Securities Act with respect to a pending sale of the Placement Shares (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act), the Company will use its commercially reasonable efforts to comply with all requirements imposed upon it by the Securities Act, as from time to time in force, and to file on or before their respective due dates (taking into account any extensions available under the Exchange Act) all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14, 15(d) or any other provision of or under the Exchange Act.  If during such period any event occurs as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading, or if during such period it is necessary to amend or supplement the Registration Statement or Prospectus to comply with the Securities Act, the Company will promptly notify Cowen to suspend the offering of Placement Shares during such period and the Company will promptly amend or supplement the Registration Statement or Prospectus (at the expense of the Company) so as to correct such statement or omission or effect such compliance; provided, however,  that the Company may delay the filing of any amendment or supplement, if in the judgment of the Company, it is in the best interest of the Company to do so.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(d)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Listing of Placement Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  During any period in which the Prospectus relating to the Placement Shares is required to be delivered by Cowen under the Securities Act with respect to a pending sale of the Placement Shares (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act), the Company will use its commercially reasonable efforts to cause the Placement Shares to be listed on Nasdaq. The Company has taken all necessary actions to ensure that, upon and at all times after Nasdaq shall have approved the Placement Shares for listing, it will be in compliance with all applicable corporate governance requirements set forth in the Nasdaq&#x2019;s listing rules that are then in effect.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(e)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delivery of Registration Statement and Prospectus</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company will furnish to Cowen and its counsel (at the expense of the Company) copies of the Registration Statement, the Prospectus (including all documents incorporated by reference therein) and all amendments and supplements to the Registration Statement or Prospectus that are filed with the Commission during any period in which a Prospectus relating to the Placement Shares is required to be delivered under the Securities Act (including all documents filed with the Commission during such period that are deemed to be incorporated by reference therein), in each case as soon as </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reasonably practicable and in such quantities as Cowen may from time to time reasonably request; provided that the Company will be deemed to have furnished such document (other than the Prospectus) to Cowen to the extent they are filed via EDGAR.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(f)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Earnings Statement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company will make generally available to its security holders and Cowen as soon as practicable an earning statement that satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the &#x201c;effective date&#x201d; (as defined in Rule 158) of the Registration Statement; provided that the Company will be deemed to have furnished such statements to its security holders and Cowen to the extent they are filed via EDGAR.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(g)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company, whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated, in accordance with the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereunder, will pay the following expenses all incident to the performance of its obligations hereunder, including, but not limited to, expenses relating to (i) the preparation, printing and filing of the Registration Statement and each amendment and supplement thereto, of each Prospectus and of each amendment and supplement thereto, (ii) the preparation, issuance and delivery of the Placement Shares, (iii) the qualification of the Placement Shares under securities laws in accordance with the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of this Agreement, including filing fees (provided, however, that any fees or disbursements of counsel for Cowen in connection therewith shall be paid by Cowen except as set forth in (vii) below), (iv) the printing and delivery to Cowen of copies of the Prospectus and any amendments or supplements thereto, and of this Agreement, (v) the fees and expenses incurred in connection with the listing or qualification of the Placement Shares for trading on Nasdaq, (vi) the filing fees and expenses, if any, of the Commission, (vii) the filing fees and associated legal expenses of Cowen&#x2019;s outside counsel for filings with the FINRA Corporate Financing Department and (viii) the reasonable fees and disbursements of Cowen&#x2019;s counsel (such legal expense reimbursement for subsections (vii) and (viii) not to exceed an aggregate of $75,000).    </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(h)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Proceeds</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company will use the Net Proceeds as described in the Prospectus in the section entitled &#x201c;Use of Proceeds.&#x201d;</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(i)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notice of Other Sales</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  During the pendency of any Placement Notice given hereunder, the Company shall provide Cowen notice as promptly as reasonably possible before it offers to sell, contracts to sell, sells, grants any option to sell or otherwise disposes of any shares of Common Stock (other than Placement Shares offered pursuant to the provisions of this Agreement or shares of Common Stock offered pursuant to the provisions of the March 2022 Sales Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire Common Stock; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that such notice shall not be required in connection with the (i) offer, issuance, grant or sale of Common Stock, options to purchase shares of Common Stock or Common Stock issuable upon the exercise of options or other equity awards pursuant to any equity incentive plan, stock option, employee stock purchase plan, stock bonus or other stock plan or arrangement described in the Prospectus, (ii) the offer or issuance of securities in connection with an acquisition, merger or sale or purchase of assets, (iii) the issuance or sale of Common Stock pursuant to any dividend reinvestment plan that the Company may adopt from time to time provided the implementation of such is disclosed to Cowen in advance, (iv) any shares of Common Stock issuable upon the exchange, conversion or redemption of securities or the </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">exercise of warrants, options or other rights in effect or outstanding, (v) Common Stock or securities convertible into or exercisable for Common Stock, offered and sold in privately negotiated transactions to strategic partners, collaborators, licensors, vendors or other similarly situated parties in a manner that would not be reasonably expected to be integrated with the offering of the Placement Shares. Notwithstanding the foregoing provisions, subject to the Company&#x2019;s compliance with the notice provisions set forth in this Section 7(i), nothing herein shall be construed to restrict the Company from entering into and/or consummating a committed underwritten equity offering or other similar offering of its registered securities, or otherwise prohibit the issuance of its equity securities in a private placement transaction, or require that the Company obtain prior written consent to do any of the foregoing; provided, however, that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Company shall not deliver a Placement Notice under this Agreement at any time that a placement notice remains effective with respect to future sales of Common Stock under the March 2022 Sales Agreement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(j)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change of Circumstances</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company will during the pendency of a Placement Notice or sale of Placement Shares, advise Cowen promptly after it shall have received notice or obtained knowledge thereof, of any information or fact that would alter or affect in any material respect any opinion, certificate, letter or other document provided to Cowen pursuant to this Agreement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(k)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due Diligence Cooperation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  During the term of this Agreement, the Company will cooperate with any reasonable due diligence review conducted by Cowen or its agents in connection with the transactions contemplated hereby, including, without limitation, providing information and making available documents and senior corporate officers, during regular business hours and at the Company&#x2019;s principal offices, as Cowen may reasonably request.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(l)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Required Filings Relating to Placement of Placement Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company agrees that on such dates as the Securities Act shall require, the Company will (i) file a prospectus supplement with the Commission under the applicable paragraph of Rule 424(b) under the Securities Act, and (ii) deliver such number of copies of each such prospectus supplement to each exchange or market on which such sales were effected as may be required by the rules or regulations of such exchange or market.  The Company shall disclose in its quarterly reports on Form 10-Q and in its annual report on Form 10-K, the number of the Placement Shares sold through Cowen under this Agreement, and the gross proceeds and Net Proceeds to the Company from the sale of the Placement Shares and the compensation paid by the Company with respect to sales of the Placement Shares pursuant to this Agreement during the relevant quarter or, in the case of an Annual Report on Form 10-K, during the fiscal year covered by such Annual Report and the fourth quarter of such fiscal year.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(m)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bring-Down Dates; Certificate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On or prior to the First Delivery Date and each time thereafter during the term of this Agreement (i) the Company files the Prospectus relating to the Placement Shares or amends or supplements the Registration Statement or the Prospectus relating to the Placement Shares (other than a prospectus supplement filed in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(l)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of this Agreement) by means of a post-effective amendment, sticker, or supplement but not by means of incorporation of document(s) by reference to the Registration Statement or the Prospectus relating to the Placement Shares; (ii) the Company files an annual report on Form 10-K under the Exchange Act; (iii) the Company files its quarterly reports on Form 10-Q under the Exchange Act; or (iv) the Company files a current report on Form 8-K containing </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">amended financial information (other than an earnings release or other information &#x201c;furnished&#x201d; pursuant to Items 2.02, 7.01 or 9.01 of Form 8-K (other than flash results)) under the Exchange Act (each date of filing of one or more of the documents referred to in clauses (i) through (iv) shall be a </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bring-Down Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">); the Company shall furnish Cowen with a certificate, in the form attached hereto as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 7(m)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, within three (3) Trading Days of any Bring-Down Date if requested by Cowen.  The requirement to provide a certificate under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(m)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shall automatically be waived for any Bring-Down Date occurring at a time at which no Placement Notice is pending, which waiver shall continue until the earlier to occur of the date the Company delivers a Placement Notice hereunder (which for such calendar quarter shall be considered a Bring-Down Date) and the next occurring Bring-Down Date.  Notwithstanding the foregoing, if the Company subsequently decides to sell Placement Shares following a Bring-Down Date when the Company relied on such waiver and did not provide Cowen with a certificate under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(m)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, then before the Company delivers the Placement Notice or Cowen sells any Placement Shares, the Company shall provide Cowen with a certificate, in the form attached hereto as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 7(m)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, dated the date of the Placement Notice.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(n)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legal Opinion</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On or prior to the First Delivery Date and within three (3) Trading Days of each Bring-Down Date with respect to which the Company is obligated to deliver a certificate pursuant to Section 7(m) for which no waiver is applicable, the Company shall cause to be furnished to Cowen (i) a written opinion of the Company&#x2019;s outside corporate and securities counsel and (ii) a written opinion of the Company&#x2019;s intellectual property counsel, each in form and substance satisfactory to Cowen and its counsel, dated the date that the opinion is required to be delivered, modified, as necessary, to relate to the Registration Statement and the Prospectus as then amended or supplemented; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that only one opinion pursuant to subsection (ii) shall be required in any rolling 12-month period and, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">further</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, in lieu of such opinions for subsequent Bring-Down Dates, such counsel may furnish Cowen with a letter to the effect that Cowen may rely on a prior opinion delivered under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(n)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to the same extent as if it were dated the date of such letter (except that statements in such prior opinion shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented at such Bring-Down Date).  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(o)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comfort Letter</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On or prior to the First Delivery Date and within three (3) Trading Days of each Bring-Down Date with respect to which the Company is obligated to deliver a certificate pursuant to Section 7(m) for which no waiver is applicable, the Company shall cause its independent accountants to furnish Cowen letters (the </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comfort Letters</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">), dated the date the Comfort Letter is required to be delivered, in form and substance reasonably satisfactory to Cowen, (i) confirming that they are an independent registered public accounting firm within the meaning of the Securities Act and the PCAOB, (ii) stating, as of such date, the conclusions and findings of such firm with respect to the financial information and other matters ordinarily covered by accountants&#x2019; &#x201c;comfort letters&#x201d; to Cowen in connection with registered public offerings (the first such letter, the </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Comfort Letter</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) and (iii) updating the Initial Comfort Letter with any information that would have been included in the Initial Comfort Letter had it been given on such date and modified as necessary to relate to the Registration Statement and the Prospectus, as amended and supplemented to the date of such letter.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(p)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Market Activities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or might reasonably be expected to </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares or (ii) sell, bid for, or purchase the Common Stock to be issued and sold pursuant to this Agreement, or pay anyone any compensation for soliciting purchases of the Placement Shares other than Cowen; provided, however, that the Company may bid for and purchase shares of its Common Stock in accordance with Rule 10b-18 under the Exchange Act.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(q)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Insurance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company and its subsidiaries shall maintain, or cause to be maintained, insurance in such amounts and covering such risks as is reasonable and customary for the business for which it is engaged.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(r)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compliance with Laws</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company and each of its subsidiaries shall maintain, or cause to be maintained, all material environmental permits, licenses and other authorizations required by federal, state and local law in order to conduct their businesses as described in the Prospectus, and the Company and each of its subsidiaries shall conduct their businesses, or cause their businesses to be conducted, in substantial compliance with such permits, licenses and authorizations and with applicable Environmental Laws, except where the failure to maintain or be in compliance with such permits, licenses and authorizations would not, individually or in the aggregate, have a Material Adverse Effect.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(s)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investment Company Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company will conduct its affairs in such a manner so as to reasonably ensure that neither it nor its subsidiaries will be or become, at any time prior to the termination of this Agreement, an &#x201c;investment company,&#x201d; as such term is defined in the Investment Company Act, assuming no change in the Commission&#x2019;s current interpretation as to entities that are not considered an investment company.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(t)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities Act and Exchange Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company will use its reasonable best efforts to comply with all requirements imposed upon it by the Securities Act and the Exchange Act as from time to time in force, so far as necessary to permit the continuance of sales of, or dealings in, the Placement Shares as contemplated by the provisions hereof and the Prospectus.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(u)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Offer to Sell</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Other than the Prospectus and a Permitted Free Writing Prospectus, neither Cowen nor the Company (including its agents and representatives, other than Cowen in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Common Stock hereunder.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(v)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sarbanes-Oxley Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company and its subsidiaries will use their best efforts to comply with all effective applicable provisions of the Sarbanes-Oxley Act.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(w)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Affirmation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each Placement Notice delivered by the Company to Cowen shall be deemed to be (i) an affirmation that the representations, warranties and agreements of the Company herein contained and contained in any certificate delivered to Cowen pursuant hereto are true and correct at the time of delivery of such Placement Notice, and (ii) an undertaking that such representations, warranties and agreements will be true and correct on any applicable Time of Sale and Settlement Date, as though made at and as of each such time (it being understood that </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">such representations, warranties and agreements shall relate to the Registration Statement and the Prospectus as amended and supplemented to the time of such Placement Notice acceptance).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(x)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Renewal</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. If immediately prior to the third anniversary (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Renewal Deadline</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) of the initial effective date of the Registration Statement, the aggregate gross sales price of Placement Shares sold by the Company is less than the Maximum Amount and this Agreement has not expired or been terminated, the Company will, prior to the Renewal Deadline, file, if it has not already done so and is eligible to do so, a new shelf registration statement relating to the Placement Shares, in a form reasonably satisfactory to Cowen, and, if not automatically effective, will use its best efforts to cause such registration statement to be declared effective within 60 days after the Renewal Deadline. The Company will take all other action necessary or appropriate to permit the issuance and sale of the Placement Shares to continue as contemplated in the expired registration statement relating to the Placement Shares. References herein to the Registration Statement shall include such new shelf registration statement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(y)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emerging Growth Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company will promptly notify Cowen if the Company ceases to be an Emerging Growth Company at any time prior to the termination of this Agreement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">8.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Conditions to Cowen&#x2019;s Obligations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The obligations of Cowen hereunder with respect to a Placement Notice will be subject to the continuing accuracy and completeness of the representations and warranties made by the Company herein, to the due performance by the Company of its obligations hereunder and thereunder, to the completion by Cowen of a due diligence review satisfactory to Cowen in its reasonable judgment, and to the continuing satisfaction (or waiver by Cowen in its sole discretion) of the following additional conditions:</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(a)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement Effective</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Registration Statement shall be effective and shall be available for (i) all sales of Placement Shares issued pursuant to all prior Placement Notices and (ii) the sale of all Placement Shares contemplated to be issued pursuant to any Placement Notice.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(b)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Material Notices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  None of the following events shall have occurred and be continuing: (i) receipt by the Company or any of its subsidiaries of any request for additional information from the Commission or any other federal or state governmental authority during the period of effectiveness of the Registration Statement, the response to which would require any post-effective amendments or supplements to the Registration Statement or the Prospectus; (ii) the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Placement Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; or (iv) the occurrence of any event that makes any material statement made in the Registration Statement or the Prospectus or any material document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires the making of any changes in the Registration Statement, related Prospectus or such documents so that, in the case of the Registration Statement, it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading and, that in the case of the Prospectus, it will not contain any materially </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(c)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Misstatement or Material Omission</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Cowen shall not have advised the Company that the Registration Statement or Prospectus, or any amendment or supplement thereto, contains an untrue statement of fact that in Cowen&#x2019;s reasonable opinion is material, or omits to state a fact that in Cowen&#x2019;s opinion is material and is required to be stated therein or is necessary to make the statements therein not misleading.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(d)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Material Changes.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  No event or condition of a type described in Section 6(g) hereof shall have occurred or shall exist, which event or condition is not described in the Prospectus (excluding any amendment or supplement thereto) and the effect of which in the reasonable judgment of Cowen is so material as to make it impracticable or inadvisable to proceed with the offering, sale or delivery of the Placement Shares on the terms and in the manner contemplated by this Agreement and the Prospectus.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(e)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company Counsel Legal Opinion</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Cowen shall have received the opinions required to be delivered pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(n)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> on or before the date on which such delivery of such opinion is required pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(n)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(f)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cowen Counsel Legal Opinion</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Cowen shall have received from Davis Polk &amp; Wardwell LLP, counsel for Cowen, such opinion or opinions, on or before the date on which the delivery of the legal opinions is required pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(n)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, with respect to such matters as Cowen may reasonably require, and the Company shall have furnished to such counsel such documents as they reasonably request for enabling them to pass upon such matters.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(g)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comfort Letter</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Cowen shall have received the Comfort Letter required to be delivered pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(o)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> on or before the date on which such delivery of such Comfort Letter is required pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(o)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(h)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Representation Certificate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Cowen shall have received the certificate required to be delivered pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(m)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> on or before the date on which delivery of such certificate is required pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(m)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(i)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Secretary&#x2019;s Certificate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On or prior to the First Delivery Date, Cowen shall have received a certificate, signed on behalf of the Company by its corporate secretary, in form and substance reasonably satisfactory to Cowen and its counsel.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(j)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Suspension</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Trading in the Common Stock shall not have been suspended on Nasdaq.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(k)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Materials</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On each date on which the Company is required to deliver a certificate pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(m)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company shall have furnished to Cowen such appropriate further information, certificates and documents as Cowen may have reasonably requested and which are customarily furnished by an issuer of securities in connection with a securities offering. All such opinions, certificates, letters and other documents shall have been in compliance with the </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provisions hereof. The Company will furnish Cowen with such conformed copies of such opinions, certificates, letters and other documents as Cowen shall have reasonably requested.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(l)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities Act Filings Made</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  All filings with the Commission required by Rule 424 under the Securities Act to have been filed prior to the issuance of any Placement Notice hereunder shall have been made within the applicable time period prescribed for such filing by Rule 424.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(m)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Approval for Listing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(n)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Termination Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  There shall not have occurred any event that would permit Cowen to terminate this Agreement pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">9.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnification and Contribution</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(a)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company Indemnification</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company agrees to indemnify and hold harmless Cowen, the directors, officers, partners, employees and agents of Cowen and each person, if any, who (i) controls Cowen within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, or (ii) is controlled by or is under common control with Cowen from and against any and all losses, claims, liabilities, expenses and damages (including, but not limited to, any and all reasonable and documented investigative, legal and other expenses  incurred in connection with, and any and all amounts paid in settlement (in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) of, any action, suit or proceeding between any of the indemnified parties and any indemnifying parties or between any indemnified party and any third party, or otherwise, or any claim asserted), within 30 days of the written receipt of the documented expenses by the indemnifying party, to which Cowen, or any such person, may become subject under the Securities Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, liabilities, expenses or damages arise out of or are based, directly or indirectly, on (x) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or the Prospectus or any amendment or supplement to the Registration Statement or the Prospectus or in any free writing prospectus or in any application or other document executed by or on behalf of the Company or based on written information furnished by or on behalf of the Company filed in any jurisdiction in order to qualify the Common Stock under the securities laws thereof or filed with the Commission, (y) the omission or alleged omission to state in any such document a material fact required to be stated in it or necessary to make the statements in it not misleading or (z) any breach by any of the indemnifying parties of any of their respective representations, warranties and agreements contained in this Agreement; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that this indemnity agreement shall not apply to the extent that such loss, claim, liability, expense or damage arises from the sale of the Placement Shares pursuant to this Agreement and is caused directly or indirectly by an untrue statement or omission made in reliance upon and in conformity with solely Agent&#x2019;s Information.  &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agent&#x2019;s Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, solely, the following information in the Prospectus: the fifth an eighth paragraphs under the caption &#x201c;Plan of Distribution&#x201d; in the Prospectus.  This indemnity agreement will be in addition to any liability that the Company might otherwise have.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(b)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cowen Indemnification</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Cowen agrees to indemnify and hold harmless the Company and its directors and each officer of the Company that signed the Registration Statement, and each person, if any, who (i) controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act or (ii) is controlled by or is under common control with the Company against any and all loss, liability, claim, damage and expense described in the indemnity contained in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendments thereto) or the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with the Agent&#x2019;s Information.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(c)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Procedure</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Any party that proposes to assert the right to be indemnified under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">will, promptly after receipt of notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, notify each such indemnifying party in writing of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify such indemnifying party will not relieve the indemnifying party from (i) any liability that it might have to any indemnified party otherwise than under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and (ii) any liability that it may have to any indemnified party under the foregoing provision of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> unless, and only to the extent that, such omission results in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly with any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable and documented costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have the right to employ its own counsel in any such action, but the reasonable and documented fees, expenses and other charges of such counsel will be at the expense of such indemnified party unless (1) the employment of counsel by the indemnified party has been authorized in writing by the indemnifying party, (2) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (3) a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party) or (4) the indemnifying party has not in fact employed counsel to assume the defense of such action within a reasonable time after receiving notice of the commencement of the action, in each of which cases the reasonable and documented fees, disbursements and other charges of counsel will be at the expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one separate firm admitted to practice in such jurisdiction at any one time for all such indemnified party or parties. All such fees, disbursements and other charges will be reimbursed by the indemnifying party within 30 days of the written receipt of the documented expenses by the indemnifying party. An indemnifying party will not, in any event, be liable for </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any settlement of any action or claim effected without its written consent.  No indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising or that may arise out of such claim, action or proceeding.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(d)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contribution</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> is applicable in accordance with its terms but for any reason is held to be unavailable from the Company or Cowen, the Company and Cowen will contribute to the total losses, claims, liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted, but after deducting any contribution received by the Company from persons other than Cowen, such as persons who control the Company within the meaning of the Securities Act, officers of the Company who signed the Registration Statement and directors of the Company, who also may be liable for contribution) to which the Company and Cowen may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and Cowen on the other. The relative benefits received by the Company on the one hand and Cowen on the other hand shall be deemed to be in the same proportion as the total Net Proceeds from the sale of the Placement Shares (before deducting expenses) received by the Company bear to the total compensation received by Cowen from the sale of Placement Shares on behalf of the Company.  If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and Cowen, on the other, with respect to the statements or omission that resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering. Such relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or Cowen, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and Cowen agree that it would not be just and equitable if contributions pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> were to be determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense, or damage, or action in respect thereof, referred to above in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shall be deemed to include, for the purpose of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim to the extent consistent with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereof.  Notwithstanding the foregoing provisions of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Cowen shall not be required to contribute any amount in excess of the commissions received by it under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, any person who controls a party to this Agreement within the meaning of the Securities Act, and any officers, directors, partners, employees or agents of Cowen, will have the same rights to contribution as that party, and each officer and director of the Company who signed the </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement will have the same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect of which a claim for contribution may be made under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not relieve that party or parties from whom contribution may be sought from any other obligation it or they may have under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> except to the extent that the failure to so notify such other party materially prejudiced the substantive rights or defenses of the party from whom contribution is sought. Except for a settlement entered into pursuant to the last sentence of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereof, no party will be liable for contribution with respect to any action or claim settled without its written consent if such consent is required pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereof.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">10.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Representations and Agreements to Survive Delivery</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The indemnity and contribution agreements contained in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of this Agreement and all representations and warranties of the Company herein or in certificates delivered pursuant hereto shall survive, as of their respective dates, regardless of (i) any investigation made by or on behalf of Cowen, any controlling persons, or the Company (or any of their respective officers, directors or controlling persons), (ii) delivery and acceptance of the Placement Shares and payment therefor or (iii) any termination of this Agreement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">11.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Termination.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(a)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	Cowen shall have the right by giving written notice as hereinafter specified at any time to terminate this Agreement if (i) any event of condition of a type described in Section 6(g) hereof shall have occurred or shall exist that, in the reasonable judgment of Cowen, may materially impair the ability of Cowen to sell the Placement Shares hereunder, (ii) the Company shall have failed, refused or been unable to perform any agreement on its part to be performed hereunder, or (iii) any other condition of Cowen&#x2019;s obligations hereunder is not fulfilled, or (iv) any suspension or limitation of trading in the Placement Shares or in securities generally on Nasdaq shall have occurred.  Any such termination shall be without liability of any party to any other party except that the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(g)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Expenses), </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Indemnification and Contribution), </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Representations and Agreements to Survive Delivery), </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Applicable Law; Consent to Jurisdiction) and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 17</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Waiver of Jury Trial) hereof shall remain in full force and effect notwithstanding such termination. If Cowen elects to terminate this Agreement as provided in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Cowen shall provide the required written notice as specified in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Notices).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(b)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	The Company shall have the right, by giving ten (10) days&#x2019; notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement.  Any such termination shall be without liability of any party to any other party except that the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(g)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 17</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereof shall remain in full force and effect notwithstanding such termination.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(c)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	Cowen shall have the right, by giving ten (10) days&#x2019; notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement.  Any such termination shall be without liability of any party to any other party except that the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(g)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 17</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereof shall remain in full force and effect notwithstanding such termination.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(d)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	Unless earlier terminated pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, this Agreement shall automatically terminate upon the issuance and sale of all of the Placement Shares through Cowen on the terms and subject to the conditions set forth herein; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(g)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 17</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereof shall remain in full force and effect notwithstanding such termination.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(e)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	This Agreement shall remain in full force and effect unless terminated pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 11(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c), or (d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> above or otherwise by mutual agreement of the parties; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that any such termination by mutual agreement shall in all cases be deemed to provide that </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(g)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 17</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shall remain in full force and effect. Upon termination of this Agreement, the Company shall not have any liability to Cowen for any discount, commission, or other compensation with respect to any Placement Shares not otherwise sold by Cowen under this Agreement, or otherwise, except with respect to reimbursement of expenses pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(g)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(f)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	Any termination of this Agreement shall be effective on the date specified in such notice of termination; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such termination shall not be effective until the close of business on the date of receipt of such notice by Cowen or the Company, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Placement Shares, such Placement Shares shall settle in accordance with the provisions of this Agreement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">12.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  All notices or other communications required or permitted to be given by any party to any other party pursuant to the terms of this Agreement shall be in writing, unless otherwise specified in this Agreement, and if sent to Cowen, shall be delivered to Cowen at Cowen and Company, LLC, 599 Lexington Avenue, New York, NY 10022, fax no. 646-562-1130, Attention:  General Counsel, email: Bradley.friedman@cowen.com; or if sent to the Company, shall be delivered to Terns Pharmaceuticals, Inc., 1065 East Hillsdale, Suite 100, Attention: Chief Executive Officer and General Counsel, and a copy to Wilmer Cutler Pickering Hale and Dorr LLP, 7 World Trade Center, 250 Greenwich Street, New York, New York 10007, Attention: Brian Johnson. Each party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address for such purpose.  Each such notice or other communication shall be deemed given (i) when delivered personally or by verifiable facsimile transmission (with an original to follow) on or before 4:30 p.m., New York City time, on a Business Day (as defined below), or, if such day is not a Business Day on the next succeeding Business Day, (ii) on the next Business Day after timely delivery to a nationally-recognized overnight courier and (iii) on the Business</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Day actually received if deposited in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid). For purposes of this Agreement, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Business Day</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall mean any day on which Nasdaq and commercial banks in the City of New York are open for business.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">13.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Successors and Assigns</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Agreement shall inure to the benefit of and be binding upon the Company and Cowen and their respective successors and the affiliates, controlling persons, officers and directors referred to in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereof. References to any of the parties contained in this Agreement shall be deemed to include the successors and permitted assigns of such party. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Neither party may assign its rights or obligations under this </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement without the prior written consent of the other party; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that Cowen may assign its rights and obligations hereunder to an affiliate of Cowen without obtaining the Company&#x2019;s consent, so long as such affiliate is a broker-dealer that is registered with the U.S. Securities and Exchange Commission.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">14.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adjustments for Share Splits</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The parties acknowledge and agree that all share-related numbers contained in this Agreement shall be adjusted to take into account any share split, share dividend or similar event effected with respect to the Common Stock.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">15.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Entire Agreement; Amendment; Severability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Agreement (including all schedules and exhibits attached hereto and Placement Notices issued pursuant hereto) constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof. Neither this Agreement nor any term hereof may be amended except pursuant to a written instrument executed by the Company and Cowen; provided, that each party hereto may amend the list of individuals appearing under such party&#x2019;s name on Schedule 2 by giving notice to the other party hereto.  In the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable as written by a court of competent jurisdiction, then such provision shall be given full force and effect to the fullest possible extent that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall be construed as if such invalid, illegal or unenforceable term or provision was not contained herein, but only to the extent that giving effect to such provision and the remainder of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected in this Agreement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">16.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Applicable Law; Consent to Jurisdiction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of New York without regard to the principles of conflicts of laws. Each party hereby irrevocably submits to the non-exclusive jurisdiction of the state and federal courts sitting in the City of New York, borough of Manhattan, for the adjudication of any dispute hereunder or in connection with any transaction contemplated hereby, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper.  Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof (certified or registered mail, return receipt requested) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.  Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">17.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Waiver of Jury Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company and Cowen each hereby irrevocably waives any right it may have to a trial by jury in respect of any claim based upon or arising out of this Agreement or any transaction contemplated hereby.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">18.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Absence of Fiduciary Relationship</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company acknowledges and agrees that:</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(a)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	Cowen has been retained solely to act as an arm&#x2019;s length contractual counterparty to the Company in connection with the sale of the Placement Shares contemplated </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">hereby and that no fiduciary, advisory or agency relationship between the Company and Cowen has been created in respect of any of the transactions contemplated by this Agreement, irrespective of whether Cowen has advised or is advising the Company on other matters;</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(b)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	the Company is capable of evaluating and understanding and understands and accepts the terms, risks and conditions of the transactions contemplated by this Agreement;</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(c)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	the Company has been advised that Cowen and its affiliates are engaged in a broad range of transactions which may involve interests that differ from those of the Company and that Cowen has no obligation to disclose such interests and transactions to the Company by virtue of any fiduciary, advisory or agency relationship; and</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(d)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	the Company waives, to the fullest extent permitted by law, any claims it may have against Cowen, for breach of fiduciary duty or alleged breach of fiduciary duty in connection with the sale of Placement Shares under this Agreement and agrees that Cowen shall have no liability (whether direct or indirect) to the Company in respect of such a fiduciary claim or to any person asserting a fiduciary duty claim on behalf of or in right of the Company, including stockholders, partners, employees or creditors of the Company.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">19.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Counterparts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. The words &#x201c;execution,&#x201d; &#x201c;signed,&#x201d; &#x201c;signature,&#x201d; and words of like import in this Agreement or in any other certificate, agreement or document related to this Agreement, if any, shall include images of manually executed signatures transmitted by facsimile or other electronic format (including, without limitation, &#x201c;pdf,&#x201d; &#x201c;tif&#x201d; or &#x201c;jpg&#x201d;) and other electronic signatures (including, without limitation, DocuSign and AdobeSign). The use of electronic signatures and electronic records (including, without limitation, any contract or other record created, generated, sent, communicated, received, or stored by electronic means) shall be of the same legal effect, validity and enforceability as a manually executed signature or use of a paper-based record-keeping system to the fullest extent permitted by applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act and any other applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act or the Uniform Commercial Code. Delivery of an executed Agreement by one party to the other may be made by facsimile or electronic transmission.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">20.&nbsp;&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Recognition of the U.S. Special Resolution Regimes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(a)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	In the event that Cowen is a Covered Entity and becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from Cowen of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(b)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	In the event that Cowen is a Covered Entity or a BHC Act Affiliate of Cowen becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against Cowen are permitted to be exercised to no greater </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(c)&nbsp;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	As used in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 20</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:</font></div></div>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;BHC Act Affiliate&#x201d; has the meaning assigned to the term &#x201c;affiliate&#x201d; in, and shall</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">be interpreted in accordance with, 12 U.S.C. &#167; 1841(k).</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;Covered Entity&#x201d; means any of the following:</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i) a &#x201c;covered entity&#x201d; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b);</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii) a &#x201c;covered bank&#x201d; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii) a &#x201c;covered FSI&#x201d; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b).</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;Default Right&#x201d; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable.</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;U.S. Special Resolution Regime&#x201d; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[Remainder of Page Intentionally Blank]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the foregoing correctly sets forth the understanding between the Company and Cowen, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and Cowen.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Very truly yours,</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">COWEN AND COMPANY, LLC</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_/s/ Michael Murphy_________________</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	Name:  Michael Murphy	</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	Title:  	 Managing Director</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACCEPTED as of the date</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">first-above written:</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TERNS PHARMACEUTICALS, INC.</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:   </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_/s/ Mark Vignola___________________</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name:  Mark Vignola</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title:    Chief Financial Officer</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SCHEDULE 1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">form of PLACEMENT NOTICE</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:-15.385%;padding-left:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From:	Terns Pharmaceuticals, Inc.</font></p>
  <p style="text-indent:-15.385%;padding-left:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cc:	[__]</font></p>
  <p style="text-indent:-15.385%;padding-left:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To: 	Cowen and Company, LLC</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subject: 	Cowen At the Market Offering&#x2014;Placement Notice</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ladies and Gentlemen:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the terms and subject to the conditions contained in the Sales Agreement between Terns Pharmaceuticals, Inc. (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), and Cowen and Company, LLC (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cowen</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) dated [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Symbol&quot;, serif;min-width:fit-content;">&#xf0b7;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">], 2023 (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), I hereby request on behalf of the Company that Cowen sell up to [&#x25cf;] shares of the Company&#x2019;s common stock, par value $0.0001 per share, at a minimum market price of $[&#x25cf;] per share.  Sales should begin on the date of this Notice and shall continue until [DATE] [all shares are sold].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SCHEDULE 2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notice Parties</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Senthil Sundaram, Chief Executive Officer</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mark Vignola, Chief Financial Officer</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bryan Yoon, Chief Operating Officer and General Counsel</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cowen</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Michael J. Murphy	Managing Director</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">William Follis		Managing Director</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adriano Pierroz	Vice President</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Madeleine Stow	Associate</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SCHEDULE 3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compensation</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cowen shall be paid compensation up to 3.0% of the gross proceeds from the sales of Placement Shares pursuant to the terms of this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 7(m)</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OFFICER CERTIFICATE</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The undersigned, the duly qualified and elected _______________________, of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Terns Pharmaceuticals, Inc. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), a Delaware corporation, does hereby certify in such capacity and on behalf of the Company (and not in such officer&#x2019;s individual capacity), pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7(m)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Sales Agreement dated </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">             </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Symbol&quot;, serif;min-width:fit-content;">&#xf0b7;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">], 2023 (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sales Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) between the Company and Cowen and Company, LLC, that to the best of the knowledge of the undersigned.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	The representations and warranties of the Company in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Sales Agreement (A) to the extent such representations and warranties are subject to qualifications and exceptions contained therein relating to materiality or Material Adverse Change, are true and correct on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof, except for those representations and warranties that speak solely as of a specific date and which were true and correct as of such date, and (B) to the extent such representations and warranties are not subject to any qualifications or exceptions, are true and correct in all material respects as of the date hereof as if made on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof except for those representations and warranties that speak solely as of a specific date and which were true and correct as of such date; and</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	The Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied pursuant to the Sales Agreement at or prior to the date hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Davis Polk &amp; Wardwell LLP and Wilmer Cutler Pickering Hale and Dorr LLP are entitled to rely upon this Certificate in connection with the opinions given by such firms pursuant to the Sales Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Sales Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Terns Pharmaceuticals, Inc.</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">						</font></p>
  <p style="margin-left:43.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name:</font></p>
  <p style="margin-left:43.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">				</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>tern-ex5_1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<html>
 <head>
  <title>EX-5.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 5.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><img src="img60210087_0.jpg" alt="img60210087_0.jpg" style="width:123px;height:16px;">&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">+1 212 230 8800 (t)</font></p><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">+1 212 230 8888 (f)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">@wilmerhale.com</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:36.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;" id="swibeginhere"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 15, 2023</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Terns Pharmaceuticals, Inc.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1065 East Hillsdale Blvd., Suite 100</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foster City, California 94404</font></p>
  <div style="margin-left:4.398%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.745716616807179%;">Re:</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prospectus Supplement to Registration Statement on Form S-3</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:13.2pt;font-family:Times New Roman;margin-bottom:13.2pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ladies and Gentlemen:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This opinion is furnished to you in connection with (i) the Registration Statement on Form S-3 (File No. 333-269508) (the &#x201c;Registration Statement&#x201d;) filed by Terns Pharmaceuticals, Inc., a Delaware corporation (the &#x201c;Company&#x201d;), with the Securities and Exchange Commission (the &#x201c;Commission&#x201d;) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), for the registration of, among other things, an indeterminate number of shares of common stock, par value $0.0001 per share (the &#x201c;Common Stock&#x201d;) of the Company which may be issued from time to time on a delayed or continuous basis by the Company pursuant to Rule 415 under the Securities Act, as set forth in the Registration Statement and the prospectus contained therein (the &#x201c;Base Prospectus&#x201d;) and (ii) the prospectus supplement, dated May 15, 2023 (the &#x201c;Prospectus Supplement&#x201d; and, together with the Base Prospectus, the &#x201c;Prospectus&#x201d;) relating to the issuance and sale from time to time by the Company of shares of Common Stock having an aggregate offering price of up to $150,000,000 (the &#x201c;Shares&#x201d;).  The Shares are to be issued and sold pursuant to a Sales Agreement, dated May 15, 2023 among the Company and Cowen and Company, LLC (the &#x201c;Sales Agreement&#x201d;).  We are acting as counsel for the Company in connection with the issue and sale by the Company of the Shares.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have examined and relied upon copies of the Registration Statement and the Prospectus as filed with the Commission.  We have also examined and relied upon the Sales Agreement, the Amended and Restated Certificate of Incorporation of the Company (as amended or restated from time to time, the &#x201c;Certificate of Incorporation&#x201d;), the Amended and Restated Bylaws of the Company (as amended or restated from time to time, the &#x201c;Bylaws&#x201d;), minutes of meetings of the stockholders and the Board of Directors of the Company as provided to us by the Company and such other documents as we have deemed necessary for purposes of rendering the opinion hereinafter set forth.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.25in;word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img60210087_1.jpg" alt="img60210087_1.jpg" style="width:622px;height:26px;">&#160;</p><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:36.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 15, 2023</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In our examination of the foregoing documents, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as copies, the authenticity of the originals of such latter documents and the legal competence of all signatories to such documents.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We express no opinion herein as to the laws of any state or jurisdiction other the General Corporation Law of the State of Delaware.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based upon and subject to the foregoing, we are of the opinion that the Shares have been duly authorized for issuance and, when the Shares have been issued and paid for in accordance with the terms and conditions of the Sales Agreement, the Shares will be validly issued, fully paid and non-assessable.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Please note that we are opining only as to the matters expressly set forth herein, and no opinion should be inferred as to any other matters.  This opinion is based upon currently existing statutes, rules, regulations and judicial decisions, and we disclaim any obligation to advise you of any change in any of these sources of law or subsequent legal or factual developments which might affect any matters or opinions set forth herein.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We hereby consent to the filing of this opinion with the Commission in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act as an exhibit to the Current Report on Form 8-K to be filed by the Company on the date hereof in connection with the issuance and sale of the Shares and to the use of our name therein and in the related Prospectus Supplement under the caption &#x201c;Legal Matters.&#x201d; In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:13.2pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Very truly yours,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Wilmer Cutler Pickering Hale and Dorr LLP</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WILMER CUTLER PICKERING<br>HALE AND DORR LLP</font><font style="text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img60210087_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img60210087_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !D P$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#6\3? FXUK
M7M2U:#Q JM=SO,(I;<G;N.=NX-T'3I7D7BCP_P"(/!NIC3]4>1"5W121R$I(
MOJI_I7V-7!?%SPJ/$W@JX>&/=?6 -Q 0.2 /F7\1^H% 'RU]NN_^?J;_ +[-
M=UX#^%E[X]T^XU+^U([2WCF,.YHS([, ">,CU'>O/J]@^ ?B;[#K]UX?G?$-
M\OFPY[2*.1^*Y_(4 >V>#_#G_"*>%K/1?M;W1MPP,S+MSDD\#G YKRS6_@#<
MW^I7M];^(@S3RO*J3P$GDDX+;N?KBO<** /C7Q+HFO>$=6;3-3>6.11F-T<E
M)%]5/I6/]NN_^?J;_OLU]._&7PL/$'@J6[ABW7NFYGC(ZE/XU_+GZ@5\MT >
ME^"OA-?^.M%&KRZS';0EVC0-&97..N>1BOH;PKH7_",^&+#1OM+7/V1"GG,,
M%N2>GXUY#^SWK^#J?A^5_2Z@!_)__9?RKW:@#QSQG\$KGQ'XDO\ 6K77$C>Z
M</Y,L).T@ 8W ^WI7ANK0:IH>KW6EW=Q(MQ:R&-PLA(R/3VK[0N9X[6VEN)6
M"QQ(78DXP ,U\:7LMUXO\8S/;H7N-3O#Y2]_F;C\AC\J -7PAX/\3>-IY%TV
M1UMXSB6YFD(C4^GN?85ZYX*^"MQX7\2V6M3ZXDK6^[,,4!&[(Q]XM_2O1_"_
MAZU\+>';32+11LA3YW[NY^\Q^IK8H \Q^(/PE?QOKT>JQZT;0I (?):#S%X)
M.0=PQG/Z5X=XR\*ZKX#U=-,N+SS(Y$\V*6(E589P>.QS7U_7R]\;]674/B'+
M;HV4L8$A/LQ^8_S% '':+9:WXAU6'3=,-Q/=2GA0Y  [DGL!7K>C? "^BO+6
M]U'7XT>*597C@B+$X.<!B1^>*Z/X'>$UT?PJ=:N(P+S4OF4D<I$/NC\>OY5Z
MI0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 44W>F_9N7=Z9YIU !1110
M 5E^(]''B#P[?Z29V@%W"T1E49*Y[XK4HH ^?]3_ &>;Z&VDDTW7(KB4#*PS
M0[-WMN!/\J\BN'U&QN9;2XDGAF@8QO&6(*D<$5]NU\G_ !?M4M?B;JNP "79
M*0/4J,_RH XW[==_\_4W_?9KT3PC\(]>\9:7%J=UJ"V5E+DPM*#([#ID+D8'
MXUYF1D8]>*^U_#D"6WAG2H8P B6D0&/]P4 87P^\"KX$TNYLAJ#WGGRB0L4V
M!3C' R:["BB@ KA/B+\.!X]%D?[4>R:U#;1Y6]6SCDC(]*[NB@#Y8\9_"_7O
M MB;]+U;K3RX5Y8,HR$]"R^GODUPGVZ[_P"?J;_OLU]>_$&T6^^'^N6[ '=:
M.1GL0,U\= Y - &II4&KZWJEOIMA)/+=7#[(U\PCGU)["O7+#]GJ[<)-J/B!
M$ER&9(8"W/\ O$C^5<]\![5)OB&TS8S!:.5^IP*^FZ ([>'[/;10[BWEH$R>
M^!BI*** "BBB@ HJBNLZ8^K-I2WUN;]4WFW#C>%]<5>H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH 2BBB@!:0@$$$9!I:* /D7XE^%SX
M5\;7EI&A%I.?M%L<<;&[?@<C\*YO3-1GTC5;34;5ML]K*LJ'W!S7T9\<O"_]
ML>$5U:"/-UIC;R1U,1X8?AP?P-?-% 'VUHNK6^NZ)9ZI:G,-U$LB\],CD?4'
M(_"K]>*_ #Q/Y^G7GANXDS);'[1; G^ GY@/H<'_ ($:]JH :Z+)&R. RL""
M#W%?'7CKPZ?"WC+4=+"X@63S(/>-N5_+I^%?8]>+?M >&_M&F6/B*&/Y[9O(
MN"!_ Q^4GZ-Q_P "H \>\$Z\WAGQCINJ@D1QRA90.\;<-^AK[(1UDC5T8,K
M$$="*^&",C%?5GPA\2'Q%X#M5E?==6/^BR^I"CY3^6/RH I_&SQ'_8O@>2RB
M?%SJ3>0H'4)U<_EQ^-<)\ _"HO-5NO$ES'F*T_<VV1P9"/F/X#C\:Y[XN^()
M/%'Q >RM#YD-D1:0*O.Z0GYB/QX_X#7T1X-\/1^%_">GZ2@&^&,&4C^*0\L?
MS_E0!NT444 5-5U"'2=)N]0N&"PVT32N3Z 9KY$TBRNO'?CV*%]QDU&[,LQZ
M[4)RWX <5[9\>?$?]G>%8-%ADQ/J,GS@'GREY/YG K$_9^\-?\?_ (DGC_Z=
MK8G\W(_04 >O:SH2:CX4NM"MIFLTEMC;QR1]8QC Q]*\#\4?"3Q3X8TJ;5K;
M77OH;8;Y%CDD1U4=3@DYKZ3JEK$:S:)?QNNY6MY 1Z_*: /C+^W=7_Z"M[_W
M_;_&M#15\1^*-7M]'L;^\EN+@X :X8* .22<]!7/)_JUSZ"O4O@+$C_$"21A
MEH[1RI],D T =[X)^$6K>'/$-IJ^H>(WN/(R3!&7P<C&"6/->N444 >&Z[\#
M]=N+V\O-.\3LWFR/*L,S.O4DXR#@=?2O(+^ZU_1=0GTR[O[V&XM7,;Q^>WRD
M?CTK[1KY4^,\21?$_4-@QOBB<_4K0!R!U[5P,_VK>_\ ?]O\:]-\/_!CQ3K>
MG0WU]KKV$<ZAQ$TDCOM/.3S@'VKRJQ59-1M$;E6GC4_0L*^WX46."-%&%50!
M],4 0:99G3]+M;-IGF,$2Q^8_5L#&35JBB@ K/UW3&UG0KW35N'MFN8C&)H_
MO)GN*T** /G+7/@_XRT"RGO=-UR2_2)2S1QRNDFT>@)()KS/^W=8_P"@I>_]
M_P!O\:^V:^*O$L,=OXJU:&)=L:7<@4>@W4 3:+K][9>(].U">^NG6&YC>3=,
MQ!4,,\9],U]FQR++$DB'*N P/L:^&",C!KZQ^$WB+_A(? -DTDF^ZM!]FGR>
M<KT)^HP: .XHHHH **** .#^+^O'0_A[>^7(4N+PBVB*G!!;J?R!_.OEV+5=
M2@!\K4;Q,]<3M_C7I/QU\3#5O%D6CP/FWTQ</CH96^]^0P*\KH [7PAX>\7>
M.KB:'3]2N5MXL">>:X8(N>@Z\GVKVKX>_#"_\':Q)J5[K\M\SP&+R1NV<D'/
MS$],?K5']G]%7P/>.% 9[YBQ]?E6O6* (;N#[59SV_F-'YL;)O7JN1C(]Z^>
MO$_P<\2:#IESJEAK\M[%;*97BWND@4<DCG!P.U?1=0W</VBRG@(!$D;)@]#D
M8H ^*_[=U?\ Z"M[_P!_V_QK3T)?%/B758],TJ^O9KIP6 -PP  ZDG/ KGY!
MB5QZ,1^M>F? ;_DHK?\ 7E)_-: +7_"J/B=_S_I_X,6_PJ*;X7?$^%2?M)DX
MSB/4"3^N*^EJ* /CC7K+Q?H++#K9U2V$GW3)*VUOH0<5ZY^SUJ$UQ9:[;332
M2&.2)U\QRQ^8,#U^@KU/Q1X?M/%'AV\TJ[12LT9V,1S&_P#"P]P:\6^ 326/
MBW7=+G&V98/G3T*/M/\ .@#Z!KRGX@>#O'VM:[+=:#KYBL&10EIYYC"D#GH.
MYKU:B@#XTUR?Q/H^K7.G:O?7\=W&<2*T['((X(.>0163]OO?^?Z[_P"_[_XU
MZ9\?H/+\>VTH4 26"9([D.X_EBO+%^^O^\/YT >EZ;\'O'.HV$-\+I(1,@D1
M9+Q]^",C/H:R=;\*^/?!:&YNFOHX >;BVN6D0?4]OQ%?4^D?\@6P_P"O>/\
M]!%6I8HYHFBE17C<;65AD$>A% 'R=I'Q:\9Z0ZD:L]Y&#S'=@29'IGJ*]L\
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MZC\ _P#D?+C_ *\V_F*\ND(,KD<@L?YUZC\ _P#D?+C_ *\V_F* /I:BBB@
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M^)?_ $%:]-\(^*+7QAH$6KV<$T,,CLFV48.5.#]:\Q_:*8#2M"7(W&>4@?\
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MF8\D_P">U%% '7YHS110 9KY;^(&AV4?Q@FL8U98+NYC>10>[X+8^IS^=%%
M'U#!#';6\<$*A(HU"(H[ # %/S110 9HS110 9HS110 9HS110 9HS110 9H
MS110 9HS110 9HS110 9HS110 9HS110 9HS110 9HZ444 &:,T44 &:,T44
M &:,T44 &:,T44 &:,T44 &:,T44 &:,T44 &:,T44 &:,T44 &:,T44 &:,
MT44 &:,T44 &:,T44 &:,T44 &:,T44 &:,T44 &:,T44 &:,T44 &:,T44
M&:,T44 &:,T44 &:,T44 &:,T44 &:,T44 &:,T44 &:,T44 &:,T44 &:,T
344 &:,T44 &:,T44 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img60210087_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img60210087_1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "D#S(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "J]_=?8=.N;S[//<>1$\ODVZ;Y)-H)VHO=CC '<U8HH \KU+X\:#
MHUPMOJGAWQ/8SL@=8[JR2)BN2,@-(#C((S[&K%A\:=-U5-^G>$O%UXA0/NM]
M.60;2S*#\KGC<CC/JK#L:T/BWX4F\3^"KE]/$@U:P1YK5H<[W4J5EA& 6(="
MPVC&XA0>*\@^ ^N1:-XU>Q::.WL-6LDPDMU"Q,Z,%4DDJP)8RA8P"V'4D,!O
MH ][U[Q1+H.G6=X_AS7+[[1P\.GP)/);MC.'4/\ 497<N1UY&>'?]H#PW'+=
M12:'XC22TS]I1K2,&'#!#O'F?+\Q"\]R!UKUBO"_CMX+F-[8>+]'2[74 \=L
MPLH2SM-O7R7RN"I^\N_).1"H'.0 =YX6^)MGXNO+2*P\.>(X[6ZW[+^>Q MA
MM#9S('(ZJ5^O%6/$_P 0$\*WDT5UX8\1W5O#%YS7ME9K+ $QDDOO&W&#G<!C
M&>A!/-_ 77X-3\!C2U:T6?37VF"W64%$<DAG+Y!=F$C?(2 ".%Z#H/BIJZZ9
MX#O+?]X9]5=-,ACBMVF=S,=KA$!&7\OS"H) ) &><$ Y^V^/&@WMQ;6]IX=\
M3SSW2%[>.*R1FF4%@2@$F6 *."1_=/H:[3_A*O\ BD/^$A_L'7/^P;]C_P!,
M_P!9L_U6?^!=?N\UQ_P+\(_\(YX&34KA<7VL[;E^?NP@'REX8@\$OG /[S!^
M[7J% 'E]U\<='L=1@TZ\\,>*[>^GV^3;36")))N.U=JF3)R00,=36YX2^(]M
MXSN(ET[P]X@BM)$9Q?W5JB6^%.#A]YW'=QA<G.>P)'F>LZ?;_$C]H)]-N[:"
M\TBRM#%(\,Q22-(7._=ALAC.6C(QRC;@.5DKZ H \W\3_&[PGX7UR;2)EOKV
MX@XF:RC1TC?NA+.OS#OC..F<@@>@6%];ZGIUM?V<GF6MU$DT+[2-R, 5.#R,
M@CK7C_C+X&WFMZU+?Z1XEGAAOI2+RVNR65(WF:9Q'MQE0Y#",@#=DELUZYI.
MFPZ-HUCI=NTC065O';QM(06*HH4$X &<#T% '+_$?Q5KWA31DN]%T:.\!25I
MKJ4.\=KL7>-\<8+$, ZALJJG!8@&O._@YXP\1>*O'T\NK:Y/?6HTIU2)_+B"
MR*\)8F&,XX,C*)",L/3!5?7/&DBP^!?$,KPQSHFF7+-%(6"N!$WRG:0<'IP0
M?0BO"/V?@(O']Y##)'):'3+B6"0I&LK*9XE_>!2Q4_NP=C,<9R.&RP!])T44
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4453U75;'0]+N-3
MU.YCMK.W3?+*_11_,DG  ')) &2: +E<'J_Q>\*::_E6<UWK4_VB*V,>DP&<
M;Y%)0!^$8G:0 &)R",<''E&J:]K7QJ\8MH>FW<EKH)1%1(IBHC4XD:6XCQF4
MC84P,(LAC ?G=)[?X5\"Z#X/25M-LXS=S.[2WCQ()7W,"5RBJ%087"* HP.,
MY- ')Z9\1O'.K^;]F^%=]'Y6-WVO4!;9SG&/-C7=T[9QQGJ*CUOXF^-/#UO]
MHU'X87:P;'=I(=26=8U498N8XV"  YRV.A]#7JE% 'D>E?M#^$+U[>*_MM2T
M]W3,LCQ+)%$VW)&4)=AG@'9W&0.<>J6%];ZGIUM?V<GF6MU$DT+[2-R, 5.#
MR,@CK7E?QA^'-IJ>@S:[IEM:0W%@ES=743N\<4JM&S/)M0<S[E0ACC=@!]P
M [CX?3PW/PY\-O!+'*@TRW0LC!@&6,*PX[A@01V((H Z2BBB@ HHHH ****
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M7Q#X[EL[BVTZ[TW1FVWEU#,SI,PD)1D!)5PVW;RNTQ@\!B#0!]6YR,BBD
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MP96&!R".HH N4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%P,;HSRI (#$=02PSG/6O4* ,+Q+XF_X1J"WE_L36M5\YBNS2[3SV3 ZL,C
MK@E_:$\,.\R+HWB%FA4M*!:Q$Q@'!+?O. #ZUZ'XIUQ?#7A?4=9>-I!:0EPJ
MKNR>@XR.,D9Y'%>7?![P5-=74WC3Q#;VTM_/(YMG+/*Q).?-W%BIXX4KV[YH
M ]'\+^*_^$HCEE30=:TV% "LFIVZPB3//RC<21COC'O70T44 %%%% !1110
M4444 ?/'COXI>./[:N]%LTBT": LHM5B:>YN%V_>5]A7!'(*X(P>>]>O?#>[
MN;[X<Z%=7EQ+<7$MJK22S.7=SD\DGDFO(_VA[>&77M+DN(;ORDLSFX@4,L67
M.-RG&<G@?,OX]*]6^%O_ "2_P]_UZ+_,T =?1110 4444 %%%% !1110!YSJ
MGQAL-&DD%_X4\60(A;][)IRJC!>K EQD>_O4&@_';PAK^LP:8J:A8R3G:DMY
M&BQ[NRDJYP3[C%>BW]A:ZG83V-];QW%K.A22*095@:^,=85HM9U(R6VJ6]O%
M<B6&Z($LL0R50M(55F!V@+\R@8SR: /M:BO+O@[\2D\7:,NF:I>*VO6H.X,N
MTSQCHXY^8^O3Z=Z]1H *\]U+XM6VDK<2WG@[QA%;VY(DN&TP+$ #C=N+@8]Z
M]"K.UZW%UX?U&$VT=SNMWVPR1"57;:2!L((;G'!!H \ZM_CYX>NY+:.VT#Q+
M-)<DB!8[.-C*1U"@2?-CVKT+0-:_M_2UOO[,U+3LN5^SZC;^3*,=]N3P>U>.
M?L[Z4JSZ[JHGD$AV6\UN]N(MC\LV,'H#QC ^@KW>@ HHHH **** "BBB@ HH
MHH **** "BBB@#+U_6O[ TMK[^S-2U'#A?L^G6_G2G/?;D<#O7G-W^T'X9L+
MJ2UO-%\16]Q$=LD4UK&CH?0@R9%>M5YQ\8O!UQXD\-+?Z>=VH:9NFCBE<&)T
MP=^48%"V.A./K0!%I/QKTO7LG2?"WBN^56",]O8(ZH3T#,),#\:]*C8O&CLC
M1LP!*-C*^QP2,_0U\Z? KQ%#I7BF;1IA):0:K;I-!"\0C3S1Q\K.Q9@0#CGD
MYX&*^C: *>JW_P#9>EW%]]DNKOR$W_9[2/S)9/95R,FO-=0^/GA[2;HVNI:!
MXEL[@ ,8KFSCC?!Z'#2 XKU221(HWDD=4C0%F9C@*!U)/I7@NGVUU\6OBG=7
M5[Y=SX5T_#1V[RN\3=0N!')M$AP2<GIC*GI0!Z-X<^),'B?4([6R\+^)8D<D
M-=7-FD<,>!GYGW^XX&3STKMJ;'&D4:1QHJ1H JJHP% Z #TIU !1110 4444
M %%%% 'E'Q9^('B?PB'@TS2I+>S>+*:QY7GJ)#T3;PJ'/=MV>RFD^!WB+4_$
MEIK]WJ6JW>H,+J/8]P FW*<A4!*H,]AQWK1^.4WD_"Z^_P!)G@WRQI^Y&=^3
M]UN1\I[]?H:YW]GAWDTSQ"\EW]K<W,69\L=WR>K 'CISZ4 >TT444 %%%% !
M1110 45EZ_\ V[_9;?\ ".?V=_:.Y=O]H[_*V]\[.<^E>'?$6;XLV!*W^HJV
MF3@,5TR$K$9,9,"L@,V".[%0>>: /?;>_L[N>X@MKN"::V8)/''(&:)CSA@#
M\I]C5BO%/V<Y()=&UUK>!H0;B/<ADW#=M/W<C('3@DGU)KVN@ HHKBOB7XX3
MP5X:DGMY[+^U)2J6\,\N" 3@R;!\S!>IP* .GU+6M*T6-)-5U.SL8Y#M1KJ=
M8@Q] 6(R:CTWQ%HFLRO%I6LZ??21KN=+6Z24J/4A2<"O*/AE\/K7Q+IO_"5^
M,U_MR_N9B]K+=2.Z^4I(!VEL%2<D*RC [5K_ ! ^$GAN^T.[U'2-,CTS5+=!
M*DMC'MX3G CWI&"?[QYH ]2HKR?X/_$B\\1H_AWQ C1ZS:1!UEEPK7$?'53S
MN (.0.1S]?6* "J.I:SI>C1)+JNI6=C'(VU'NIUB#'T!8C)K ^(OB]/!GA*>
M_66)+R0B*U$@##>>Y7() ZG&3[&O/_AC\/\ _A(X;GQ'X[M)-5OGN!]CDOVF
MYC&>?+? ,9R"H((QV% 'K>F^(M$UF5XM*UG3[Z2-=SI:W22E1ZD*3@5I5Y?\
M0?A!HVN:-]H\/V5KI.K6@,D+6D C67'.U@@Z\<$#(-0_"OXBW^J3IX6\3PR1
MZY%%OAG(R+F,#J2.-PP<GO@]P10!ZM117-^.?%L?@WPS<ZG]G:ZN%4^3;J>6
M/<GOM'4D=!0!M7^I6.E6INM1O;:SME(!FN)5C0$]!EB!5.P\4^'M5NA:Z=KV
MEWERP)$-O>1R.0.IPI)KQSP%X)B^)&J:CXM\:6E]*_G*EO;3S@)@*"054*P4
M$@@<#!YW<D]OXO\ A%X9UW2Y#IVF6^E:G$A:UN+",0X<<C*KA6R1U/([$4 >
MA45XO\)?B%?R:@_A;Q+=322!F2QO;T%9)Y%.'B+997(.<'=D_B,>T4 %%?.&
MK>%]:^+WC37]2LM/MH;&V_T*WNKN5X</&<<;0X<YSGC&,<J:CC_9Z\2^5(DK
M>'RQAV))'>7"LK@YWG,9!ST(QC'3!YH ^DZ*^<)OV>/$DM@RIJ.APRE@X@C6
M0J",#_6LI?!&21TSV[CF_&?PLU3PBNF7&H7NFO<7UPD*O""L2,%^Z8Q%R.!\
MW?)RO>@#ZSHKD_A[X.B\&>&8[0A6O;AO/NY!$B9D;JH"\;5Z <^U=90 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7RI\4=,MOA_\ %(WFAQQZ
M>YMTOK*-(DGC64N5)V.H$8&UV  ?!"XVY 3ZKKSOXR^'EUKP4UZT$ET-)<W<
MEJ)VC$L6TK(0=P4.JDNK%6P4QM(8@@'8>'-=M/$OA^SU>RECD@N$)W1[]NX$
MJP&]58@,",E1G&<"CQ)HD/B/PUJ6C3^6$O+=X@[QB01L1\K[3U*MAAR.0.17
MC?[/?B4P17OA6\:Q3&RZLVCDA#REUW,IPVZ1@H!Z$IM96(PJU[Q0!\F?#S5[
MOP=X_M?/CCM_L#_V7J\;E,"-YV5I6D6/:J1N8@2SDDA0&VG"^A^-(K/XG_&'
M2/"T#>;8Z%YLNI$*-I7]V74.LF3DA8B %9&W'YOX<SX_^'IK3Q!I?BBRO+N*
MYD3RU.XK'"T(:3<)6<!'(QMC4#<58CYC@[_[.Z6@\*ZDRWL=S>)<)&P65SY4
M.P2(FQL;0)))^0,%M^"P&: /9*P_&.NMX9\':KK,:1O+:6[/$LC*%+]%SEER
M-Q' .3T7)(!W*\;^*5R/%7Q!\+^![.ZC)AN%OKV$K&^[D8 W!AO6+SI"K@*5
M(X8E5(!J? OPP-#\#)J$L$"76J;9?-B\X-)$ 2F]9, ,"[C*#:5VD%NI]0J.
M""&UMXK>WBCA@B0)''&H544#   X  XQ4E !17S!X_\ &OCF74=0T;Q&/)M+
M3$=U;:%<B)67*9>1B'?RWCF"C=A2S+P61E/O_@3_ ))YX:_[!5K_ .BEH /'
M?_)//$O_ &"KK_T4U>&?L_Q30^/W$GEM$VA.T,B0&,.IGC)Y*J7*OO0L<\H0
M"0HKW?QI!-=>!?$-O;Q233RZ9<I''&I9G8Q,  !R23QBO!/V=IK>3QO/'':^
M5<1Z5,)91(2)09H2I*GHPR02#@@+P""6 /I>BBO _C+XP\9:1JC:5_:4>BV$
MZ&6SFLDD)G1<DJ\^-RR[D3"HN,389L#) /?**\+^'&OZ_J/P\@\.^![*19+)
M[B)]8U.%4@0M([H H=COVODX#A6"@J5?>M/Q)X(^+L.G7.L2^+;Z^ON2UGI%
MRZ+M4+@A08QT#Y"*6+!<!M[%0#Z HKY\^'7QGOK$7VG^)IY-8M+5&^S7UJNZ
M=A'&S8*$*[H5B8^8PRI(\P@-E>SU:W^*/BZSEN-*O;'PQ831-]FM9@WVQU8J
M!YS;6\IMNYAL^920IY^90#U"BOF#7K3XH^ -1LY[KQ5?-O\ W<5Q<7C2VDLS
M';Y8,A*C"-NW3+&/D?&=H)]O^'?C?_A-=#EDNK7[#J]C*;;4+,G!CD'\04G<
MJGG ;D%6'.W) .PHHKS_ ,>?$*XT2\@T#PO:0:MXFN)8XQ:LX(@# L"ZA@QR
MJD\$!1AF*@J& /0**\WE^'7B758FN-7^(FN1WQM(XXUTYUMX8I0IWE@@7S5W
MDD<(VT $G@CB[_QGXO\ @[XEL](\07\GB/0;A!(EW+$RSA<MO"N3RZL02K,W
MR[ "F[@ ]\HJ.">&ZMXKBWECF@E0/')&P974C(((X((YS7SI\1?B)X]M=6GT
M>^AGTJ&VE::Y32@4,EH9$$<BW1W'DY7<$0 G!!)** ?1]%>)V_B/QY<?#G2H
M/"6A7=K'IUDUG>7$]NC72SV\:@B*%V 9"RE,X=L[QL#* V1\'M8\=2>/#8WD
M^LWNDM;EKYM65\V[*&7Y-['!\Y7CX/S!6)4%?D /H.BBB@ KY_\ C[XI1M<T
MC01>0);V,L5Y=1B);AR[;@,QL-IV("2C.-_G+Q@9'T!7QQ\0-02\\?>*/[3N
M?/:6[F$;P0KO@>%WBB1]RC*E% .QOXE8EF3;0![G\!= L=.\!C6;99!/JS[I
M=[;BHB)CV]AC<)'' (#A26V[CZI6'X-@FMO!6B)=12179LHGN5E4JYF90TA?
M/.\N6+$\DDD\UN4 %%%% $<\$-U;RV]Q%'-!*A22.10RNI&""#P01QBJ^EZ7
M::-8+9622+ KN_[R5Y6+.Y=B6<EB2S$Y)/6KE1SB9K>5;>2..<H1&\B%U5L<
M$J""1GMD9]10!)17RYXR\8?$/1=4G\-ZQX[M%G5X%G:SA:,Q!_GW>8D"MA0%
M+;220X #?,!]1T %%</\1K;QR=.^W^#M9@M?LD3O+9FS$LEQ@$_*Q#Y;A0J!
M1DL<MT \D^'GC;Q7X@^+?AU=5UO4I[.YMY"(WC%O%,!#+D^6GR.!(K@/U.P9
MP1@ 'TG5>_OK?3-.N;^\D\NUM8GFF?:3M102QP.3@ ]*L5\\?&N_\:P7FGZ;
MJMWI1TC5=R065O(T:!U YFD;;G8TJD$L$/EJS(O(H ]O\+>)+/Q=X<M-<L(Y
MX[6ZW[$G4!QM=D.0"1U4]ZV*\#\":/\ %#4/!EM>>'_%^C6NF3(\MK;K9J L
MC2DR(P,'R ,9/N[AD  ;2"/1/"&D_$+3]<ED\4^(['5-,-H D<,"QNLYV$GB
M-?E'[P [N>#@9P #F_VB#"O@"Q,\<CI_::@!'"G=Y$VTY(/ ;!([@$9&<@_9
MXC6'P+JD231SHFL2JLL88*X$47S#< <'KR ?4"I/VA&\OX>6THE@1EU!0J31
M[_,W12H0H*D!@&+ G&-N0=P6C]GWRO\ A [WR?(V_P!H<^1OV[OLT&[._G=G
M.['R[L[?EQ0!ZQ117F_BKQYJEQXH@\'>#;?S=4FBE>?4)(=\-J &0$9(!VR#
M#-\P4@KM=\H #TBBO+V^&7BG4=.DN-3^)&N1ZW-L)>QD,5I%@*"HB4KNZ-\P
M*9R"5SG/-VOCWQ-\-?&+:%XTOY-9T-4BC&HI:LK6P;?Y;,VP>865&+#+GY6P
MQ964@'NE%1SF9;>5K>..2<(3&DCE%9L< L 2!GO@X]#7RQXZ^(GC341=:-XD
MDDT4H[P26FG,J[BL;9$B%B[(_F1@-O\ +*@D*Y' !]5T5XGXJ\9?$3Q!I<6H
M^%_#6I6OAF9$8S1&,:A<1ME6V*"YC!W?*RHQ& ^<'%1_ ;7_ !3K%YJ<=[>7
MVI:$D2L+R_R7CNL)NC1BQ)7!;CGHIPA?! /<**** "L/QH85\"^(6N(Y)(!I
MER9$C<(S+Y39 8@@''?!QZ&MRN?\=_\ )//$O_8*NO\ T4U 'B'[/:/;>/M9
MM-\]GY>GA)["=FWM*KHK.1M"C:V\8;YE\S W?,:^CZ^;/V>Y(4\?ZDEH8_L\
M^F22B-P'E@VSHJHTA1<G:<G9\K94D9&%^DZ .#^,T+7/PIUB!#&'D>V13)(J
M*";B,<LQ 4>Y( [UXY\ 4O;KQS!)9O!#'9VDR7NYHU:>!B"BJ@7>S"7!+DGY
M=JY4 !NC^,WC^#6DT_0/"6N1SW*7"SRBP,K/+*&C\F.)XQM8Y<OC/!B'(8 '
MK/@SX%_X1K0SJ]_I?V#5[^)$>)GWE(UZ'!&Z-GX9TW,,@?=^XH!ZA17)_$'4
M/%&F^&II_"\%HUPJ,9)KB1%$"@??_>,J  ;FW$M@JHV$,63QCX2)J_BOXI:;
MXCU:]NYI(;*YG\^:43+*V\QF- ,"$*)U;R^<<$ +(N #Z3HHKB_'WQ,T7P!;
MQK>"2ZU"=&:"RA(W$ '#.3]Q"PQGD]< X. #M**\KLM"^)'C"RDNM8\4R>'K
M.\MXWBL;&S$4\3[/XFR70!PIQO)920?+)VCG_%'P_P#B'X<TNVU3P]XU\0:U
M>6[AI[9IFP0N]MZHTA## 1?+PQ8D]CM ![I7A?[19F5-#*QW;V_V>\%R+=RH
MV[K?87."-@E\HX/4@ $$@CO/A7XAUGQ+X7NKO6ES)%J$T%O-\C>;$I&#OC C
MDP2R[T 4[.F<UP?[0L!N=4\'0K%'.[/=[+=UD83L/)(BQ'\Y+D!!C'+#D=0
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MA\9^-]%U06C1W>G:&;@ 3Z=E#<1?*RC[402DI*2Y0*NT=?,4YK0^&&K>*_\
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M$94S&Q*PPEK:$"7(#D\@;@$R5C !)/R_1G@'_DG?AK_L%VW_ *+6OG/XS27
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M+_%+XV6C16LC>&]&@?+SJLUO= .Z%T#*T9#N-H/4K$2"&4!?=,8&!0 4444
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M2?8/''CC2_ FA-J&H-YDSY6VM48!YW]!Z 9&6[#U) (!TU%>7+IOCSQ_H_\
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M: %XPS'HSQ#X \1Z#I)U?P_X_P#$3WEDAEDCU*Z^T0R =3M/  &YN0_3@9H
M]9HKS#X4?%1O''VG3-42WBU6V&X/"=J7"=-RJQW COVYSQTKT;4-0L])T^>_
MO[B.WM($+RRR' 4?Y[=Z +-%>5V&L^,?B/?W?]EW-SX8T&WF:$RR60-Q<+@
MX+GY6^]T4;>.6/ @\0_#WQ-H=I-K/A[XB:_OL8&F^SZI<&X20J"3D\+C'8HW
M/Z 'K=%>;?#'XD7GBJ6XT?7[:"UUFWC653"X\NYB/1T^8Y]25)'((QTJ]\0I
M_'<&GWLOAY=+33(K?=,_GNMZ0.7,9*^6AVYP3N]>N!0!IP^-[.?Q^_A-+6<R
M+;&<78*F)F4X9!SU'0^^1CC-=17Q_P##:TUW4O%"-X/U2#3]::*8R/>MYN4R
M#G_5,!G('<D@G@&O:+'0/C5'J%L][XOT62U653,B1*"R9&X#_1QR1GO0!ZQ1
M110 4444 %%%% ')?$]UC^&VN2/--!L@#"2!<NK!E((Y'?'?C]*Y6+X>67C+
MX1:+#JEG)'K,.GCR+AT/G1L>2""R[L^C'&3FNG^*9A7X8Z^;B.22/[-RL;A&
M^\,<D'OCM4_PWC6+X<>'XTFCF46:8DC#!6^FX _F* /G+PEXUUKX=>(KJ1K>
M[DM!-Y>JV+6JPI&<X4J%.U7P/0 ].>M?5.D:K::YI%KJEBY>UNHQ+$S*5)!]
M0>E<!\6/AP?%6FR:GHP%OK<<921U=E^TP@9,;!02YX&!_P#6KRCX9?$NX\&W
M\%CJ=RI\/R$0SI+$J/:2@9++&F689X)(^8^A!H ^HZ\T^.]M]H^&%T=LY\J>
M.3]U%OQC/WN1M7G[W/;CFO1+*]MM1LH;RSGCGMID#QRQG*LIZ$&O.OCLDC_#
MQ?*,/F+?1,/.*!.-QYW_ "GIT/7IWH W_AA_R3'P[_UY)76URGPS<O\ #7P^
MY !:S4G: !^ ' KIKFXBM+6:YG;9#"C2.V"<*!DG ]J ):*\EB\2>+OB7>75
MOX7N6\-:=93M!<W%S KSRJ5R"JGE6QSCC&<[\\ O?AEXSTZUBO="^(^M7&I6
M\18PWTC213R>P9BJC'9@_/?T /6J*\=^%WQ7U+7-43P]XH6T%^ZL(+F*1%,C
M(<,LB!N&/)& ,CH,<U8^)K_$'PS8WOB#2?&$?]G)(6^Q'3$+0H>@#A'W?5MH
M]Z /6J*\#^&WB'QY\0;NY \<-:06J1M*/[-M&D9C]Y0O4#T<C!].U>S:[I^K
MW^D"VT?7#I5X&4_;&M4N"0.H*-A>?6@#6HKYGUSQO\3?#OBDZ!J?C*PMI_."
M"66TB\L(1E9"5A.%/YCN .:]V\*:7K]A;O+KOBDZX\RJ8]EG%!'&,=M@RV?4
MG&.U '145YS\26\3Z+87VOZ?XZ@TBRAC4164VG1R!W]!(06RW8;3^7-9_P ,
M7\>>)-+T_P 1:QXLD%H\C%].?28D\Y!P")  <'KD"@#U:BBB@ K$\7>'+?Q9
MX7OM&N O[^,^6Y ^1QRK D''/?&<9K;HH ^3/ ?B:^\'>/E%_:7?VB*5X-5F
M:20[HL@;Y%8@ J<?,2  >F>:^L4=)8UDC=71@&5E.00>A!KY_P#CUX/V:LGB
M@6-]>02Q".X-O)@0%!@,W[M@%.5Y)Z@^M:_AKXG_ -E_"B[6\N//UK38-EOP
M^ZX0CY)@'!8J,C+,H7(Q0!-\0IXOB%X[T[P)97&(K*87&H$2DB1<<J%4X)7O
MD@@MP#S7KUE96NFV4-E901V]M"H2.*-<*H'8"N$^$GA!_#OAO^T-0M8(M7U(
M":X:,[C@\C)[$YR0#MST KT*@ HKQ[Q?\9I1KDOAKP7;P7VI?ZM;EPSHTG0I
M&JCYF'7<Q"C!SD5?A^&_BW5=.>ZUWXB:W!K,J+M73I/)MX3CH43:'^HV_C0!
MZE17@>MZC\2/A1J%E$==C\2:5.&*"^"B21\C<@RQD+<C: S#GIVKU_PGXLTW
MQAHRW]@S*ZG9<6TG$EO(.J,.Q_G0!NT54U22^BTNZDTR"*>^6-C!%,^Q'?'
M)QQ_GD=:^4O%?CC7=2\4Q_\ "2:K=K!9W(<Z9#;&(1.C@[6C+;?7#;G.,>M
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MM-+M[?4;_P#M"\1<2W7DB+S3Z[%X'T%7* "FNB2QM'(BNC JRL,@@]013J*
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MW)(& VX^XS7U%7QA-%;OX[OI8T@AB_M3;&;B8O*K"3)"A ,[L$9*[1G&0>:
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M_)//$O\ V"KK_P!%-7AGP"97^)=](E_)>H='D5'E5ED1$FB1%<'(!V*I 5F
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M=W!RH=48KCG;U!P1W?P9,+?"K2&MHY(X"]R8TD<.RK]HDP"P #'&.<#/H.E
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M:ZCQ#XAN_BYX8M=*\-Z+K,=A>7 >[GNH4@C>&.2,%1*=R@$ECE-[@PD;"&)
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M[-/1/B=%!\#[Y?M3V5U9SKI=L0PEG2)_N, @CPRQ;PK$J&:+.<G% &KX:/\
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MAP"<_P  KI: "BJ\5_9SWL]E%=P27=N%,T"2 O$&&5W+G(R.F>M6* "BBB@
MHHHH *\5\0V6H?%_QO#9Z?=1OX+TF<)=S),"EQ,,,P"C#$X;:&R5 R0><'H?
M&>N3>,+B\\!>%YI#>L574]00'R;.')WJ7# F0X VX((+ XP<=EX:\-Z;X5T6
M#2],@CCCC10\@C57F8 #>Y4#+'')H NZ=I]KI.FVVG6,7E6MM&L4,>XMM4#
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M(BA5&<X KY/FU$^#?C#-J3W5H)(+V43S7):X$B^;L;:OSR1L%)(W-D[2=V"
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MJ:A:6,#.$62ZF6)2V"< L0,X!./8UEIX%\)Q7EK=P^&]*@N+6430R0VB1E7
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MW.ERVP4 1L%$8\Y@S2;>%>)QC .#B4M7UG!!#:V\5O;Q1PP1($CCC4*J*!@
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MX." ?PH \7^#WQ(T+2O#UOX6UN;^Q[BWP]J;W*I+'(GFEC(0%&69V&=HVO&
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M_P#Q-6-,\*>']%U&6_TK1;&QNI8A"[VT"QY0$G& ,#)/..N%SG:, 'SI\1_
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MM3[Q!;C.,#!)P :[3&!@5CWWA/PWJ=Y)>7_A_2KNZDQOFGLHY';  &6(R<
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MG9A'&&-?3?@#6[OQ#X(TW4;_ &&\97AG>.1)%DDC=HV<,@VD,4+#;QSP3UH
MZ6BBB@"O?7]GIEG)>7]W!:6L>-\T\@C1<D 98\#)('XU\^?&_7=(\7:IHVG:
M1+)?/ EQ'#=6V7@DN&\EA$C(K>:^T!=JX :6/+##"OH._L;?4].N;"\C\RUN
MHGAF3<1N1@0PR.1D$]*PX/A]X-MK>*!/"NC%(T"*9+*-V( QRS EC[DDGO0!
MYG\"_%&A:%X/NM*UB]L=(ODNOM&R[E,#3QR1HR2?O#@Y' V\;0IQ\V6]L@GA
MNK>*XMY8YH)4#QR1L&5U(R""."".<UCGP7X5:W2W;PUHQ@1V=(S81;59@ Q
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MAA@KKD<,O(4DC&:V[/P9X8T[5(-2L= TVTO(%=(Y;>V2,J&QG[H S@8SU +
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MJ^F_#'P1I5NT%OX8TUT9RY-U"+ALX X:3<0..F<=?4T =6"" 1T-+1C P**
M"L_4]=T?1/*_M;5;&P\[/E_:[A(M^,9QN(SC(Z>HK0K'UOPMHWB.6V?5K/[3
M]GR$0RNJ,"R,5=5(5U+1H=K CY1Q0!\P_$W7-.U7XG7MS8ZO!>6+RQ-!("SV
M]O,HCC=Y$:-A(I$7.P$,-G+8VGU'X2?%70I?#EOH.L:I'9W6G0(D<]Z4@CFC
M 'RJ<[04^Y@G+ !NI8+VL'PM\$P6DEK_ &!!+"\1A N)))C$A+$B,NQ,7+L<
MIMY.>M5W^$/@B6:ZFDTF=Y;O/VEVU&Y)FRP8[SYGS?, >>X!H V/^$[\'_\
M0UZ'_P"#&'_XJJ>J_$WP7H]O;W%UX@M'@N'=(Y+7=<J60*6!,08 @.IP<=:K
MM\)O Y=G308X'9Y6+6\\L)_>+M=<HP^0CC9]T G &3G0TKX?>$-%CMUL?#FF
MHUN^^*:2 2RJV=P/F/EL@].>.,=* /(-67QI\:=3L+O1EN]*\*!Y(A-,5C"_
M>1W(#[IB4)7@!069,\,Y]>\&>"['P9ICPPR27=_<MYM]J$_,MU)W9B22!R<#
M)QD]223TM% !7B/QG^'FJ7%T?%OAI)Y;XRVYG@M8-TX>,,JS(^=ZX!0%$'.
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M/<P+)A"0<8(P>1QGIDXQDY1/"?AN.T:TC\/Z4ELV[="ME&$.2I.5QCG8F?\
M<7T% %S3=7TS68&GTO4;2^A1MC26LZRJ&QG!*DC."./>O OC%\.XM*\0Q^)K
M'2WNM/OIS_:.^]V)')(=H.2!Y0).X.S,H8X*A0 WT#::?96'G?8[2WM_/D,L
MODQA/,<]6; Y8X')YJQ0!X+\+_BY'IN@V&C>(8IWMXU>*VO;6V>18DB4DQRA
M5Y*H%.Y WRLI;&":[N7XT^!$L+B\BU:>XC@ !$5C/RQ!*IED"AFVG&2!P>>#
M5RX^$_@>XU0:G_8,<%V'5U>TGEMPC+C#*L;*%/ .0!SSUJ]H/P_\)^&91-I.
MA6L,ZN76=P995)&#M=R6 QV!QR?4T ?,%WJ5W<?$^\UW4K&Z:[M-92>6WCND
MFDACC=G>,+UD"K'C<I"J%YX(Q]3Z;XT\.:SJXTK3-8M;V]-N;DQVS^: @(!R
MZY4')'&<\]*P9?@_X,NO$M[KMYITEW<74PG,4TS&)),Y8A1C(8\D-N'8 #BN
MKTS0=&T4RG2M)L+ RX\PVMLD6_&<9V@9QD_G0!H4444 %%%% ',ZW\0O"F@6
MMY+>:[8--:9$EI#<(\Y8'&P1@YW9XYQCO@ FODK1K^VTCQ1;7\)CFM[*X2:Z
MDW(?.19U;,*R*K*<!1@?-]X\*2!]<6_@#PC;0RPKX=TYXI;A[DQS0"55D8 ,
M5#Y" A5X7 X'%6_^$2\-BZANO^$>TG[1#L\J7[%'OCV !-IQD;0!C'3 Q0 E
MAXO\-ZI<Q6MCX@TJYN9?N00WD;R-QDX4,2> ?RK9K#@\'>'+._M[VST>TLY[
M=S(AM$\D%BI7+*F Y 9@-P.-QQC)K9FABN8)()XDEAE4I)&ZAE=2,$$'@@CM
M0!\_?M :UI>IW&@16-W8W[V2/=SP^>-K1.8M@R&!;<.<*=VWYN!S76_!KQ/X
M<M/ ECHKZ_IHOH;F:$1--Y9D+2L5V+)M9@0RXX[XZY%=O_P@G@__ *%30_\
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M=!GI7F'P0\0Z-X<\17]MJ4B:8MY86[I+=X@C)49)R[G.[=D$<$9.%Z5[Y?\
MA;0-5NVNM3T>ROYFP ]Y"LVT 8PN_.T=\# R2>I)J)?!?A5()(%\-:,L,A#/
M&+"(*Q&<$C;SC)Q]30!IV&HV6J6BW>G7EO>6S$A9K>59$)!P<,"16#X_\(Q^
M-O"-UHY=(YV(DMY7SM21>A(!Z8)'?KG!Q6MH^@Z3X?MY8-(T^WLH996E=($"
M@L>I_H!T X'%:- 'R%H&NZ[\-/$"20VUWI\1O#%<6U_;$(\>%/SRA0[$ [@
MG .0#N(/M^@?'7PCJL$9U"632I6<18G(=&?C."OS!1D?.ZH/R..WUGPOH?B
MJ^J:9;W$R ".XV[9H\'<-DBX=.>?E(KGH?@_X"A+$>'8G9I%D)EGED)922.6
M8\<\CH>^: *UMXMU/QKX@-CX8DFTW3]-N2NH7ES9;FE*D8B16P K GYOOC ^
M5>"W0^-?#2^+O"MWH[321&;:RLDC)D@@X)'8].0P&0<' %:]AIUEI=HMIIUG
M;V=LI)6&WB6- 2<G"@ 59H ^1-&UG7_A1XP>TNHX[2YA $D#R*8I8CN?;(8T
M8NQR-K9RO?C('MNA?'/PMJED)K]+O39%@\Z13&;A5&[:>8MS* <<NJ9R,=:[
MC6?#.B^(898M5TV"X\V+R'D(VR>7N#;0ZX8#(!P#7.+\'? "FW(\.0_Z.<IF
M:4YYW?-\WS\_WL\<=.* ,E?'NJ^,O%,&D>$[74K*RM+K&H:C<:>-C*N2R#>1
MLR-O!&_YLX7;SZ)J.J:?I%M]IU._M;*W+!?-N9EC7<>@RQ SP:=8:=9:7:+:
M:=9V]G;*25AMXEC0$G)PH %0ZGH>DZTL:ZKI=E?K$28Q=6Z2A">N-P..@H ^
M5-4U-1\7I]0MVC>%-<DN#&U@7F6,$%G(:,DJ%!(')!4G ZGZLTK6M+URV-QI
M.HVM]"IVL]M,L@4XS@X/!P>AYK-_X03P?_T*FA_^"Z'_ .)JWI/AG0]!N+F?
M2-)L[&2YV^:;>((&P, 8' 'L.^3U- '(?%OQ)HEIX*U72YM:TZ'4W5/+MI2)
M6+!@X#1@,<$+_$NWD9X->8? GQ3H^D:OJ<&JZW';1RVL7D?;6$,:L&9I%0DE
M0-S9'(SUQUQ[P/!WAH:G<ZD="TY[VY8M+.]NK,Q*[3R1QD9SCKDYZFH[GP/X
M4N[06LWAK26A5&C119QKY:L23M(&5Y).1CDYZT ;RLKJ&4AE(R"#D$4M0VEG
M;6%G#:6<$<%M"H2.*-=JHHZ "IJ /DCQ5X0N=&^*T_AZ'2DN+34;I9+:':YW
M1-G!63:7&W<22,C*\A@,5]5:1IMOHVCV>FVD7E6]M$L4<8<MM '3)Y/UJI>^
M&=.O_$5EKDXG^UV:E8PLS+&W7:64'!*[GQ_O'VQL4 >0?M!>&(]2\'Q:Y#;[
MKO3I 'D7:/W+<')/) ;;@ _Q'BJOP(\,RJ-3\67?SF_(2U::9+F4)U8F5>0Q
M)P00I^7D5['=VL-]9SVERF^">-HI$R1N5A@C(Y'!JOH^C:=H&EP:9I5I':V<
M(PD29X]22>23W)Y- %ZJ&IZYI.BK&VJZI96"RDB,W5PD0<CKC<1GJ*OUEW_A
MO1=4U.UU*_TNTNKRU!$$TT08IR#QGT(R#VYQC)H ^4_!NOZ7HWQ"M]1-Q/;V
M2ZIN>-[C>)(V#*K'"JIV%B2Q(X;@=:^L]-UG2]9A>;2]2L[Z)&VN]K.LH4]<
M$J3@U1_X0WPOY4L7_"-Z/Y<S!I$^PQ8=AG!(V\D9/YFK6CZ!I/A^"6#2-.M[
M**60RND"!0S'O_@.@' XH \5^-/@">"^E\4Z/:R3+/B2[AAL(YPDD?(=L\A"
M-Q;@@D#=D$8R?AM\8)/#.FW.DZM&=2TVP7=#-8QR-*%+=</A1&,@<[,9  /;
MZ1KE=6^&WA#6]675;W18_MZMO^T6\LD#%LYW$QLN6S_$>?>@#!N?CEX)CLFN
M+.XOM1=%#R06MD^^->[,7"J "0"=W<5)X-U'7_&?B5O%L@N--\-BW-O86$KM
MNN@3GSG4':.^#SQW(&3KZ?\ #'P=IEY#=P:*CS0 B'[3/+<+'EMQ*K(S '=S
MD#.2?6NMH \@^.&OZ'?^$9-!M]1L+K5VNE"6:.\DH=3@@+'G:_S8 ?@\]\5D
M_ ;7_#VDZ5J6G7&JVUE=7%X'CL[N;;*HP$"EF559B1T7)Y&0*]2C\ >#XS(?
M^$7T=S([2,9+.-SDG)Y8' ]N@[4^3P+X3DM)+3_A&]*2"5D:1(K1(PQ4Y7.T
M#./ZD=": -F\O;73K22[O;F&VMHQEYIY B*,XY8\"OEOXS:Q;W7Q#N+BVU*Z
M;;:QFTN+:<21,C1K\JX(V@Y<E@3G.-O4U]-ZKH>EZWIPT_4[""ZLPRL(9$RH
M*G(P/\\9'0U6C\(>&84C2+P[I*+%)YT86RC 1^/F'R\-P.>O H H^#_%^@^(
M=(T]-/U.T>Z:U5S9^>AG0  '<@8D8KIZPX/!OAFUU2'4[;0--M[V$L8YH;94
M8%NI^4#)]STR?4UN4 %%%% '@/Q<N[[P-\2[+Q=I=Q)')<VZ1S(\>5F ;#1H
MQ0JORJN<G(W BO7?#OC71?$FR&UNXX[_ ,M9'LI& D (!RO9UY'SJ2OO6U>6
M=KJ%I):7MM#<VT@P\,R!T8>X/!KB+KX,^")[0P0Z;-:_O/.0Q74C*C\?,(W+
M1G( &"I&.,4 =CJNL:;H5@]]JM[!9VJ=9)G"@G&<#U/!P!R:\%U2R?XX?$R.
MXTU/^*9TM5BDO)(F3S5SN90,@DL2<?=(')QQGTG1O@UX*T=$(TZ2[N5F6<7-
MQ*?,#*VY<;-JJ >P !P,YQ7;65A9Z=;_ &>QM(+6'<6\N",(N2<DX'&2: )8
MHDAA2*,81%"J,] .E>!?M$65P^L:%=,MF;7;Y2)-A#+)ORREQ@A -N<LH&[(
MYSCZ JEJNCZ;KM@]CJME!>6K]8YD# '&,CT/)P1R* /-OA;\1M!?PQ::'?W-
MOIU[IUJ-X:=7A,0P _F@E5Z@;6.0?7K7>^'_ !3IGB=;I]+::2&W95\V2%HU
MDW*&!3< 2N#UQ@]LCFL.'X1^ H+R"Z3PW;&2%0JAW=T( Q\R%BK'W8$GKUKL
M+:UM[*VCMK2"*"WB4+'%$@54'H . * /(_CMXETW_A"WL;#6[3^U(;U \$%T
MOG(-K!LJ#N'!P?K6-\"_%WAC3=*U:VN[VRT>22=)1#<W6U2-@!*L^.,@_+DD
M=R>M>OKX.\+HTS)X;T=3,I64BQB'F G)#?+R,@'GTJ.\\#^%+\S-=>&M)EDF
M!$DALX]YR,9W8R#[YS0!O*RNBNC!E89!!R"*\X^+W@1O%>C6^H6,._4]-8R(
M$A21I4QG9M;[_(&%) Y;@G@^@V=G;:=9PV=G!'!;0J$CBC7"JH[ 5/0!\K_#
MSXCZOX$GGTFXT^YN(U<F?3)-RRH^26>)1'\@51\R,>>HQS7M$/QD\(FV#WLE
M]IERRR,EK?VCQ.VS.0&Y3)Q@?-UXX-;_ (B\#>&O%FS^VM+CN2CEPRR/$2V
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MWUC?216A03Q[9XTD+<*26$>"#R3NV\=#7K'PKUG3'\#Z'I O[;^THK7#6ID
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M<9]" ?45Z37-S_#[P;<0M$_A71@K=3'91HWX,H!%=%'&D4:1QHJ1H JJHP%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% &1XC\-:?XJTY-.U7SWLA*))8(IFC6; ("N5()4$AL CE5]*MZ;I-
MAH]NT%A:QP([;Y"O+2O@ N['EW.!EF))[DU<HH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!E>
M(?#UCXGTS^S=2,[6;2!Y8HIFC$H&?E8K@E<X. 1R!5K3=+L-'LDLM-LX+.V3
M[L4$810>YP._O5NB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@!LD8EB>-BP5U*DJQ4X/H1R#[BN;\,^ /#?A-WGTS3U^V2$E[R=C
M+,V>OSMR ?08![UTU% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%<_\ \)WX/_Z&O0__  8P_P#Q
M5'_"=^#_ /H:]#_\&,/_ ,50!T%%4]-U;3=9MVN-+U"TOH%<HTEK,LJAL X)
M4D9P0<>XJY0 4444 %%%% !15/4M6TW1K=;C5-0M+&!G"+)=3+$I;!. 6(&<
M G'L:L03PW5O%<6\L<T$J!XY(V#*ZD9!!'!!'.: )**S_P"W='_MC^R/[5L?
M[3_Y\OM">=]W=]S.[[O/3IS5R>>&UMY;BXECA@B0O))(P544#)))X  YS0!)
M15/3=6TW6;=KC2]0M+Z!7*-):S+*H; ."5)&<$''N*N4 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !17/\ _"=^#_\ H:]#_P#!
MC#_\51_PG?@__H:]#_\ !C#_ /%4 =!15/3=6TW6;=KC2]0M+Z!7*-):S+*H
M; ."5)&<$''N*N4 %%%% !1110 4444 %%%4X]6TV;5)M+BU"T?4(4WRVBS*
M947CEDSD#YEY([CUH N457OK^STRSDO+^[@M+6/&^:>01HN2 ,L>!DD#\:+&
M_L]3LX[RPNX+NUDSLF@D$B-@D'##@X((_"@"Q1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%5[Z_L],LY+R_NX+2UCQOFGD$:+D@#+'@9) _&L?
M_A._!_\ T->A_P#@QA_^*H Z"BN?_P"$[\'_ /0UZ'_X,8?_ (JMR">&ZMXK
MBWECF@E0/')&P974C(((X((YS0!)1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !114<\\-K;RW%
MQ+'#!$A>221@JHH&223P !SF@"2BN?\ ^$[\'_\ 0UZ'_P"#&'_XJC_A._!_
M_0UZ'_X,8?\ XJ@#H**KV-_9ZG9QWEA=P7=K)G9-!()$;!(.&'!P01^%6* "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BJ=YJ^FZ=<6U
MO?:A:6LUTVRWCGF5&F;(&$!.6.6' ]1ZU<H **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBHYYX;6WEN+B6.&")"\DDC!510,DDG@ #G- $E%<__P )
MWX/_ .AKT/\ \&,/_P 51_PG?@__ *&O0_\ P8P__%4 =!11G(R** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBLO4O$N@Z-<+;ZIK>FV,[('6.ZNDB8KDC(#$'&01GV-
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M HHHH **** "BBB@ HHHH **IZEJVG:/;+<:IJ%K8P,P02W4RQ*6()QEB!G
M/'M4]O<07=M%<VTT<T$JAXY8V#*ZGD$$<$'UH EHHHH **** "BBB@ HHHH
M**** "BBB@ HHJG::OINH75S:V6H6ES<6K;+B*&97>%LD8< Y4Y!Z^AH N44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%9^FZ]H
MVM-*NE:M87S18\P6MRDI3/3.TG'0_E0!H4444 %%%% !1110 4444 %%%% !
M1110 4444 %%,FFBMH))YY4BAB4O)([!510,DDG@ #O573=8TS68'GTO4;2^
MB1MC26LZRJK8S@E2<'!% %VBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHJIJ.JZ=H]L+G4[^UL8"P02W,RQ*6.2!EB!G@\>U6E974,I#*1D$'((H 6BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK+L/$N@Z
MK=FTT[6]-O+E06,-O=I(X ZG:I)Q6I0 4450U/7-(T58VU75+*P$I(C-U<)%
MOQUQN(SC(_.@"_12*RNH92&4C((.012T %%%% !1110 4444 %%%% !1110
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M(K>WB&Z269PB(/4D\ 5'I^IV&K6OVK3;ZVO;?<5\VVE61,CJ,J2,T 6J***
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M@C.#Z&N?U+QE-IWQ(T;PFVD2-!JEO)*FH&4JJLBNS(%VX8@(N?F&-XX]>LH
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M.*U8,IBVKACAWYW%AU[#CUXO0$MV_:5\521OY<R:5$DD;L6,I(@.]<* J@!
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MDDJ!P >P445R_CCQO9^"-)2ZFM9[VZF\P6]I;D;WV1L[.<G(C4+\S ';D'%
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MDD@#FO(K7XH^._%]Y-)X*\,6+Z='&S(]\Y=I2LFW:65U2-R"&\MCG )!((R
M>T5Y/\+9;9_B'\0HTM?+N8]0(DF$A(E4RS$94]&'(R#@C;QD$F>R^)^KZ)JM
MKI?C[0X-)\[:O]I0SD0&1QN"A6Y(4':[JS*K8S@$&F?#!S-X^\>.'=HX[XP@
M/<J^/WT[_(G5$^?W!;<0>H !ZI1535-4L=%TRXU+4KF.VL[==\LLAP%']23@
M #DD@#FO)KCXJ>-?$.H2P^!_!<CV]M/]GGEU12K>9MW;2H=1&1ALY8]5SM)
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MLQX[(-W8<B@#V:BO,_ OQ8?Q!K*^'/$.C3Z-KPCW>7*-B28 /"OAU)R2%PW
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M(=N!R"TD>X'U"X[9.*LZ1\9KS2]831/B#H4FB7KMM6ZC!\AN2,D$G"\8W*S
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M&2UL+X^3<2162CDG#!G"DNS<=>0!Q7ME %74;Z#3--N;ZYFBAA@C+N\S[4
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M.K-@ %B<DG'))->)_&+3%U?XN>&+"_CC73[JWBME=HF5I'DG,;A)%7ET5UD
M8[1CD'=M?H(?V=?!L3EGN]9F!1EVO<1@ E2 WRQ@Y!.1VR!D$9! /4-5TJQU
MS2[C3-3MH[FSN$V2Q/T8?S!!P01R" 1@BO*_A!J%QIGBWQ9X,O;F?_091-:6
M\L(C&-Q$TD:JH6.-V:-UC' #C&?F8V$_9[\'K9M;/=:K(IR4<R0AXV)3)#",
M$\)@!LJ-S$ $YKI/!GPPT'P+>O=Z1)=M++;^1*;@HY?YRV[.P%3T7"D*0JD@
MD9H C^+_ )1^%NLI-Y CD\B,O/OV1[IXUWG9\WRYW< _=Z,.#L>!/^2>>&O^
MP5:_^BEK'^+R/)\,=3CBL_MLC2VH6UPQ\XFYBPF$(8YZ?*0>>#FMCP)_R3SP
MU_V"K7_T4M '#^)(=O[2'@V?[-.N_3YT\]C^[?$<YVJ,?>7=D\GAUX'4^L5Y
M/K_FP?M*^%9!Y!CN-*EA(.QW&T3L2 <LG\.&&,_, 2-PKUB@#R/]G>-8O %\
MJ31S ZFS;D#  F"$E?F .03@]L@X)&">@^,\:R_"37E>:.$!(FW.&()$R$+\
MH)R2,#MDC) R1A_L^^;_ ,('>^=Y&[^T./(V;=OV:#;G9QNQC=GYMV=WS9KH
M/B\VSX8ZFWFP18EM3YEQ'YD:?Z3%RZ[6W*.XVMD<8/2@"/X1>'H=&\!V5ZUM
M:)J&K)]NNIK= HD\PEXQ@ !0J,!M4!0=V!R2>\KG_ G_ "3SPU_V"K7_ -%+
M704 >+_#.QN/#'QA\7>'4CL4L)(A)"L##?&D7E^4I'!_U=P S,#N92=S$,3J
M?'K5UL/!5I92^9]FU"]6&YQ;M(!$%9L@@J-ZL$=5++N*8Y7<*K^'XU'[3/BF
M431EVTQ5,0#;E 2TPQXQ@Y(&"3\IR!QG'_:,CN5'ARZAFDM8D2]B>X <+EXT
MQ$2H/,BJZ@'@\YP,D 'J'@/PI#X,\'6&C((S.B;[J1,?O)FY<YP"1GY02,[5
M4'I6QJNE6.N:7<:9J=M'<V=PFR6)^C#^8(."".00",$58@GANK>*XMY8YH)4
M#QR1L&5U(R""."".<U)0!X7\,-%OO#_QGU[3KF?4IX([>[99+P[@SM- VX."
M0[M$;=F.%.6 (X!/NE>/^$;O3M2_:)\77-I/NFBM#;N&+#?L^SHVU=G&QXW!
M);YMR[1@$U[!0 4444 %%%% !1110 4444 %%%% !1110!\P?"VQ\67=UXC'
M@'5]*LU;RQ=&>)_+0^;(8S 75V9=BD9D .)"""0&KTN\T#XN7SSJ_B/38+>=
MTW16UP(RD94B54?[*74DGY&R2@'.\_-7-_LW^:O_  D4,OD?NXK+:8=ARK><
MXW,GWF^?!W$L,;3C;@>\4 ?/%IH&N^%=<NKCQMX8G\80-=I#97EW.)I!"GFC
M<JMO7YO,7;"[J6=D"AF&5][TK5;'7-+M]3TRYCN;.X3?%*G1A_,$'((/(((.
M"*DO[&WU/3KFPO(_,M;J)X9DW$;D8$,,CD9!/2O%_P!G6^>6+Q-91R0?84EM
M[J*&!6V0O*K[U!?YS@(B\D_<X)SN(!8^.FK/J-UH?@2SFVW6K2HS_O&C5295
M2(R$ AXR?-RHY#(C=L-ZQH>C6?A[0[+2+!-EK:1+$F0 6QU9L  L3DDXY))K
MQ/XQ6:ZI\7/#&E:I;W<NDZA;Q6D;QRM'Y,KSD.\9(*;P/+W J<J0.#M8;G_#
M./@__H):Y_W_ (?_ (U0!ZQ?V-OJ>G7-A>1^9:W43PS)N(W(P(89'(R">E>1
M_!B[;1_$?BCP8^HR36EE<22:9!(ZR,D23R12$E1\A+",[3C.[<%PQ)L2?LZ^
M#72%5N]9C*)M9EN(\R'<3N;,9&<$#C PHXSDGJ/"7PRT7P7K,^H:3=:ELE25
M$LYIP\$(D9&;8-N<_NT&222%&<XS0!7^,XA;X2:\)Y)$39$040,=WG)M&"1P
M6P">P).#C!L?"G15T;X<Z0?/DN)[VWCO)I7+$DO&NQ>2<!(Q&@Q@80<#-1_%
M]+>3X6ZS'=/Y<+^0AD+%1&3/&%=L*Q*J<$@*20"!@G-;'@3_ ))YX:_[!5K_
M .BEH Z"O(]"$(_:=\3F*21G.CH90R!0K8M^%.3N&W:<G')(QQD^N5Y/HTJ2
M?M->(51LM'HB*X\A8]IS <;@<R<$'<V#SMZ** /0/%GVS_A#=<_L[S_MW]GW
M'V?[/GS/,\MMNS'.[.,8YS7+_!+_ ))#H7_;Q_Z425TGC2":Z\"^(;>WBDFG
METRY2..-2S.QB8  #DDGC%<W\$O^20Z%_P!O'_I1)0!R_P =+>\O=:\'V6G7
ML%I?7,LL-O+*#N$C36P4HX4F-@<-N&#M5ADYVMZYI6E6.AZ7;Z9IEM';6=NF
MR*).BC^9).22>222<DUY?\6X)IO'_P -GBBD=(=3WRLJDA%\^V7+>@W,HR>Y
M [UZY0!A^,= 7Q3X.U7166,O=6[+%YC,JK*/FC8E><!PI[].AZ5Q_P #-2N[
M[P'<6]XMH'L-3N+<&U";#DB4D;#LQND8#9A< 8]3Z97E?P%@N[7P9J5O>Q1Q
M3QZF5Q&J!646\&U@4^5@RX;>,[\[LG.2 >J4444 %%%% !1110 4444 %%%%
M !1110!P?QGF:#X2:\Z",DI$GSQJXPTR*>&!&<'@]0<$8(!K@_A_I/Q%N/!>
MDS^'M?TJWT5MAB@C;:54%A.I,MM(?,9\G=DJIW84J5 ] ^+XN'^%NLQ6D'GW
M$WD0QQ"$2ER\\:X52#EN>,#(.",$ U'\&3"WPIT=K>.2. O<F-)'#LJ_:),
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MG!YK+\6_#S1/&5[:7U\UU;7UHA6"[LI!%+&=ZN&W8))4J<9X&]CC)!')ZS\
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MN[63.R:"02(V"0<,.#@@C\*YOPW\.]$\*:_>:MI#7<#7B.LUJL@%N29"X8(
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MUV@ KPW]H[R9;70;=[>-YV6ZDAF:X$7E[!$S#YCM8,N1M^\6V;3U5_<J\/\
M&$I\:?'/1- _L[^T-+T^+S)/-7$2L)-TL@90P9<QK"RN"NX.GRL=P /;DX1>
M,<=#7B/@9?\ A8/QIU?QM'<_\2W2LVUE']HRYRAC5O+(W+&R^8^"%^9^-Q#5
M[AC P*^9/A=\.=%\9SZL-3%UIM[IR):S6D1!8.0Z.[++$P4D 8 8E75V&T;
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M<US?P)TR;_A$'\0W=W=W%WJCL&,]R91M260Y *@J2SN2-S9/S9!8@ $WQO\
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MS7H]>+_ .R>4>(->-UYPO98XI1+*TDPF3<7+DHHPV\,,%N#@G(- #OCSI_\
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ME L:X'#;I%<$LH'EX.0<'N?"?A;3/"&@0:7I=OY4:@-([$%Y7QRSMW/Z= ,
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M=6: NUX+=&4KNC)QNW88E,C[N%WGELE1['9VD%A9PVEK$D4$*"..-%"A5 P
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M,-S&^X+\P;:/G) 3E\[B>,?C6K\,[B.X^&^@M'/',4M$21DD#X<<,"1W!ZT
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MP%H^O>*-/\0:@T\MU8,#!&=ABQ_=*E>1G+9SG/?& .HKQGQOK&O^-?'[>!=
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M\3O">D6=U'YT,J22QR7BA$RVX?NL;MQ"GYAGC&0.M 'ME%%% !1110 4444
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M+&XN=F_R8VDVYQNP,XS7C/PBT1O%6N7WCS6%M+EWF8V8$*[HI"?FRP"Y90%
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M0_*JGL&((/'/!/J%<WKO@'POXDN)+C5-)CDGE39-)%(\+3+E2!(8V4R &-"
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MAN .#UY /J!7KE5[6PL['S_L=I!;^?*T\WDQA/,D;[SMCJQP,D\F@"Q1110
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MR%A]WY\!B,$':6 ]>1GB_'/Q)'BBZB\$^#9-VI7<JQW$MW:S($(E :$QE,G
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M%GW/-.;5&"%W8M@%B68*"$#,22$&?2MC3=)TW1K=K?2]/M+&!G+M':PK$I;
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MFN)I)O/+E2WF[V/F#<BL ^0&&X8/-=1!!#:V\5O;Q1PP1($CCC4*J*!@  <
M <8H \W^,]EKS^'[74]$U74K$6;LMR;.X>)8XW*9GE"99T0(V54$C?NZ*0;_
M (<^+WA'7-/LY+G5K73+V>W,TEM=S!?*PQ0@R'"YR,@9#%2&V@&N]KE]4^'?
MA76;PW5WI6)CYI8V]Q+;AC*,2L5C906<<,Q&6  )( H Y3XC_$[0$\-WNA:5
M(^KZIJUNUI:PVB,R2"4-'O60#:X!RN$))8;>,$KM?"?PE_PB'@>*V=IS->2M
M>2"=/+=-P 563JC!%3<N6PVX D8K9\-^!_#7A'S#H>D06DDF0TV6DD(.,KO<
MEMOR@[<XR,XS704 >1_&GPS,ITWQYI<,DNI:$R.\2Q&19(TD#JS_ #C:B'>2
M5!)W<X W#I_#'Q3\*>)K=O+U>TMKN)6::":0Q@!=Q9D9PN]-J%LX!"X+!3P.
MUKC]9^%G@G7]1>_U'0('NGR7>&22'>222S"-E#,23ECR?6@#E_B1\5;*TM9?
M#?ANZ^TZ[?1>7'+")"L0DB#(8V0$O(X=1'LR S L0!@]/\-/"4OA'PDMO=/F
M_O93?7B"-(TBF=5W1HJ?*%7 '''!(P" -70/!^@>%T5='TV. JAC61G:5T0M
MN**[DL$W?-M!QDDXR2:W* /)OB\UO_PF'PX1DS='6D,;;"<()(MPSNP,DIQM
M.<=5P0WK-5[NPL[\0B\M(+GR)5GA\Z,/Y<B_==<CAADX(Y%6* /"_#/B^]^'
M'B_4M!\<:G=W%M]G$D5_<7$LAVK-(J/Y;EMQD#)Q#NVA1N&5D*^H2^/_  I%
M;02G7+5GG6%XK:,E[AQ*%,>(%!D)8.I VYP<UJ:SH>E^(=.>PU>P@O;5LG9,
MF=I((W*>JM@G##!&>#7+I\'_  #'+:R#PY 6M<>6&ED(;#%OG!;$G)/WL\8'
M0 4 <'#"GQ4^,.G>(+72]1@T/2U1K?4Y%:.*Z$,CGY08R"3*Z\;@0L;Y^8X7
MW2J]C86>F6<=G86D%I:QYV0P1B-%R23A1P,DD_C5B@ HHHH **** "BBB@ H
MHHH **** "L3QE.]MX&\03QB,O%IMRZB1%=21$Q&58$$>Q&#WK;J.>"&ZMY+
M>XB26&52DD<BAE=2,$$'@@CM0!\_?!SXA>#_  ?X8U'3]4UB2!GU*26#S+23
M<\11%#$('"D[3QN./UKO;[XZ^ ;2SDGAU2>]D7&((+20.^2!P755XZ\D=/7B
MNP/A/PVUY->'P_I1NIM_FS&RCWR;P0^YL9.X,P.>N3GK48\%^%5MWMU\-:,(
M'=7>,6$6UF4$*2-N"0&8 ]MQ]: /+]1^*GB/QF+G2O GA^1Y \!:>2?+&%XV
MD8%HSLA/R[,F4.,X4!\[.L^%_P ,T\ :?,US<V]YJ5Q@O+';JOD@A=T:N1O9
M<C/) . 0JG.?0** "O#_ !&9?A9\5%\06^D_:-)UR7;)-N2-87E(\Y3(W\1:
M..12[*@!D  R67W"HYX(;JWEM[B*.:"5"DD<BAE=2,$$'@@CC% '/:?\0/"F
MI6\T\6N6L*PHLD@NR;9E1@A5RLH4[#YB8;&#N&#7F/B_QOJ/Q+O8/"_@"X06
M[.LTM\VY'9HWC8%1C?"B%E;S&"[BA5"2-K]W_P *?\ _VC]N_P"$<@\[S?.V
M^;)Y>[.<>7NV;<_PXVXXQCBNHT;0M*\/:>EAI%A!96RX^2%,;B !N8]6; &6
M.2<<F@!^CZ9#HNB6.EV[.\-G;I;HTA!8JBA03@ 9X]!7FFAK_P 9(^(F\J ?
M\2\CS%ES(?W=GPR;CA1G@[1DLW+;<#UBJ<>DZ;%JDNJ1Z?:)J$J;)+M85$KK
MQP7QDCY5XSV'I0!<KB?BYY7_  K/5//\CR?,MM_VCS/+V_:(\[_+^?;CKMYQ
MTYKMJKWMC9ZE9R6E_:P75M)C?#/&'1L'(RIX/(!_"@#%\ _\D[\-?]@NV_\
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M26&52DD<BAE=2,$$'@@CM4=C86>F6:6FGVD%I;1YV0V\8C1<G)PH  Y)/XT
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M^TLHG?>Z6T*QJS=,D*!D\#GVH XKXO>"H?%_A(R+;W4NH:>WFV_V;#/M+*)
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MOODY YP> >:^$OAG5-4UW4/'_BBR@-SJ0673F,OF&)&!)*C)VKM*J,G< ",
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M<C%U$>0),KE_+VG:ZIC(&<-VU]&^.'AJ\6XAU:#4-)O+.,-=)+:/(J'.UL%
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M2(L!TSL89/;)YQ@=J .5\??%6SBT2]T[P?,NL:LZK$SV4A<6XD^4.I4Y<Y(
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M:Z@T3NO/(0A=W!'(V].?K7O%9>N^'-'\36)LM9TZ"]@YP)%Y0GNK#E3[@@T
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0B@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>tern-20230515_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-05-15T13:32:00.0075+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Information, Former Legal or Registered Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>tern-20230515.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-05-15T13:31:59.9773+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.ternspharma.com/20230515" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:tern="http://www.ternspharma.com/20230515" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tern-20230515_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tern-20230515_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:roleType roleURI="http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>tern-20230515_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-05-15T13:31:59.9818+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="tern-20230515.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10200.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="10150.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140312423665312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>May 15, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 15,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Terns Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001831363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">001-39926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1448275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1065 East Hillsdale Blvd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Foster City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">525-5535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TERN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>tern-20230515_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tern-20230515.xsd" xlink:type="simple"/>
    <context id="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001831363</identifier>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_f56cf9f4-58fb-4c89-af41-1770cbae2738">0001831363</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_d86f097c-e11b-4c57-b73e-49c2206583a1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_02003622-2c09-43ae-a277-bd0069ec1c63">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_8ec5f9ce-20f9-4d6d-ba04-e63210e11ca1">2023-05-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_047373b3-d5e3-4037-aa0b-81dd1a3b6d25">Terns Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_fd9a4bbe-9ceb-482d-be2f-390eb8ee9cae">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_965f27e4-ba36-4028-b6b9-26c26b36f30d">001-39926</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_92c751e0-4fab-45e1-a6cd-e2d52b1cb75f">98-1448275</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_1b1fbd51-1800-42c4-8524-db249acda9ed">1065 East Hillsdale Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_a1fe2e0a-48c4-4fa3-8659-1dcf2433fb4a">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_d1d3b7fb-3c27-4326-af07-08d345cf4b14">Foster City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_ed52d6a0-0022-4b8e-99ee-09ec0418d5bc">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_ad479786-169b-455e-8a9c-64c50d1196f4">94404</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_67a91fe6-1255-4c4f-aa36-ff4dae9e6bb6">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_b275a92d-77f1-4fa6-bc1b-4b3565312c11">525-5535</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_493d2375-eb9e-4e2c-be63-e882231caf2a">N/A</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_d33847cb-6f0e-43b5-821d-10f2d260728f">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_9e4c5499-d0c8-4916-9edc-54c32d512272">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_218f6234-a586-4a0e-933b-d09b88966cf5">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_01923edb-09e5-4715-8a6e-9581531c59e7">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_6e932075-b725-4d60-b805-8d0beec70b9d">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_2f19d6d0-b5a2-4493-9ad4-f478ca7cb3ad">TERN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_6fc7aa51-f081-442c-9779-bbae35a694ea">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_51025c74-f953-45b6-91cf-7dc927a84bf9">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_eb493fc0-5c00-4036-89c7-e55c9ec3d652"
      id="F_de4c9f74-0ebb-4f38-b2af-e83846937f39">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M;'] GN Z\B6MCQTNZ7N=@-PS;<@G$<<Z8I SM_$ZPG:O7]4"'W=S%'BVD;7
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ B86O5CJJHN=  0  / (
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M7>EYIM<WDUM)Z.#<@V#OX96,'<V/'W?W U!+ P04    " ")A:]6)!Z;HJT
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M2P$"% ,4    " ")A:]6!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( (F%KU8\C1?2[@   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M (F%KU:97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ B86O5K^C,3J_!   E1(  !@
M     ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M (F%KU:?H!OPL0(  .(,   -              "  0(-  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ B86O5I>*NQS     $P(   L              ( !
MW@\  %]R96QS+RYR96QS4$L! A0#%     @ B86O5CJJHN=  0  / (   \
M             ( !QQ   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( (F%
MKU8D'INBK0   /@!   :              "  302  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( (F%KU9ED'F2&0$  ,\#   3
M          "  1D3  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(  &,4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="tern-20230515.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tern-20230515.htm">tern-20230515.htm</File>
    <File>tern-20230515.xsd</File>
    <File>tern-20230515_lab.xml</File>
    <File>tern-20230515_pre.xml</File>
    <File>tern-ex1_1.htm</File>
    <File>tern-ex5_1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tern-20230515.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 25
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tern-20230515.htm"
     ]
    },
    "labelLink": {
     "local": [
      "tern-20230515_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tern-20230515_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "tern-20230515.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 25,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "tern",
   "nsuri": "http://www.ternspharma.com/20230515",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tern-20230515.htm",
      "contextRef": "C_eb493fc0-5c00-4036-89c7-e55c9ec3d652",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tern-20230515.htm",
      "contextRef": "C_eb493fc0-5c00-4036-89c7-e55c9ec3d652",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ternspharma.com/20230515/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000950170-23-022264-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-23-022264-xbrl.zip
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MP8]@Y"21<3PFGZ*$)3QB,>G50^[#''F+',4QN<2O<G(I<YG=2-'"+O]RV"\
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MQ?GEU9N UME2T%Z,LGP$WC4I4M*37 6_=).D&='M7;%'TI 4?8FO1EE41##
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MLJ^R>),TV"77]:Y ;&P@8DX3@3M4D@1CPE6V(*S[*WAO4A6/7TCEBW("JY6
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M'+5Z6<9IZDRL_&S<*TFZM3\QMW&\>CR->#Q6/N+U:*(YKKH.+-E@X,TPT##
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MH>]6N[+1HYUM!9W-;B3-/7/]!U!+ P04    " ")A:]6WHMI.A,&  #K.
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M!8%<1\LRS\N;NFL;I-GU4=KPHJ\(19F9-SY;YOKC6=VHJAG6@VZ<\O01*L;
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MS)?6#%WD0D?O*T5QXY?PYUD8;3R9BI&O%CS\PM=E;ETL<WRYSHSR;\%IP\.
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M/S_*U1 9XQFX?2N;WX.Y K)NAIPTJK'@DK2M9>: WX-MW.$B*USE.DN=#1G
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M:(MY<NF\ /WT2?$NPQ?"F "'RX69I'J9)9DN$@'NFCR14.T>YCI88**GAO-
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MRL90XI+D)!R$8J1#]_CBU+F@%26DP73V?6<)/Z+@);;_3A228(2^7HJ)57
M ^N-%EXKNVWC0CN\* 1H2<KMSF+^I*T-QUV[WX&+A\B6MA#2J=+"9/SO9A(A
MX']9GI "Q(.+2KG?<R\P(R) .A2UDGI CJ4R&F7V@B=9%D3ZO-'IS@]T\?X1
MVJ2+AO0/03^D&\Z1OLMT0[0JE3\5LT;[9'<*[X2CW]UY7B7<!AN$IKYGJL8
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M=(31Q756E06U$,X1EKW)&MOB4$B"V?95;;,N*W$=O,3N H2KAEU6V$>^,2F
MO$0>W5S=H  '8Y;1HM(= 25QYOH),$7VP4[/)B=PA[78]RY_;;K#X,6R/1QB
MUCZ4FZ942+<5(N,4!Q>MLUP&CN/S<K\*UAX/;AP))O(&ZWTY%ZRR'+NOP=#,
M)N($J"_D[QB/[3T94]P1/)F6V TH#LD$XBOPIE:4S:8<D8I^,H?F*L6R:)@
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M  ,','   ^_F[=TV1685=4ZM3T1C)5D%"IW;#-92^&Y;FRZY834:07%/#X8
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M6"<W_<6U3,#W&[+9R$IG<_K@BFKJW+F'*C*!<0^&<<PMCXW.(GZ(_F8%J%J
MJFV"JGT7H&H!JA:8B7?S]I*GXJINNQD$$/Z<&]!@&B>-E&)AT1[Z/$8SP<.P
M'NDHBB[*(2U#AD5LOXHJBFG6>@_ EY-Q-> 3\Q!I0.4< P19+3_Q5TT8HFBX
MIR;7I*77-"E1;MAC1VR79@:W$%Z-%B5#8MR,/2N'3!S\ASQ^KIA9F98/3%+5
M&(4>@G^[=_2C@]N9)G.MK+@N9S"X!ENK;!Z602:Q\:7)%'37)UYS.KD"G[QZ
M^";\EIU*A=&A7"LV[8>/OK !()C+AJVQ[L<>9,7AZTX]+<<)UA_LHZ$=W,HM
M"C"<L<-PT@##&9&.&"/'5A2]\0K:)89-GC$>=(YB_]%F#3G,B;< %$?)*G#4
MN:$IQ4=<_RPKZZ6FWT;'IQQ[[&4;7:E;2#?NZ%$B6\)1P0\PW*!=C1R<-64,
M3&:%0V7X[9G.#3U!6[A0M,T0>2P/'J^2CZ@WY$=Y[LZJC64W9:/^/8XA,:+N
M1Q;DQ?[O1QM$=$%#;$'WX)@9Y';AS S'@^'JM4ECYM"YR+;G\63965!:=RXB
MJ&5R%)V4M>=@=&T_@>4%!L!_=V7!$+>+H<7J5S[@D^\L?. ML]44W4=P\8/*
MZ])F55P(T%^,0\=8,WRVY.N&J,:$8 F_6'$ UD2;)[K3)PX>7.EI;M(+['X1
MEWBAIW@UUNU#R8N'$=T9'Q8S&/,7W!M.[_W93^6_V?FD6"N<6D"FBX=WY^]N
MVX5NHG=\3.];RW\PT:@8O!-KKM3AVLE,M*JZUQQ]%?B26CGA'@V9/Y0A]O1!
M:AC4F%.OSB";LAB"%2K[NDY&Z?0<.DR8?4%IATX9,Q2+H^T)SUS=KCR54BC>
MM;6;8LH1!@XBB^2A(XAO9TS(FE,SU96PQ:QH:SL+$B]XJ3H/F:HV;U8N8.^\
MQ>[ Q9T3%Z]4;C2S=;48["$R9H6EZZ>13'#5A^7UL>]DCAZJ++G5R.16>V *
M]&IOD&NB8Q?5&;)/$6O-R@088F,;+E[BC[W5\FX8LU3SD:!MH*4F,KMYB<)3
M)#'FI%"N:?E9F[J53Z2+\M=S(\W0*J-03NTMZ8@X=@.J6\D&!$Y':V=D-IA3
MXG.@-4(*).OSH2AO<YWB9H$]065TW?>1ZEW@H6^IHJM!-511&I=T)-."<S!C
MB-FCVZW,B4&JZ;.@'V84%]#(@&F<=6_G "7)_ABTX/:.Q::]12 &J[ONS02A
M&L'*JHZ$KBS]%=W).5S-,A6(L/D0':BTU*P &F3:@KM0DK'<%I(37R=9?+&,
M0BJ3T^O;CI317=*WI3_L*H*B)MQ [<GI.V1F?'^AZ8]13<H;;0FZP@W8P1LP
M8/M)Q#>V: >0=5B]LX>^^W@V.MX(<QQR9B?+=:"2 8B-YS6SNTJP)NM4=Q!6
M)C'7A=^2**P;IBH*?+D[><AL@UCL,86[B+%#.@1KJ@_V,1XX)IGB]^,5X]DG
M(O6"=%X(#'&('\G4]T"+4GW?\>6SQJ]<ZG+^%:5$IN!8P8>BZS;+&3D^K52;
MMCE^$)[:I1R-#NX@PC@^F!X.QZ\.!\L*.BZ[D)\OS<@P*'4K:% W/H;@;1CD
M4?0:C3Q6NN&&[/8-Z1T'2\YBT_(KC);W#ZB:T++K-^ U(1AJ/8"6?;?S0-RK
M#Z!HGQ3_](^W$L"Y5^K1(;3Q([1WQ'@#+#/ ,C?!,K\/L,P RPRPS-V\O6L2
M>)^H:+S<@I>-(X7#Q3^EH#&M*V&<#\<]LLY2^]+T%/TTI$DS4FIG+XOSQV3B
MF4H49@5<^H?"*U$BYP#,H/G@2:BI5'J 60+3,Y998H!!PMACG_HJYZQP**B<
MY*8L-3/-/I:.7" <TIT^I*94>:#BG2(S*LM;SH3471H3/AQ\PDQZ,,?TB/Z]
M34%.LCE_!W. EP5<KCN<<+#X8!XAOZ0IJU8^3H:L=,H#(Y2MDW_#E#J*8Y.Y
MAC?NT3$=6_PPINA.A\IA#9YG)1<_5 #"1VAC_0?F=Z5 77ZN72!K+]M'C^]4
M!5K,L>/QP8D,7:2=%];IM471N5/77PMDV65;W:#&?L4T-\N17'=IY.KU0"G2
MGG^YILW8_@CWD6RUS8UT<T/<#7;U^'O=YGKA:0;;"&]*HJN&*QO@@\(!Y9L!
M7$@G6:^:+Q&!"8=:WJ7X%$3-7*LJS27I9<C]NG1 % T8:%PH@7H+["[SG)*H
M#,R.#>&TF8MAFQX:S4"F(#(F5?>QAS&3SLG\A9<]0<M<%<EZ>"]^;*&6CM<:
M338FB9=),\S*@EZ[^Q>4].B5]'%0TE: 7;F[$$[^V$_^@=JG<E$?&M(CX@(=
M=\WD53U:156+)N:H/*HMQIT)ZQ$Q'F' 1ZZ-[FO_S.E6QH5S587PH!$ZOEDN
M>AU#C%7T_.#Z4'Q%?]QE(H X;-I OR;RLXCY-253[Q%"6>H&I[HQC.I%SS)0
MU!DK;5,6;SY+(3BL21A4KC@X$DJBG'VU[XT8PWE8'@;*E[IB4G=QC>7[AOL-
ME#PB[#E<8E>/8K\U15X$%"V?@V=XK^YH<^&,\M>8)N(Z4[C(LC<!4R$S;?-I
MEM-HZ;$WAQ)"KQ&9*&&</)MGC3,8*FY.;+H?KE3V5%Q?9[$2U[K SN$Y%45=
MJ#I5?PSMK[#64QC(MU$L0M;$CQR9@22%+)+#+8CDGR3J:N*L7=S;WK@;+^!B
MC<7C.#@WU6I?O+EQ\!?__=WK]2F3>B"O0'2/=O7XT6BV]=.#77NUT<]'L]&G
MKHCVK;H]P;MK.+3^YM%D'M()V)\-?C&:#?Y5X?5$\PCV<QE=H<G<L\HK/5<9
M%:>!]9AC3C"1?H#$](9V9:?VH&_1$5\]6]O"];[)I?"IO_>NTNWX>$R=!'V7
MU%#AL/,FF=Y5=]2YH/N4'SA^/)(]CPXN:"OKPQ!>&WUX;:_Z2E\-AWYLD"WV
MHFPHT@Z.'QT2-[<)S-P9<]L89^-(45WFV'N@3BKMDY-[//5$]XT/6,WTA'!+
M"+?<K;/W9M?&$F/9HRT;30!EG_9L-+&0$.'8R6W[<T,9P:L9NU>S5ZW>UX,&
M@C\3_)G=E_Y[9&@%?V;GMBSX,SNX9\&?V<EM"_[,I_@S@1@H$ /A/)Y8#16(
M@0(QT,,2 X5@R>X%2_:J(=<OW,=/*S!9,#1A@AOI'I/3'Q^/1-/%_1 5&UBJ
M!6D"BYI0/8.+9[4+:;*1U;CS8G69[B?XS74%F\VL0MZ5;G,8;N-$CQ#N+:%9
ML84>-=)JH('7S"3>=K)K1@9_'X?Y,FM !B=K-\,  '=L@FNMP1!1#!'%W=NU
M$%'<N2T+$<4=W+,04=S);0L1Q8"0V$NG7^^3TW\UY!7>=4E:CA2LB1#LBXBL
M1U;.-/I].YB$S=J=S4H.F<-C/*3)W-[0=$N[S6JB9YNW38LMP1UM2J?)Z1Z$
MP>)H5M[J&^2"V;&YKIL9!<34$'QO:,-9Z8*VQ?]@,X*ZVT#1U9;"4T=_\4-0
M;9=W+035=F[+0E!M!_<L!-5V<MM&$U2[5Z#@*/J%\LB;&'KC =9!9/*C<@WJ
M,6SK&\ 4XJSR5"B)L;0"6X#&7LO/V+4CAE\BMYI:V]EA)7F-+W;&>5WFU#>4
M7]H.M Z-.]9\;"HL^N^J=#:?M%5M[7O;*'D?XR9CLNQ".'CTX>#I/H6#3^\B
M5'?U9RSBB06^<'5L'8(C\GY= SSOP7L5U=BQJ6Z&^:PI2)1NW>Y0@%K.F'8X
MR<N:]G_2UG!-L&5!T2E\]+HE^B?&:MYN0X+8]'.DMHW<A(XHV-:,C/AXHT65
MX6-*:7QLFX"]PC$8>\+@V_IV0<S/7C$7I&4#/8WB-PEHTY3@<F0"K$*B0G>"
M_=(>\+C0G< ($.%.&XDXQ )M:=29,$VX]3KF;2&$P%[;-VRHB<*I:3BJ"]+R
M&@0EA80WEFWW6Q,RF':#9@9)A,R#67$=FU2MY]3X"KKOS:#KAJWK-+]-Z.;M
M@UWS&NN*@4:0?Q#SL4CHMV_/XNC9]]]';_5'&$8#PO@4IMJ"BX2K_/>R^@#_
M^GMT_.C1X\=Q-%4?81V/HN=/GW_[[/GC;X^/GSR*HU/D3J2C&45_9<YU>$,+
M?E..3>A5EK^,?JA4FNOET;2"&<'6_?\$!W,$>W!"Q.UN+MT.P(,SNM(5;-@[
MD.US.%0MH:)!]K\IDJ,8AOK\672.72%_S/*\3D%5Q-%E"V<09]$9[=DLT]/H
M_*-.6E*%/WL-[5<F0GUPX- L:.]_S?(Y?/*L!8U21>^RY .<P>(Z^A$U$W[T
M55E5L+SOXNA%]&M9@8-Z56&?GS,J+8NCQ\\>17^%_2QNL6'P90/_;#J++O_"
M03]ZT1GV#U6FBNAOY:RHD=3T7-FVLP;V[\X:JMUDIHIKS:I1I6F%YPPUJ;D1
M<*YA\0E%8YHK2T/9U>?UF#*ILT(!0_6?RWUPVVH!Y@1</AI?Q\(<O('^7E-"
MA2\=MG6XG<$_O(9,U*F(B?TK'/T-WG]I%*F2.@.)H;%=0%&;;KH'I.85FB@9
MZ%;85YC:M,SS\O8PXF8#$^Q8I*.G+Y\\BA9'\R-O"\XHJ &R)\;/JN@'8Q^]
M@M4]4-@L:DJ]Q"8:'XC!AMAVEDSA,]+TH/=-L:X*D._XT41KV@/_,]+OP?]D
MYQ%"3@%#@\6P+9M0-D5L6^$J?0MV6WE=@&0%X08?**@91U*V52:'G=LZR%O,
M"[Z4^)^4>?IPMO!(E!AM=H+Y2-AHLL-O-*F 5,,URQJC)G3TR]'E481"-SJ0
MAF:LTRKJSDX7"/^*74*:MBJL48_Z3\,'P!^")S;J&DUBO5!9>G@4O4:ER#=Z
M0*/%$9.Q)"=?],Q\></(OWLC.5B\<^F)B-^Y5@6';%E <3][:9["#17GH/B2
M#$3H1!4?:G/LSH38Q@I-<+RB<B%!8.-1!D=J]([4D^!(N4 Z:O6ZQFZ+U)D"
MC)'K8D1^U2 H-2NDI3R*A0F8T? UIKQ" RF:9&QJVLI%DU)BQ\2X*"LM+.ON
M6E(3+;#7\XP;;0YWR)2VE_0-U_FRTE-=B2^Q3_3N8\%\F,;>T7O<2%TD[*JX
MYJ?6@<'OV#:_Z]QP!^#*BB1OI3E [[RYD(#B6VRCH.1Z'447X-/8]F1=ZTA_
M7)!SA([N?)%G:&-EJ#EA/BF_&08*4^%+X8(,["8UX+]U9B6-:#G<NO&6K(X:
M'T[$>M2<%N:=X>WQ>[51XS5.Y>++.)W*CA9WNQLR "6A"KZ03!;,U)7V&1YG
MWH7.O,@)>JD\0*+CX_&1G^B-R\OK!K:8X"QM8HNQ9 "!+2:PQ3PL6\RCK^*=
M;(,Y_5"WUPLV"G,JI^<P+VC"CXFT_Q)U[T7A]R!AO6,3W!H4Z)?;*0$4[-C\
M-E'2V/31L*F&MN9POU^RRYVGYAH>F\M=3M!"I^2#<P9=%V&YZ3#&,LI+^!0V
MYZ),AGTD&(0JFE3E!UV!7Z5R-ID;_+T7]+2)?@J07KHVP3CV\X^2)#FS^,00
MJAI]J.II"%4YK9OBTG';5(S8$G(FN@1OM1E5P,IYT3"!HKS-=7K-&5NJ\V+)
M06@A7(!O*YU3W731SB<82+I70$'16@KUO/J B7X4@PEAH".!3U>8XH?5C>4'
M.':@W MN-X\I3%5)+WO&:AD1YL&516#.P26_;,KD0Q!9HQ=9SX+(LO?YO&@R
MN#CV IY$I_"?E/]YB0:8%"2,27YU),X!!RS1>"*1E<QTVN9BT^B/LVR"-IIJ
M&H5_,7%#_*.#2 K8BP@$?8((_O A&6!-UK2-9C2GYE5W5;',%H@Q=YWBJQ'*
MR?X8N6R<-(0YS!=P- I=MK7[,H^4C@H(2IA''4<@4&;6T2/#LE*(OYF78B/V
MPJ B%:]5E1JA:,@+YS!U&(@)%YN@8T]N%X(J1;R6(:%AN"J\E".T$M[T$5[*
MCC&#!:I:>I0F+)&F:I3!W,9)Y&#'I&JT0^_(?,C"QO?2$W*P7]%HQJP)?*]5
M.:S98J$5P8W8QG9A:&<W%_ (3.!>RIF('GN-5 2((ZOE8]AX#'#2WG#(F360
M+9,N"X+OS!$I8T+M#C?KE",S0\8&$:RX>S<E(1I9X8P#W4E6)>T<:7P235'Q
MF<Y1N=Z SL P>9[#SN;XH+;0!14N$= 'W "S_HC+(S@++105$^&-B7[W&H-3
M]9( W>V(G<9FK-$PB8JL$OY1PUXL2G /< 0@[^S:9.1MR)AYQ/0$-^#89JVX
M%BOE9M==TDUO+7D%W0CI&E8M1?(MMNCN9:(SC> -.^=;Q6"DU<V:H#=6Y$LS
M8W^"<G#<DO16\M,G9YF>)FLAV90@Z?,LX/PK/<W9)%I-+00;:.PVT/-@ SFW
MC24K7O6WZO8$E$QA@+1_\\3?:"R@0<0!"G "-I+BC8W)(?)R5;C$5KI4" 7-
MU6UMA,QE(T$JBV,R<:JNA0&V39%DBYSA<)B]A6UHZ =\7 >5B](.=%165?JF
MQ+U"NI')'$TS>5I1%M^"B9&W->9P?;UEQE73N'!B4["R$)A,"J\&5[%I;-IY
M%8:%YA3S/,,O?U+%#(U!D/53HYG!54V-:I:^9'A]P(CQ@GB8N*:@>R%( H'3
M+AEEJ_B78N6QP\R3YKT86(!;!3.M8^=XLU)"NZJ&,] 8\Z!NT4.6%[ >$YQL
MS.9#KK*YKX/Q*1Y N$=CW5]:2_U"JQE[E5/K7XQOF=":RB@1-E 68$!D>"1A
M9=LY&SY"MDR >@L7V/S@; X_P_@-;GKM">(%M%/%BW,CB&QZ8EW;:T!V-M/3
MT.\GF@@3X0MR.\PB;!@:TN&HC- U!@0O2OPS4::'SHB@*<I:&1PY#$ML#1^I
MCA"-9K# VS](WB;*HK"8<)X,B(LR%<<%(4*T<6M6T-C*QHFP0(^^ 34$*,FS
M>6;/\JU:.O@%31^WP+Y,/@7"L-!^"0HL/8B48->,WJYY$>P:J^E_1?%&3@28
M,<OHJLI4/AHCAL+0J[!'"@6L%_5.=&1<U\.-4C$2T52$QUZB?ENB(#%!8E%Q
MK"4GJ@9Q0A SC'B )D0Q1CFXE1HU$Q+9K-Z#4!J]4/HN""7G;$UJ!)OB=7F=
MI6V2*;AM[S%#A%&-6;;8,0EU?T #R*P=F]NZF71$K\L UGT#\F40;2,7;0=J
MGPACV,28*73_-!H(XKM@ZW,.^8*:Q]@JHG6JN4LDY+JX;F9<7\$5B!'EL77E
MU1R[.S40)Z#XA3!V#+:BZE@6 =L=L-V;L-V/ [8[8+L#MGLW;Z]XMYPM5)AZ
MCZ;&DHXCE=YD=5D1K0,<WB+!BB-G78/F:FY1>0U7#5K=EL"9E]Q@SP\V.4GG
MU?:4#Z7MNY5-Z(G;\BIXP.U,4[[<O92&S>'/3'[JP5F)8H*^Q8B$^B18EV.W
M+B?[9%UV+$"X4VI!*4ED4+U1>:LH166A/K9I4_<WXH,E"+6I'7@@CJJL_F#3
M&:8-Z:??Y7#I1G_IDGV]=%;Y&67DE6P061A"[6RY/)%S@%\'2I8S@)C05&E4
M40T$WBS_5C$'"$:<L^*FS&\D=:[K1G)M:3;%XN5I56(J5D@D^TK:&]",($A>
MP0@ZD<@13024@FPR;Z#O^L/I.9S(_Y15#6=8\1?W-RA.\.%!*(Q=*.Q5<WC_
M:AB010_!*+B^?H;9 U34G123NE8(<34L@\3G4U&R"FZ<O6U1VC9\T1"+B$]=
M]YD[0D0KX:%[Y?M9LG *GD9=E!XC_8&QVID$A $M_._#@0B6YS9PK9DW!<ZE
ME95AG& $AL!6&!_1FZ]\HP !#<.;XE,94,/9O*ZLC".'Z:ZQJ&-6YF@@Q823
M*.A?:.*42\UDEN#M@$F$A _=!X7<W-@%V_'W(3=G!=^9BTF/JEYMA<T3R;M-
ME0&"_FY+B\CWXO(H)43ZLOG6!R=Y7)B,_*:Z#?/IIKQF>;F"G,(*  /VKK'&
MP%4_'!&NX;:LP),SA( \5 3@6Z(Y\R>L(=;I\.]5TU;:_0E?R,]%?&6&%758
M3=(,%.&Q9'74O().2\#LC?W>?: *RH2+-DR-WPK;*9%X>CRTAAXHFZMK!G["
M7C(EH]T2._K:,) :%>NH22T!JD84>U4668):=:[\BI[8(D\)1*:XBL$LTB*=
MKJX<3-3^#MYA?OW[XMK\^I +:OHO]P9]UP!>P:I=8O4W$9JEY43C3X>\]RV;
M_L-/IH((]Q<D)<4=O>N%9)1(\LFM''_;A/KBZ)KH>NF?7"[NN&7Q=X8QDRI2
M0*U6O"7><)#XL#YTU\3@;O&(<VT%XQ%CKO) HZ)3X<%V!D8#-QT**M"HA3=W
MH<!V^)91.3R?;S]HO2#-OZP;/;^/X:8< )QL.&<]X#=?"UCXW$WTTNT(7)2_
MYN5$BE4NA#"62DHU%L&<)M+UQX*A&1X]_#1\QGO9U--$+#1[#]>.<_VN,^89
M/BW()>&+^Z7(\++XH[CR_<-3/B?^1\\<:>59F>JCZ)6ARB6?T6V4DR,3+G;J
MY#A-")>$\!S9G/O7VCM0/O]PL,7&;HL]?K2UMMA8,LI?WJ9\S[S9?AT&DX<@
M-3_(DO>Z+G.R;N"?U_B&L5B>05Z-7%[M%_AIM9B9PT7$''16<EL!I!,0JVX"
M%Q_?XU4/*;\:AB-2Z@YI$+L$E0V/2Z.D50)-8RV9P'>/4@EM-2KN'>IM>)OU
M.WV9.GBT7L5JE&9,=CBW99NG_590_/2[Q!RZ1>O&WXG>]R8!(X5?^[5Z7.+N
MU=^!Q89V&-F9%-Y28@8._3V(J=&+J;W*HG^*F**K\<./9^3NG*[2J_U9(NR5
MGJHV;Z+W3/0V&(NGH;K8%#A:Z*YUT@:4<>RW57*?A9^+,KHF;[X*$-!Q&.P/
M-8\G3P($-$!  P1T-V^O8Y41.IZ>ADFL76JUP^?;I<'@W,5#$A!D7ZJ+=(W9
M",>B-/J(GNF$\OC12&RA=66*5K>+$$&E^_+XR=&3)T_^\V0KS*0=7&R34%UQ
MNVS6=291%LPF$A:HYBRWWQ+6YF75RM>S@@,IE(5<9^2&'?WS=G0B6%9X=[.&
M*NKX,5D=9T<1VHTO3J+C[YX>'WPX/-JY_;G+R/Z3[\J D;W]:[2#9]B(DVZ
MR,H4 C;XU4_<]A:DT\N=VYUP@D=Y@K''L[)J,9%SK+OG6 G0EU1HYGHN&YUY
M#SE^=O3ZZ+V5XX^?/3[Z[O'!Y'#W]CC<@Y'>@\&+@'UV'^X:/'UQ] 0O0516
M.[?'X1Z,]1X,7H37EV\>[AX\^>[Q$6J#8->'6[ 5M\"<_DY\_)Z1!GLQ_(!"
M=#]OMW,M?%OI.$9E\1B#Y'A9X$=5>[C><''"Q=FJB[,Y6=1SD$VU#/HB/G+^
ME5Z4==9$;XJZK>BB&&P[MSNX;J6>&,$5\S:_YE(2QYV-'R7#[BIK<AV]>6/\
M\%=EFG[[&I[Y(?H5;^=E4VG=8$]KA*PSKPF\= [/>%>5C42N/^WMX4[^&W<R
MK$=8C[ >6[(>,I&O@LN:E'GZ8&OZVWN_9<X[=0TZ@OZ620N#'W)0$?^XSZ*O
MX T>8MD_\QP^/((GP ,#/)#@@4^WXV $>.!G+1N18NR(EON: G<';^8;DX $
MQZ7D%BH54K!@GQ[-?8>%"Z9+$[>1]S&.%KE6R!M5$J=+0BW!^<,T5=MQ$9Z3
ME[?2^DA1-T?P[72,E([@+RU*04'EFKI&KE ?J&B2"6^=*Q/>-+2C(8FZC1OC
MV-TW^8E/Z?)_?;#P#I[\_\5:\Z9JX:0OR[:JXUU:[RT2OMNX/#OG<9S]_.OY
M171Z\2HZ^_FG=Z<7?X^CMV_/=FG)PXD,R[-=%_:!]<</RY=?O /+ET=G__,O
M]5^BG[)DIG0>_036V6SYS_[_PD%[V)* "S77<-:ZN_!-6/6'777*#<&R?X,]
M6M4U^ABOB)WR?J"<;5GZH'C"\H3EV2&Y]J!^QNG9V?F[J_-7"!.1G'>J&AW6
M_ '7?)I5-4QH4M[HZ+9"LH7B7C#_;5GP( /&=1ZOSM]?7$;O?CQ]_]/IV?DO
M5V_.3M]>QM&;B[-[05.V9=W#L0S+LUVW]DL$'/8EXJ"J#]'_PN:5N5J)-X2(
MPP.?-!-P\#8AK/C#MD"68$,4G<TRC;VL"U402/;GZ31+]-J0PQ<&>'T6$F#/
M<$;;>+[6)I.__FV]X_1\-];#$[!(H\<B?2V!_& NZ5=@!SK[\?S5+V_/H^,M
M6?#/PI;2]YGF%^3\RW:QT%6B:KU36T$U,(B'?GMZ=O[3^<55=/'SU9NS\ZW>
MF"V5#-\>/SMZ\MVS_SQ9J!3A:]VJGV QW[W6KRN8W#=7NBKJZ-U,P;L2W399
MHO(ZCMX4R=I85MB&/Q6XE+S\YK=__O->M1!AM?]M-[%\&7WC.LC:_H0>5BQX
M(O=3%R,Y$9?,)6Z/Q6E#23T,W>@&@P?P[4)ZC3T]<7T\+TJ0E6OS?E]X+\8#
MIW^KTDQSWZV_PF]R7.RUR;ZPRI^YRN_:JFY5T?@4CKSH'K4^_L'K38_?5D)'
M0G^[5+GV:8E-V< &DR(ZP"^:6O;11^)%O8RD!LWV6XQ=-<B*%HT.]FAW80'&
MMK>$9DFCW[9O7I?+.?CM]Y[.]-'DQ9<^@P^U._^(H\>/'C_9,^EI-<M(=M&3
MGV\BK,Z;+*-*_]%B3ZE.(W6_[L[O Z_S/&H7J)I_PV<]2Z8G_\"*/FQ4VOT:
MO^K[DYI:QL+#J>LZM5O'5J^MCOX#S*%'CXZQ?0T_ H1Z@WU>LR*;M_-HSO;O
MH@(C%Q_^']XK[7>.(C$"ZIDT.+C&EEZ%A<79IF!L+7NT3;@L6=%B5623Y=%O
MKTZOSO\1_89_DAEA<YVZS--_W"L0L:VINST+G.]M)C,DHT(R*B2C[IV,>KPE
M"[Y3.8]M3<[MT@D40^2=JIK,M3;>G\#25UKV7B1D?];[H:/7\)\9V,^7,&A5
MJ7DL\+?SCSIIJ?_M=L'?QK/R/K8SWG+0X7A6_8=JJ8KH[R7V7>8U_QF\49!B
MQ;59<Y,[(*;3,Y@=^,W;O0_[:VZ$!=E#2\"+FN_/:C^T-A)J@[\=&7:#>]?<
MAS7_S#7_-<OS3,VCUR7\M_XFK/B#K_AI6F6J**-WF:ZJ\E_?_"^Y<I6NL]1+
M$X3E_M-,W%3G&I1!=-F4M]^<UG699!N*W7<AXCH:VV'7:EC#8FQ96#FD:D*J
M)J1J0JKFKE3-DRU9\)"JV;-4#>8,=%'3Z[9DS4>">1<\D>F?ME!9BD AN]J"
M,GH""VJ 13##FAHR)5JG=32MRCFSD1/^!XO:+#+^DO$[BT&,L0$$67#7UT'W
M!(,Q+,8#+D:PG8/MO+NQBFUNN31:,3-V?^+\XRR;9$WTXF!^^*>56CXHS=^6
M4+[LM]\3EN-SEF-$<N/GUZ_?G)V_C^#_KM[ /T^OO@Y?1CB(8S)QOMIZ[&"T
MX,KV+J-F[#%7]V#;IS]:F.LTTREAKG2N$ZP='*";Q/_%Z/M_J5*NA^7_W5#@
M/)):M2]>Q;L=N.0=WS6_0CMZI7-UBT5TL)P+6=$X2DMXK!0?)KI"$87U_'6;
MS*)$P<BSAIO]K:U(/,"_%F5COU8R[M+5'&)#P9LL!>%@'PDC\N.!HZ]=O93.
M]NN\G1T\7.8<]&D?N&!\]#L:^?\;R9:&*O]MVHVO6N7_M;+,76$RDIUT;!H;
M6^FND*?$7.XO";,)$0.PT/U0E+>Y3J^U^85GD&])!FVW',#0Y?K3_('L\!OT
M RL-;Z_A=XI)H? $@Y%9@5V7K;!0H(4X>KO 6'K/1R*[UIEY!Z>'1C#!&N-O
MR/B_XT 0B8>C%). 0>)]6'],]*+/,-:@AP*GIP(?AFJ[X+MSL#.K#+X/#DI9
M13_)C]%I>@.2$ [=3!772&,"KVRJELE&I!D[>C/X8[=I%_E!\/-M)AW::S6G
M3N["5**G4_PN?"F;PCAQHG6^A(&D>N,#8YF4=&4OZSOO#8G]>J'5!Z0\T? 2
M?K#"7R:X8OQ\^MHL@W6_U4/3Y&_1QN#GF:CKX(?/W3GT\KS=PRO=VT&8H-O
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MJF^-B!VJB4B+;^YI@YV<'"ZP.$^]SNL'X7CDH4.9DT[E*<[<E3&7:ZWPK*5
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M<FXM,C R,S U,34N:'1M4$L! A0#%     @ B86O5@G0I!D. P  K0D  !$
M             ( !%1@  '1E<FXM,C R,S U,34N>'-D4$L! A0#%     @
MB86O5MZ+:3H3!@  ZS@  !4              ( !4AL  '1E<FXM,C R,S U
M,35?;&%B+GAM;%!+ 0(4 Q0    ( (F%KU:>8E[/SP0  +HI   5
M      "  9@A  !T97)N+3(P,C,P-3$U7W!R92YX;6Q02P$"% ,4    " ")
MA:]6FM?-2F.K  ![P 8 #@              @ &:)@  =&5R;BUE>#%?,2YH
M=&U02P$"% ,4    " ")A:]6"!=$#B0+   F2   #@              @ $I
GT@  =&5R;BUE>#5?,2YH=&U02P4&      8 !@!\ 0  >=T

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
